Processing 00000000.tx.1: High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy Rosa Rademakers1,, Stacey Melquist4,, Marc Cruts1, Jessie Theuns1, Jurgen Del-Favero1, Parvoneh Poorkaj7,8,9,10, Matt Baker4, Kristel Sleegers1, Richard Crook4, Tim De Pooter1, Samira Bel Kacem1, Jennifer Adamson4, Dirk Van den Bossche1, Marleen Van den Broeck1, Jennifer Gass4, Ellen Corsmit1, Peter De Rijk1, Natalie Thomas5, Sebastiaan Engelborghs2,3, Michael Heckman6, Irene Litvan11, Julia Crook6, Peter P. 

Phrase: "High-density SNP haplotyping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0018591:Haplotype [Organism Attribute]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "altered regulation of tau gene expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C0017263:Regulation of Gene Expression [Genetic Function]
           Gene Expression Regulation
           Gene Regulation
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "in progressive supranuclear palsy Rosa Rademakers1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: ", Stacey Melquist4,"

Phrase: ", Marc Cruts1,"

Phrase: "Jessie Theuns1,"

Phrase: "Jurgen Del-Favero1,"

Phrase: "Parvoneh Poorkaj7,"

Phrase: "8,"

Phrase: "9,"

Phrase: "10,"

Phrase: "Matt Baker4,"

Phrase: "Kristel Sleegers1,"

Phrase: "Richard Crook4,"

Phrase: "Tim De Pooter1,"

Phrase: "Samira Bel Kacem1,"

Phrase: "Jennifer Adamson4,"

Phrase: "Dirk Van den Bossche1,"

Phrase: "Marleen Van den Broeck1,"

Phrase: "Jennifer Gass4,"

Phrase: "Ellen Corsmit1,"

Phrase: "Peter De Rijk1,"

Phrase: "Natalie Thomas5,"

Phrase: "Sebastiaan Engelborghs2,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "Michael Heckman6,"

Phrase: "Irene Litvan11,"

Phrase: "Julia Crook6,"

Phrase: "Peter P."
Processing 00000000.tx.2: De Deyn2,3, Dennis Dickson5, Gerard D. 

Phrase: "De Deyn2,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "Dennis Dickson5,"

Phrase: "Gerard D."
Processing 00000000.tx.3: Schellenberg7,8,9,10, Christine Van Broeckhoven1,*, and Michael L. 

Phrase: "Schellenberg7,"

Phrase: "8,"

Phrase: "9,"

Phrase: "10,"

Phrase: "Christine Van Broeckhoven1,"

Phrase: "*,"

Phrase: "and"

Phrase: "Michael L."
Processing 00000000.tx.4: Hutton4, 1Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, 2Division of Neurology, Middelheim Hospital, 3Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Belgium, 4Department of Neuroscience, 5Department of Pathology and 6Biostatistics Unit, Mayo Clinic, Jacksonville, FL, USA and 7Department of Medicine, 8Department of Neurology, 9Department of Pharmacology and 10Geriatric Research Education and Clinical Center, Seattle Veterans Affairs Medical Center, University of Washington, Seattle, WA, USA and 11University of Louisville School of Medicine, Louisville, KY, USA * To whom correspondence should be addressed at: Department of Molecular Genetics (VIB8), Neurodegenerative Brain Diseases Research Group, University of Antwerp, Building V  Room 0.10, Universiteitsplein 1, B-2610 Antwerpen, Belgium. 

Phrase: "Hutton4,"

Phrase: "1Department of Molecular Genetics,"

Phrase: "Flanders Interuniversity Institute for Biotechnology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "2Division of Neurology,"

Phrase: "Middelheim Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "3Laboratory of Neurochemistry"

Phrase: "and"

Phrase: "Behavior,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0004927:Behavior [Individual Behavior]
  1000   C2707008:Behavior [Clinical Attribute]
   928 E C2986890:Behavioral [Idea or Concept]

Phrase: "Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021622:institute [Organization]
  1000   C1272753:Institute [Idea or Concept]

Phrase: "Born-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004897:Bear [Mammal]

Phrase: "Bunge,"

Phrase: "University of Antwerp,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Belgium,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: "4Department of Neuroscience,"

Phrase: "5Department of Pathology"

Phrase: "and"

Phrase: "6Biostatistics Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439148:Unit [Quantitative Concept]
   861   C1519795:Unit [Quantitative Concept]
   861   C1704753:Unit [Manufactured Object]
   861   C1880519:Unit [Quantitative Concept]

Phrase: "Mayo Clinic,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   861   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   789 E C0205210:Clinical [Qualitative Concept]

Phrase: "Jacksonville,"

Phrase: "FL,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "and"

Phrase: "7Department of Medicine,"

Phrase: "8Department of Neurology,"

Phrase: "9Department of Pharmacology"

Phrase: "and"

Phrase: "10Geriatric Research Education"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0013621:Education [Educational Activity]
   827   C0013622:education [Classification]
   827   C0013658:Education, NOS [Finding]
   827   C0039401:Education [Educational Activity]
   755 E C1555905:Educational [Intellectual Product]

Phrase: "and"

Phrase: "Clinical Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2347782:Clinical Center [Organization]
   861   C0205099:Center [Spatial Concept]

Phrase: "Seattle Veterans Affairs Medical Center,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1549054:Veterans Affairs [Organization]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0042610:Veterans [Population Group]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]
   771 E C3245459:veteran [Intellectual Product]

Phrase: "University of Washington,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C0043038:Washington [Geographic Area]

Phrase: "Seattle,"

Phrase: "WA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043038:WA [Geographic Area]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "and"

Phrase: "11University of Louisville School of Medicine,"

Phrase: "Louisville,"

Phrase: "KY,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed at"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0376649:Address [Intellectual Product]
   799   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Department of Molecular Genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587466:Genetics department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "(VIB8"

Phrase: ")"

Phrase: ","

Phrase: "Neurodegenerative Brain Diseases"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   901   C0006111:Brain Diseases [Disease or Syndrome]
   827   C0012634:Diseases [Disease or Syndrome]
   755 E C1836721:MALS [Finding]
   755 E C3538764:MALS [Gene or Genome]
   755 E C3540595:MAL [Gene or Genome]

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "Group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "University of Antwerp,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Building"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1547706:Building [Functional Concept]
  1000   C1999269:Building [Manufactured Object]
   966 E C1707059:Build [Conceptual Entity]

Phrase: "V  Room 0.10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1547703:Room [Spatial Concept]

Phrase: "Universiteitsplein 1,"

Phrase: "B-2610 Antwerpen,"

Phrase: "Belgium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]
Processing 00000000.tx.5: Tel: +32 32651001; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+32 32651001"

Phrase: ";"
Processing 00000000.tx.6: Fax: +32 32651012; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+32 32651012"

Phrase: ";"
Processing 00000000.tx.7: Email: christine.vanbroeckhoven{at}ua.ac.be  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Two extended haplotypes exist across the tau geneH1 and H2with H1 consistently associated with increased risk of progressive supranuclear palsy (PSP). 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "christine.vanbroeckhoven{at}ua.ac."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1412573:AC [Gene or Genome]
   804   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   804   C3539770:AC [Gene or Genome]

Phrase: "be"

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Two extended haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "exist across the tau geneH1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]
   760   C2987476:Exist [Conceptual Entity]

Phrase: "and"

Phrase: "H2with H1 consistently"

Phrase: "associated with increased risk of progressive supranuclear palsy (PSP)."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   800   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   770   C0270920:Supranuclear palsy [Disease or Syndrome]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0035647:Risk [Qualitative Concept]
   744   C0205217:Increased [Quantitative Concept]
   744   C0205329:Progressive [Functional Concept]
   744   C0442805:Increased [Functional Concept]
   744   C0522224:Palsy [Finding]
   739   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.8: Using 15 haplotype tagging SNPs (htSNPs), capturing >95% of MAPT haplotype diversity, we performed association analysis in a US sample of 274 predominantly pathologically confirmed PSP patients and 424 matched control individuals. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "15 haplotype tagging SNPs (htSNPs),"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   844   C2985510:Tagging SNP [Nucleotide Sequence]
   812   C0752046:SNPs [Nucleotide Sequence]
   779 E C1527094:SNP [Conceptual Entity]

Phrase: "capturing"

Phrase: ">95% of MAPT haplotype diversity,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0018591:Haplotype [Organism Attribute]
   760   C1446659:MAPT [Gene or Genome]
   760   C1880371:Diversity [Qualitative Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "association analysis in a"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "US"

Phrase: "sample of 274 predominantly pathologically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "PSP patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030705:Patients [Patient or Disabled Group]
   756   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "and"

Phrase: "424 matched control individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]
Processing 00000000.tx.9: We found that PSP risk is associated with one of two major ancestral H1 haplotypes, H1B, increasing from 14% in control individuals to 22% in PSP patients (P<0.001). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that PSP risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0035647:Risk [Qualitative Concept]
   756   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "is"

Phrase: "associated with one of two major ancestral H1 haplotypes,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   742   C0018591:Haplotypes [Organism Attribute]
   742   C0205164:Major [Qualitative Concept]
   742   C0205447:One [Quantitative Concept]
   742   C0205448:Two [Quantitative Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "H1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415389:H1B [Gene or Genome]

Phrase: "increasing from 14%"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0442808:Increasing [Functional Concept]
   756 E C0442805:Increase [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "in control individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "to 22%"

Phrase: "in PSP patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030705:Patients [Patient or Disabled Group]
   756   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "(P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.10: In young PSP patients, the H1B risk could be localized to a 22kb regulatory region in intron 0 (P<0.001) and could be fully explained by one SNP, htSNP167, creating a LBP-1c/LSF/CP2 site, shown to regulate the expression of genes in other neurodegenerative disorders. 

Phrase: "In young PSP patients,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030705:Patients [Patient or Disabled Group]
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "the H1B risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035647:Risk [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "localized to a 22kb regulatory region"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
   753   C0220905:regulatory [Regulation or Law]
   753   C0392752:Localized [Spatial Concept]
   753   C1704735:Regulatory [Conceptual Entity]

Phrase: "in intron 0"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "could"

Phrase: "be"

Phrase: "fully"

Phrase: "explained by one SNP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205447:One [Quantitative Concept]
   770   C0752046:SNP [Nucleotide Sequence]
   770   C1527094:SNP [Conceptual Entity]

Phrase: "htSNP167,"

Phrase: "creating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706214:Create [Activity]
   966   C3244320:create [Functional Concept]

Phrase: "a LBP-1c/LSF/CP2 site,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0205145:Site [Spatial Concept]
   804   C1515974:Site [Body Location or Region]
   804   C2825164:Site [Spatial Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "the expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in other neurodegenerative disorders."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
  1000   C1522560:Neurodegenerative Disorders [Functional Concept]
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.11: Luciferase reporter data indicated that the 182bp conserved regulatory region, in which htSNP167 is located, is transcriptionally active with both alleles differentially influencing expression. 

Phrase: "Luciferase reporter data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the 182bp"

Phrase: "conserved"

Phrase: "regulatory region,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "in which htSNP167"

Phrase: "is"

Phrase: "located"

Phrase: ","

Phrase: "is"

Phrase: "transcriptionally active with both alleles differentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205177:Active [Functional Concept]

Phrase: "influencing"

Phrase: "expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.12: Further, we replicated the htSNP167 association in a second, independently ascertained US PSP patientcontrol sample. 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "we"

Phrase: "replicated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205173:replicated [Functional Concept]
   966 E C0205341:Replicate [Functional Concept]
   966 E C1883725:Replicate [Qualitative Concept]

Phrase: "the htSNP167 association in a second,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "independently"

Phrase: "ascertained"

Phrase: "US PSP patientcontrol sample."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0370003:Sample [Substance]
   804   C2347026:Sample [Conceptual Entity]
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
Processing 00000000.tx.13: However, the htSNP association showed that H1 risk alone could not explain the overall differences in H1 and H2 frequencies in PSP patients and control individuals. 

Phrase: "However,"

Phrase: "the htSNP association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that H1"

Phrase: "risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "explain"

Phrase: "the overall differences in H1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "H2 frequencies in PSP patients"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   748   C0439603:Frequencies [Temporal Concept]
   714 E C0376249:frequency [Quantitative Concept]
   714 E C0871396:Frequency [Quantitative Concept]
   714 E C1561548:Frequency [Qualitative Concept]
   714 E C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "control individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]
Processing 00000000.tx.14: Thus, risk variants on different H1 htSNP haplotypes and protective variants on H2 contribute to population risk for PSP.  

Phrase: "Thus,"

Phrase: "risk variants on different H1 htSNP haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:variants [Qualitative Concept]

Phrase: "and"

Phrase: "protective variants on H2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205419:variants [Qualitative Concept]

Phrase: "contribute to population risk"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0242444:population risk [Population Group]
   833   C2987720:Population risk [Quantitative Concept]
   770   C0032659:Population [Quantitative Concept]
   770   C0035647:Risk [Qualitative Concept]
   770   C1257890:Population [Population Group]
   770   C1880177:Contribute [Activity]

Phrase: "for PSP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]
Processing 00000000.tx.15: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Progressive supranuclear palsy (PSP) is the second most common form of parkinsonism after Parkinson disease (PD) (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Progressive supranuclear palsy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "(PSP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: ")"

Phrase: "is"

Phrase: "the second most common form of parkinsonism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "after Parkinson disease (PD)"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: Distinctive clinical features include vertical supranuclear gaze and pseudobulbar palsy, early postural instability and progressive subcortical dementia (2). 

Phrase: "Distinctive clinical features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1521970:Feature [Qualitative Concept]
   793   C1706388:Feature [Conceptual Entity]
   793   C2346469:Feature [Qualitative Concept]
   793   C2348519:Feature [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "vertical supranuclear gaze"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0553544:Gaze [Finding]

Phrase: "and"

Phrase: "pseudobulbar palsy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033790:Pseudobulbar Palsy [Disease or Syndrome]
   861   C0522224:Palsy [Finding]

Phrase: "early postural instability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1843921:Postural instability [Finding]
   827   C1444783:Instability [Finding]

Phrase: "and"

Phrase: "progressive subcortical dementia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C0743039:Dementia, progressive [Disease or Syndrome]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.17: Abundant subcortical neurofibrillary tangles (NFTs) and neuropil threads of hyperphosphorylated tau protein characterize PSP neuropathologically. 

Phrase: "Abundant subcortical neurofibrillary tangles (NFTs)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   827 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "neuropil"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0228081:Neuropil [Cell Component]

Phrase: "threads of hyperphosphorylated tau protein"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   797 E C1421563:protein tau [Gene or Genome]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1710394:Thread [Manufactured Object]
   760   C1720655:Tau [Intellectual Product]
   760   C1882475:Thread [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "characterize"

Phrase: "PSP neuropathologically."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   861   C0270920:Supranuclear palsy [Disease or Syndrome]
   847   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   812   C0205329:Progressive [Functional Concept]
   812   C0522224:Palsy [Finding]
Processing 00000000.tx.18: The deposition of hyperphosphorylated tau in neurons as fibrillar structures of varying morphology is also seen in other neuropathological disorders including Alzheimer's disease (AD), frontotemporal dementia (FTD), Pick's disease, corticobasal degeneration (CBD) and argyrophilic grain disease, collectively known as tauopathies. 

Phrase: "The deposition of hyperphosphorylated tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333562:Deposition [Functional Concept]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "as fibrillar structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "of varying morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "is"

Phrase: "also"

Phrase: "seen in other neuropathological disorders"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0012634:Disorders [Disease or Syndrome]
   760   C0205397:Seen [Qualitative Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD"

Phrase: ")"

Phrase: ","

Phrase: "frontotemporal dementia (FTD),"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0236642:frontotemporal dementia [Disease or Syndrome]
  1000   C0338451:Frontotemporal dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "Pick's disease,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0236642:Pick's Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C1707391:Pick [Activity]
   861   C1826583:PICK [Gene or Genome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "corticobasal degeneration (CBD)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0393570:Corticobasal degeneration [Disease or Syndrome]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "and"

Phrase: "argyrophilic grain disease,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0007757:Grain [Food]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0086369:Grain [Plant]
   827   C1552950:Grain [Quantitative Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "collectively"

Phrase: "known as tauopathies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205309:Known [Qualitative Concept]
   790   C0949664:Tauopathies [Disease or Syndrome]
Processing 00000000.tx.19: Tau is a microtubule (MT)-associated protein that promotes MT assembly, increases MT stability and plays a role in maintaining neuronal integrity and axonal transport (3,4). 

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "a microtubule (MT)-associated protein"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0026046:Micro-tubule [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]

Phrase: "that"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "MT assembly,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "MT stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205360:Stability [Qualitative Concept]
   861   C2347098:Stability [Qualitative Concept]
   789 E C1547311:Stable [Intellectual Product]

Phrase: "and"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in maintaining neuronal integrity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "axonal transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0004462:Axonal Transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]
   789   C0004461:Axon [Cell Component]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.20: Tau binding to MT is mediated by imperfect repeats of 31 or 32 amino acid residues encoded by exons 912 of the tau gene (MAPT, MT-associated protein tau) located at 17q21.31. 

Phrase: "Tau binding to MT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1149274:microtubule binding [Molecular Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "mediated by imperfect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "repeats of 31"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205341:Repeat [Functional Concept]
   790   C0450355:31 [Intellectual Product]
   790   C1547730:Repeat [Temporal Concept]
   790   C1705914:Repeat [Conceptual Entity]

Phrase: "or"

Phrase: "32 amino acid residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "encoded by exons 912 of the tau gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0017337:Gene [Gene or Genome]
   744   C0679058:encoded [Mental Process]
   744   C1720655:Tau [Intellectual Product]
   744   C1947974:Tau [Research Activity]
   744   C2700640:Encoded [Activity]

Phrase: "(MAPT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1446659:MAPT [Gene or Genome]

Phrase: "MT-associated protein tau"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1446659:MICROTUBULE-ASSOCIATED PROTEIN TAU [Gene or Genome]
  1000   C2700455:Microtubule-Associated Protein Tau [Amino Acid, Peptide, or Protein]
   923   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0085401:Microtubule protein tau [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1421563:protein tau [Gene or Genome]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332281:Associated [Qualitative Concept]
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")"

Phrase: "located at 17q21.31."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1711405:17q21.31 [Cell Component]
   770   C0450355:31 [Intellectual Product]
   770   C1520768:17q21 [Cell Component]
Processing 00000000.tx.21: In adult human brain, six major tau isoforms are generated by alternative mRNA splicing (5). 

Phrase: "In adult human brain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0001675:Human, Adult [Age Group]

Phrase: "six major tau isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "generated by alternative mRNA splicing"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0086934:mRNA splicing [Genetic Function]
   797   C0002345:Alternative Splicing [Genetic Function]
   760   C0035687:Splicing [Genetic Function]
   760   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1523987:Alternative [Conceptual Entity]
   760   C2610186:splicing [Genetic Function]
   760   C3146294:Generated [Activity]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.22: Alternative splicing of exon 10 results in two major classes of tau isoforms with three repeat (3R) or four repeat (4R) MT binding domains. 

Phrase: "Alternative splicing of exon 10 results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002345:Alternative Splicing [Genetic Function]
   753   C0035687:Splicing [Genetic Function]
   753   C2610186:splicing [Genetic Function]

Phrase: "in two major classes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456387:Class [Intellectual Product]
   827   C1705943:Class [Classification]

Phrase: "of tau isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "with three repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205341:Repeat [Functional Concept]
   861   C1547730:Repeat [Temporal Concept]
   861   C1705914:Repeat [Conceptual Entity]

Phrase: "(3R"

Phrase: ")"

Phrase: "or"

Phrase: "four repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205341:Repeat [Functional Concept]
   861   C1547730:Repeat [Temporal Concept]
   861   C1705914:Repeat [Conceptual Entity]

Phrase: "(4R"

Phrase: ")"

Phrase: "MT binding domains."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C1149274:microtubule binding [Molecular Function]
   827   C0026046:Micro-tubule [Cell Component]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.23: In PSP, selective deposition of 4R tau isoforms was observed, although 3R and 4R levels in soluble tau were normal suggesting that alternative splicing of exon 10 is not altered in PSP (6). 

Phrase: "In PSP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "selective deposition of 4R tau isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0333562:Deposition [Functional Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "although"

Phrase: "3R"

Phrase: "and"

Phrase: "4R levels in soluble tau"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that alternative splicing of exon 10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002345:Alternative Splicing [Genetic Function]
   753   C0035687:Splicing [Genetic Function]
   753   C2610186:splicing [Genetic Function]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered in PSP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   806   C0270920:Supranuclear palsy [Disease or Syndrome]
   770   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   760   C0205329:Progressive [Functional Concept]
   760   C0392747:Altered [Functional Concept]
   760   C0522224:Palsy [Finding]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.24: Identification of MAPT mutations in rare familial forms of FTD with parkinsonism linked to chromosome 17 (FTDP-17) pointed to a central role of tau pathology in neurodegeneration (79). 

Phrase: "Identification of MAPT mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "in rare familial forms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C1832428:Familial form [Finding]
   827   C0348078:forms [Qualitative Concept]
   827   C0376315:Forms [Manufactured Object]
   793 E C1522492:Form [Functional Concept]

Phrase: "of FTD"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0236642:frontotemporal dementia [Disease or Syndrome]
  1000   C0338451:Frontotemporal dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "with parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "linked to chromosome 17"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0008659:Chromosome 17 [Cell Component]
   770   C0008633:Chromosome [Cell Component]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "(FTDP-17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0338451:FTDP-17 [Disease or Syndrome]
  1000   C1446659:FTDP-17 [Gene or Genome]
  1000   C2697954:FTDP-17 [Gene or Genome]

Phrase: ")"

Phrase: "pointed to a central role of tau pathology"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   750   C2924612:Point A [Body Location or Region]
   744   C0030664:Pathology [Biomedical Occupation or Discipline]
   744   C0035820:Role [Social Behavior]
   744   C0205099:Central [Spatial Concept]
   744   C0205469:pathology [Functional Concept]
   744   C0677042:pathology [Pathologic Function]
   744   C1705810:Role [Conceptual Entity]
   744   C1720655:Tau [Intellectual Product]
   744   C1879652:Central - [Laboratory Procedure]
   744   C1947974:Tau [Research Activity]
   711   C1552961:Point [Quantitative Concept]
   711   C2347617:point [Quantitative Concept]

Phrase: "in neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "(79"

Phrase: ")."
Processing 00000000.tx.25: Forty different MAPT mutations have been identified (http://www.molgen.ua.ac.be/FTDMutations) in patients that were clinically and pathologically characterized by variable neurodegenerative conditions including atypical PSP (10,11). 

Phrase: "Forty different MAPT mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.molgen.ua.ac."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1412573:AC [Gene or Genome]
   812   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   812   C3539770:AC [Gene or Genome]

Phrase: "be/"

Phrase: "FTDMutations"

Phrase: ")"

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "that"

Phrase: "were"

Phrase: "clinically"

Phrase: "and"

Phrase: "pathologically"

Phrase: "characterized by variable neurodegenerative conditions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0439828:Variable [Qualitative Concept]
   760   C1880022:Characterized [Activity]
   756   C0013675:Variable, Conditional [Functional Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "atypical PSP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   861   C0270920:Supranuclear palsy [Disease or Syndrome]
   847   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   812   C0205329:Progressive [Functional Concept]
   812   C0522224:Palsy [Finding]

Phrase: "(10,"

Phrase: "11"

Phrase: ")."
Processing 00000000.tx.26: In addition to the highly penetrant MAPT mutations, common genetic variations have been identified in MAPT, which constituted two major MAPT haplotypes (H1 and H2) in a 1.3Mb genomic region (1215). 

Phrase: "In addition to the highly penetrant MAPT mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "common genetic variations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0042333:Variations, Genetic [Natural Phenomenon or Process]
   827   C0205419:variations [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified in MAPT,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205396:Identified [Qualitative Concept]
   790   C1446659:MAPT [Gene or Genome]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "which"

Phrase: "constituted"

Phrase: "two major MAPT haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018591:Haplotypes [Organism Attribute]

Phrase: "(H1"

Phrase: "and"

Phrase: "H2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0919509:H2 [Gene or Genome]
  1000   C1419394:H2 [Gene or Genome]

Phrase: ")"

Phrase: "in a 1.3Mb genomic region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   804   C0017428:Genomic [Gene or Genome]
   804   C0017446:Region [Geographic Area]
   804   C0205147:Region [Spatial Concept]
   804   C0887950:genomic [Biomedical Occupation or Discipline]
   733 E C0205276:Regional [Spatial Concept]
   733 E C1947913:Regional [Spatial Concept]

Phrase: "(1215"

Phrase: ")."
Processing 00000000.tx.27: Association of the common haplotype H1 (80%) with increased PSP risk has been consistently replicated in different Caucasian populations worldwide (12,1619). 

Phrase: "Association of the common haplotype H1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "(80%"

Phrase: ")"

Phrase: "with increased PSP risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0035647:Risk [Qualitative Concept]
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "has"

Phrase: "been"

Phrase: "consistently"

Phrase: "replicated in different Caucasian populations worldwide"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0007457:Caucasian [Population Group]
   753   C0032659:Population [Quantitative Concept]
   753   C0043157:Caucasian [Population Group]
   753   C0205173:replicated [Functional Concept]
   753   C1257890:Population [Population Group]
   753   C1705242:Different [Qualitative Concept]
   719 E C0205341:Replicate [Functional Concept]
   719 E C1883725:Replicate [Qualitative Concept]

Phrase: "(12,"

Phrase: "1619"

Phrase: ")."
Processing 00000000.tx.28: Significant H1 associations were also reported in two CBD populations (20,21) and in a genetically homogeneous PD population from Norway (22,23). 

Phrase: "Significant H1 associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0004083:Associations [Mental Process]
   793 E C0439849:Association [Qualitative Concept]
   793 E C0596306:Association [Phenomenon or Process]
   793 E C0699792:association [Social Behavior]

Phrase: "were"

Phrase: "also"

Phrase: "reported in two CBD populations"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0393570:Corticobasal degeneration [Disease or Syndrome]
   753   C0011164:Degeneration [Pathologic Function]
   753   C0032659:Population [Quantitative Concept]
   753   C0205448:Two [Quantitative Concept]
   753   C0684224:Reported [Intellectual Product]
   753   C0700287:Reported [Health Care Activity]
   753   C1257890:Population [Population Group]
   753   C1880269:Degeneration [Functional Concept]
   753   C3496591:Reported [Clinical Attribute]
   719 E C3273238:Report [Intellectual Product]

Phrase: "(20,"

Phrase: "21"

Phrase: ")"

Phrase: "and in a genetically homogeneous PD population"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0030567:Parkinson Disease [Disease or Syndrome]
   770   C1521736:Parkinson's Disease [Functional Concept]
   770   C2681933:PARKINSON DISEASE [Gene or Genome]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0032659:Population [Quantitative Concept]
   744   C1257890:Population [Population Group]
   744   C1515981:And [Idea or Concept]
   744   C1881065:Homogeneous [Qualitative Concept]

Phrase: "from Norway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028423:Norway [Geographic Area]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.29: Recently, Stefansson etal. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "Stefansson etal."
Processing 00000000.tx.30: (24) and we (25) showed that MAPT is flanked by inverted low copy repeats that likely mediated inversion of the 570kb MAPT segment, explaining the extended LD and suppressed H1/H2 recombination in the MAPT region. 

Phrase: "(24"

Phrase: ")"

Phrase: "and"

Phrase: "we (25"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that MAPT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1446659:MAPT [Gene or Genome]

Phrase: "is"

Phrase: "flanked by inverted low copy repeats"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C2717928:Low-Copy Repeats [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205251:low [Qualitative Concept]
   753   C0205341:repeats [Functional Concept]
   753   C0443241:Inverted [Qualitative Concept]
   753   C1299352:Low [Qualitative Concept]
   753   C1550472:low [Idea or Concept]
   753   C1705914:Repeats [Conceptual Entity]
   753   C1948062:Copy [Manufactured Object]
   719   C0230171:Flank [Body Location or Region]
   719 E C1547730:Repeat [Temporal Concept]

Phrase: "that likely mediated inversion of the 570kb MAPT segment,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0021943:Inversion [Cell or Molecular Dysfunction]
   742   C0021945:Inversion [Anatomical Abnormality]
   742   C1705687:Inversion [Cell or Molecular Dysfunction]
   742   C2349984:Inversion [Spatial Concept]

Phrase: "explaining"

Phrase: "the extended LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "and"

Phrase: "suppressed H1/H2 recombination in the MAPT region."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0034865:Recombination [Genetic Function]
Processing 00000000.tx.31: To investigate whether specific genetic variants in MAPT on the H1 haplotype are responsible for the increased PSP risk, we analyzed a highly informative panel of 15 haplotype tagging SNPs (htSNPs) for genetic association in a large US PSP patientcontrol sample. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "specific genetic variants in MAPT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:variants [Qualitative Concept]

Phrase: "on the H1 haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: "are"

Phrase: "responsible for the increased PSP risk,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "a highly informative panel of 15 haplotype tagging SNPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0441833:Panel [Idea or Concept]
   742   C1999270:Panel [Intellectual Product]
   742   C3537156:Panel [Manufactured Object]

Phrase: "(htSNPs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C2985510:Tagging SNP [Nucleotide Sequence]
   827   C0752046:SNPs [Nucleotide Sequence]
   793 E C1527094:SNP [Conceptual Entity]

Phrase: ")"

Phrase: "for genetic association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1328885:genetic association [Occupation or Discipline]
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "in a large"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549177:Large [Quantitative Concept]

Phrase: "US PSP patientcontrol sample."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0370003:Sample [Substance]
   804   C2347026:Sample [Conceptual Entity]
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
Processing 00000000.tx.32: To optimize our chances to finemap the associated genetic susceptibility in MAPT, we stratified the large US sample for age and PSP pathology. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "optimize"

Phrase: "our chances to finemap"

Phrase: "the associated genetic susceptibility in MAPT,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0314657:Genetic Susceptibility [Organism Attribute]
   753   C0012655:Susceptibility [Clinical Attribute]
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0220898:Susceptibility [Organism Attribute]
   753   C0314603:Genetic [Functional Concept]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "we"

Phrase: "stratified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205363:Stratified [Qualitative Concept]

Phrase: "the large"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549177:Large [Quantitative Concept]

Phrase: "US"

Phrase: "sample for age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001779:Age [Organism Attribute]
   790   C0370003:Sample [Substance]
   790   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "PSP pathology."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0030664:Pathology [Biomedical Occupation or Discipline]
   812   C0205469:pathology [Functional Concept]
   812   C0677042:pathology [Pathologic Function]
   756   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   741 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.33: The association was subsequently replicated in a second independently ascertained US PSP patientcontrol sample.  

Phrase: "The association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "subsequently"

Phrase: "replicated in a second independently"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0205173:replicated [Functional Concept]
   760   C0205436:Second [Quantitative Concept]
   760   C0457385:Second [Temporal Concept]
   760   C0565930:/second [Quantitative Concept]
   760   C1561503:second [Idea or Concept]
   760   C1705190:Second [Qualitative Concept]
   726 E C0205341:Replicate [Functional Concept]
   726 E C1883725:Replicate [Qualitative Concept]

Phrase: "ascertained"

Phrase: "US PSP patientcontrol sample."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0370003:Sample [Substance]
   804   C2347026:Sample [Conceptual Entity]
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
Processing 00000000.tx.34: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  H1H2 extended haplotype association We genotyped htSNP16 in the US patientcontrol sample and analyzed association with the MAPT extended haplotypes H1 and H2 in the overall sample as well as in the age and pathology strata (Table 1). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "H1H2"

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "haplotype association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "We"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "htSNP16 in the"

Phrase: "US patientcontrol sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "analyzed association with the MAPT extended haplotypes H1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "H2 in the overall sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0919509:H2 [Gene or Genome]
   760   C1419394:H2 [Gene or Genome]

Phrase: "as well as in the age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0205170:Well [Qualitative Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "pathology strata"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.35: In the overall sample, highly significant association was calculated for H1/H1 versus H1/H2+H2/H2 with an odds ratios (OR) for PSP of 3.9 (95% CI 2.65.9). 

Phrase: "In the overall sample,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "highly significant association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
   734   C1299395:Highly significant [Qualitative Concept]

Phrase: "was"

Phrase: "calculated for H1/H1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444686:Calculated [Functional Concept]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]

Phrase: "versus"

Phrase: "H1/H2+H2/H2 with an odds ratios (OR)"

Phrase: "for PSP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "of 3.9"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442760:3/9 [Finding]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "(95% CI 2.65.9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0067503:CI-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0450385:65 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.36: The strongest H1/H1 risk association was obtained in the subgroups of young PSP (OR=5.1; 95% CI 2.610.1) and PSP-pure (OR=4.1; 95% CI 2.18.1) patients. 

Phrase: "The strongest H1/H1 risk association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0004083:Association [Mental Process]
   804   C0439849:Association [Qualitative Concept]
   804   C0596306:Association [Phenomenon or Process]
   804   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "obtained in the subgroups of young PSP"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   764   C0270920:Supranuclear palsy [Disease or Syndrome]
   742   C0205329:Progressive [Functional Concept]
   742   C0332239:Young [Temporal Concept]
   742   C0522224:Palsy [Finding]
   742   C1079230:subgroups [Virus]
   742   C1301820:Obtained [Functional Concept]
   734   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   708 E C1515021:Subgroup [Classification]
   708 E C1706701:Obtain [Activity]

Phrase: "(OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "=5.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "; 95% CI 2.610.1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C0067503:CI-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "PSP-pure"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C2247561:PurE [Molecular Function]
   756   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   741 E C1882508:Purity [Quantitative Concept]

Phrase: "(OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "=4.1"

Phrase: "; 95% CI 2.18.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C1417647:CI-18 [Gene or Genome]
   840   C0067503:CI-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: "patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.37: View this table: [in this window] [in a new window]  Table1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table1."
Processing 00000000.tx.38: MAPT H1H2 extended haplotype association  Single H1 htSNP associations We genotyped the 14 H1 htSNPs in the four LD blocks along MAPT in the US patientcontrol sample (Fig.1A). 

Phrase: "MAPT H1H2"

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "haplotype association  Single H1 htSNP associations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0004083:Associations [Mental Process]

Phrase: "We"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "the 14 H1 htSNPs in the four LD"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   739   C2985510:Tagging SNP [Nucleotide Sequence]
   738   C0752046:SNPs [Nucleotide Sequence]
   704 E C1527094:SNP [Conceptual Entity]

Phrase: "blocks along MAPT"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0028778:Block [Pathologic Function]
   790   C0332206:Block [Functional Concept]
   790   C1446659:MAPT [Gene or Genome]
   790   C1533157:Block [Substance]
   790   C1706084:Block [Geographic Area]
   790   C2828370:Block [Quantitative Concept]

Phrase: "in the"

Phrase: "US patientcontrol sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "(Fig.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.39: In the overall sample, significant allelic associations were seen with five htSNPs with the strongest association observed with htSNP167 in block 2 resulting from a significant 11.6% increase of the allele A (OR=1.6; 95% CI 1.22.0; P<0.001) (Table 2). 

Phrase: "In the overall sample,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "significant allelic associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0004083:Associations [Mental Process]
   793 E C0439849:Association [Qualitative Concept]
   793 E C0596306:Association [Phenomenon or Process]
   793 E C0699792:association [Social Behavior]

Phrase: "were"

Phrase: "seen with five htSNPs"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   773   C2985510:Tagging SNP [Nucleotide Sequence]
   753   C0018591:Haplotype [Organism Attribute]
   753   C0205397:Seen [Qualitative Concept]
   753   C0205451:Five [Quantitative Concept]
   753   C0752046:SNPs [Nucleotide Sequence]
   719   C0037293:Tag [Neoplastic Process]
   719 E C0042789:see [Organism Function]
   719   C0181496:Tag [Manufactured Object]
   719 E C1527094:SNP [Conceptual Entity]
   719   C1710492:TAG [Gene or Genome]
   719 E C1947903:See [Activity]

Phrase: "with the strongest association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "observed with htSNP167"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "in block 2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0028778:Block [Pathologic Function]
   861   C0332206:Block [Functional Concept]
   861   C1533157:Block [Substance]
   861   C1706084:Block [Geographic Area]
   861   C2828370:Block [Quantitative Concept]
   789 E C2983591:BLOCKED [Research Activity]

Phrase: "resulting from a significant 11.6% increase"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0237881:significant [Quantitative Concept]
   748   C0442805:Increase [Functional Concept]
   748   C0678226:resulting [Functional Concept]
   748   C0750502:Significant [Idea or Concept]
   748   C1546944:Significant [Qualitative Concept]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "of the allele A (OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0028873:Odds Ratios [Quantitative Concept]
   812   C0456603:Ratios [Quantitative Concept]
   812   C1610540:*Ratios [Quantitative Concept]
   779 E C1547037:Ratio [Intellectual Product]

Phrase: "=1.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; 95% CI 1.22.0"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   853   C0962010:CI 22 [Carbohydrate,Lipid]

Phrase: "; P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.40: Significant associations were also observed with three htSNPs located within MAPThtSNP364, htSNP510 and htSNP519and htSNP563 localized 3' of exon 13/14 (Fig.1A). 

Phrase: "Significant associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0004083:Associations [Mental Process]
   827 E C0439849:Association [Qualitative Concept]
   827 E C0596306:Association [Phenomenon or Process]
   827 E C0699792:association [Social Behavior]

Phrase: "were"

Phrase: "also"

Phrase: "observed with three htSNPs"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   773   C2985510:Tagging SNP [Nucleotide Sequence]
   753   C0018591:Haplotype [Organism Attribute]
   753   C0205449:Three [Quantitative Concept]
   753   C0752046:SNPs [Nucleotide Sequence]
   753   C1441672:Observed [Functional Concept]
   719   C0037293:Tag [Neoplastic Process]
   719   C0181496:Tag [Manufactured Object]
   719 E C1527094:SNP [Conceptual Entity]
   719   C1710492:TAG [Gene or Genome]

Phrase: "located within MAPThtSNP364,"

Phrase: "htSNP510"

Phrase: "and"

Phrase: "htSNP519and htSNP563"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "3'"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "of exon 13/14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Fig.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.41: Genotypic association was only significant for htSNP167 (OR A/A versus A/G+G/G=1.7; 95% CI 1.12.5; P=0.008) (data not shown). 

Phrase: "Genotypic association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "only significant for htSNP167"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237881:significant [Quantitative Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]

Phrase: "(OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "A/"

Phrase: "A"

Phrase: "versus"

Phrase: "A/G+G/G=1.7"

Phrase: "; 95% CI 1.12.5"

Phrase: "; P=0.008"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.42: Association analyses in the age-strata showed allelic association in patients with age at death 75 only with htSNP167 in LD block 2, whereas in patients with age at death 76, the same five htSNPs as in the overall analysis gave significant association (Table 2). 

Phrase: "Association analyses in the age-strata"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "allelic association in patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "with age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "at death 75 only"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0011065:Death [Organism Function]
   827   C0205171:Only [Quantitative Concept]
   827   C1306577:Death, NOS [Finding]
   827   C1720467:Only [Intellectual Product]

Phrase: "with htSNP167"

Phrase: "in LD block 2,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   861   C0023746:Linkage Disequilibrium [Quantitative Concept]
   812   C0023745:linkage [Molecular Function]
   812   C0028778:Block [Pathologic Function]
   812   C0281825:Disequilibrium [Finding]
   812   C0332206:Block [Functional Concept]
   812   C0394006:Disequilibrium [Disease or Syndrome]
   812   C1533157:Block [Substance]
   812   C1706084:Block [Geographic Area]
   812   C2828370:Block [Quantitative Concept]
   741 E C2983591:BLOCKED [Research Activity]

Phrase: "whereas in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "with age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "at death 76,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]

Phrase: "the same five htSNPs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   823   C2985510:Tagging SNP [Nucleotide Sequence]
   804   C0752046:SNPs [Nucleotide Sequence]
   771 E C1527094:SNP [Conceptual Entity]

Phrase: "as in the overall analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0282416:Overall [Intellectual Product]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1561607:Overall [Qualitative Concept]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "significant association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.43: The htSNP167 association was strongest in young PSP patients and resulted from an increased allele A frequency of 15% (age at death 75: OR=2.2; 

Phrase: "The htSNP167 association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "strongest in young PSP patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0442821:Strong [Qualitative Concept]

Phrase: "and"

Phrase: "resulted from an increased allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0002085:Allele [Gene or Genome]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "A frequency of 15%"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0376249:frequency [Quantitative Concept]
   770   C0439603:Frequency [Temporal Concept]
   770   C0871396:Frequency [Quantitative Concept]
   770   C1561548:Frequency [Qualitative Concept]
   770   C1705502:Frequency [Quantitative Concept]

Phrase: "(age at death 75"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   909   C1543138:Age at death [Clinical Attribute]
   909   C1546180:Age at death [Clinical Attribute]
   819   C0742983:age death [Finding]
   770   C0001779:Age [Organism Attribute]

Phrase: ":"

Phrase: "OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "=2.2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ";"
Processing 00000000.tx.44: 95% CI 1.63.1; 

Phrase: "95% CI 1.63.1"

Phrase: ";"
Processing 00000000.tx.45: P<0.001 and age at death 76: OR=1.5; 

Phrase: "P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "age at death 76"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   909   C1543138:Age at death [Clinical Attribute]
   909   C1546180:Age at death [Clinical Attribute]
   819   C0742983:age death [Finding]
   770   C0001779:Age [Organism Attribute]

Phrase: ":"

Phrase: "OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "=1.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.46: 95% CI 1.12.0; 

Phrase: "95% CI 1.12.0"

Phrase: ";"
Processing 00000000.tx.47: P=0.005). 

Phrase: "P=0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.48: In addition, logistic regression analysis in the overall sample showed evidence of an interaction of age with the allele A of htSNP167 with the OR approximately doubling with a reduction of 10 years in age (OR=2.0; 95% CI 1.33.0; P=0.002). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "logistic regression analysis in the overall sample"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0681925:logistic regression analysis [Research Activity]
   778   C0034980:Regression Analysis [Intellectual Product]
   774   C1303103:Sample analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "evidence of an interaction of age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "with the allele A"

Phrase: "of htSNP167"

Phrase: "with the OR approximately"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0028873:Odds Ratios [Quantitative Concept]
   827   C0456603:Ratios [Quantitative Concept]
   827   C1610540:*Ratios [Quantitative Concept]
   793 E C1547037:Ratio [Intellectual Product]

Phrase: "doubling with a reduction of 10 years"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0205173:doubling [Functional Concept]
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0439234:years [Temporal Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]
   748   C1705764:Doubling [Activity]
   714 E C0439508:/year [Temporal Concept]
   714 E C1705765:Double [Qualitative Concept]

Phrase: "in age (OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0028873:Odds Ratios [Quantitative Concept]
   827   C0456603:Ratios [Quantitative Concept]
   827   C1610540:*Ratios [Quantitative Concept]
   793 E C1547037:Ratio [Intellectual Product]

Phrase: "=2.0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "; 95% CI 1.33.0"

Phrase: "; P=0.002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.49: Allelic association with htSNP167 was also stronger in the PSP-pure patients (P<0.001) compared with the PSP-plus patients (Table 2). 

Phrase: "Allelic association with htSNP167"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "also stronger in the PSP-pure patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0442821:Strong [Qualitative Concept]

Phrase: "(P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared with the PSP-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   790   C0270920:Supranuclear palsy [Disease or Syndrome]
   756   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   753   C0205329:Progressive [Functional Concept]
   753   C0522224:Palsy [Finding]
   753   C1707455:Compared [Activity]

Phrase: "plus patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.50: As expected from the high proportion (63%) of patients with an age at death 75 included in the PSP-pure group and the high proportion (65%) of patients with an age at death 76 in the PSP-plus group, the genetic findings in the PSP-pure and PSP-plus groups largely mirrored the association results obtained in the young and old PSP patients. 

Phrase: "As"

Phrase: "expected from the high proportion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C1517001:Expected [Idea or Concept]
   760   C1709707:Proportion [Quantitative Concept]
   760   C2700149:HIGH [Intellectual Product]

Phrase: "(63%"

Phrase: ")"

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with an age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "at death 75"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]

Phrase: "included in the PSP-pure group"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   800   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   770   C0270920:Supranuclear palsy [Disease or Syndrome]
   744   C0205329:Progressive [Functional Concept]
   744   C0332257:included [Functional Concept]
   744   C0441833:Group [Idea or Concept]
   744   C0522224:Palsy [Finding]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1552516:Group [Health Care Related Organization]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]
   744   C2247561:PurE [Molecular Function]
   744   C3538986:INCLUDED [Gene or Genome]
   739   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   711 E C1552866:include [Idea or Concept]
   711 E C2700399:Include [Activity]

Phrase: "and"

Phrase: "the high proportion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1709707:Proportion [Quantitative Concept]
   789 E C0205351:Proportional [Qualitative Concept]

Phrase: "(65%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")"

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with an age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "at death 76"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]

Phrase: "in the PSP-plus group,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "the genetic findings in the PSP-pure"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   748   C0730319:Genetic finding [Laboratory or Test Result]
   742   C2607943:findings [Functional Concept]
   742   C2926606:Findings [Clinical Attribute]
   742   C3539655:Findings [Intellectual Product]
   720 E C0559563:Birth finding [Finding]
   708 E C0037088:Finding [Sign or Symptom]
   708 E C0243095:Finding [Finding]
   708 E C2825141:Finding [Finding]
   706 E C0577203:Genital finding [Finding]

Phrase: "and"

Phrase: "PSP-plus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332287:Plus [Qualitative Concept]
   756   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "largely"

Phrase: "mirrored"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0181868:mirrored [Manufactured Object]
   966 E C1706183:Mirror [Manufactured Object]

Phrase: "the association results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "obtained in the young"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0332239:Young [Temporal Concept]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "old PSP patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030705:Patients [Patient or Disabled Group]
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
Processing 00000000.tx.51: Further stratified association analyses were therefore only performed in the young and old PSP groups. 

Phrase: "Further stratified association analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "therefore only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "performed in the young"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0332239:Young [Temporal Concept]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "old PSP groups."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1552839:groups [Idea or Concept]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
Processing 00000000.tx.52: View larger version (26K): [in this window] [in a new window]  Figure1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure1."
Processing 00000000.tx.53: Schemeof MAPT genomic structure. 

Phrase: "Schemeof MAPT genomic structure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.54: MAPT exons (black boxes) are not drawn to scale, H1 SNPs located <1kb apart in the genomic sequence are shown together at one position and htSNPs are in bold. 

Phrase: "MAPT exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(black boxes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0179400:boxes [Manufactured Object]
   861   C1638312:Boxes [Quantitative Concept]
   827 E C1533124:Box [Medical Device]

Phrase: ")"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "drawn to scale,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0175659:Scale [Medical Device]
   790   C0349674:Scale [Intellectual Product]
   790   C1947916:Scale [Activity]
   790   C3536777:Scale [Manufactured Object]
   756   C0013113:Draw [Intellectual Product]
   718 E C1710017:Scalar [Qualitative Concept]
   706 E C0222045:Scales [Body Part, Organ, or Organ Component]

Phrase: "H1 SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0752046:SNPs [Nucleotide Sequence]
   827 E C1527094:SNP [Conceptual Entity]

Phrase: "located"

Phrase: "<1kb apart in the genomic sequence"

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "together at one position"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205447:One [Quantitative Concept]
   770   C0733755:Position [Spatial Concept]
   770   C1883357:Together [Qualitative Concept]

Phrase: "and"

Phrase: "htSNPs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C2985510:Tagging SNP [Nucleotide Sequence]
   827   C0752046:SNPs [Nucleotide Sequence]
   793 E C1527094:SNP [Conceptual Entity]

Phrase: "are in bold."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1551058:Are [Quantitative Concept]
Processing 00000000.tx.55: (A) Fourteen htSNPs respective to their LD blocks (gray boxes). 

Phrase: "(A) Fourteen htSNPs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   823   C2985510:Tagging SNP [Nucleotide Sequence]
   804   C0752046:SNPs [Nucleotide Sequence]
   771 E C1527094:SNP [Conceptual Entity]

Phrase: "respective to their LD blocks"

Phrase: "(gray boxes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0179400:boxes [Manufactured Object]
   861   C1638312:Boxes [Quantitative Concept]
   827 E C1533124:Box [Medical Device]

Phrase: ")."
Processing 00000000.tx.56: (B) Frequent H1 SNPs located within the 63kb region selected for sliding window haplotypes analysis. 

Phrase: "(B) Frequent H1 SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0752046:SNPs [Nucleotide Sequence]
   779 E C1527094:SNP [Conceptual Entity]

Phrase: "located within the 63kb region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]

Phrase: "selected for sliding window haplotypes analysis."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0018591:Haplotypes [Organism Attribute]
   753   C0332246:Sliding [Functional Concept]
   753   C0557702:Window [Manufactured Object]
   753   C0936012:Analysis [Research Activity]
   753   C1272706:Window [Temporal Concept]
   753   C1524024:analysis [Functional Concept]
   753   C1704674:Window [Manufactured Object]
   719 E C0444330:Slide [Research Device]
   719 E C1705201:Slide [Manufactured Object]
   719   C1707391:Select [Activity]
Processing 00000000.tx.57: (C) Rare SNPs located within the 22kb candidate region, of which SNP164 and SNP205 were observed only in the PSP patients (Supplementary Material, Table S1). 

Phrase: "(C) Rare SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0752046:SNPs [Nucleotide Sequence]
   793 E C1527094:SNP [Conceptual Entity]

Phrase: "located within the 22kb candidate region, of which SNP164"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0017446:Region [Geographic Area]
   742   C0205147:Region [Spatial Concept]

Phrase: "and"

Phrase: "SNP205"

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "only in the PSP patients"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   778   C0270920:Supranuclear palsy [Disease or Syndrome]
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0205171:Only [Quantitative Concept]
   748   C0205329:Progressive [Functional Concept]
   748   C0522224:Palsy [Finding]
   748   C1720467:Only [Intellectual Product]
   746   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]

Phrase: "(Supplementary Material,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936424:Supplementary Material [Intellectual Product]
   861   C0520510:Material [Substance]

Phrase: "Table S1"

Phrase: ")."
Processing 00000000.tx.58: (D) Conservation plot extracted from the UCSC genome browser. 

Phrase: "("

Phrase: "D)"

Phrase: "Conservation plot"

Phrase: "extracted from the UCSC genome browser."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0017428:Genome [Gene or Genome]
   753   C0185115:Extracted [Therapeutic or Preventive Procedure]
   753   C1883464:UCSC [Organization]
   753   C2338314:Genome [Conceptual Entity]
   753   C3541890:EXTRACTED [Finding]
   719 E C2828366:Extract [Substance]
Processing 00000000.tx.59: Peaks represent sequences with >50% conservation in chimpanzee, dog, mouse and rat.  

Phrase: "Peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:peaks [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "sequences with"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   833   C0162326:Sequences [Nucleotide Sequence]
   799 E C0004793:Sequence [Nucleotide Sequence]
   799 E C0162327:Sequence [Nucleotide Sequence]
   799 E C1519249:Sequence [Functional Concept]
   750 E C1548958:Sequential [Idea or Concept]
   750 E C1705294:Sequential [Qualitative Concept]

Phrase: ">50% conservation in chimpanzee,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347858:Conservation [Qualitative Concept]

Phrase: "dog,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012984:Dog [Mammal]
  1000   C1280551:Dog [Mammal]

Phrase: "mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]
Processing 00000000.tx.60: View this table: [in this window] [in a new window]  Table2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table2."
Processing 00000000.tx.61: Single H1 htSNP allelic associations  H1 htSNP subhaplotype associations We estimated htSNP subhaplotype frequencies in LD blocks 1, 3 and 4 in the US patientcontrol sample; 

Phrase: "Single H1 htSNP allelic associations  H1 htSNP subhaplotype associations"

Phrase: "We"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "htSNP subhaplotype frequencies in LD"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4 in the"

Phrase: "US patientcontrol sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.62: LD block 2 with only one htSNP is represented by allelic frequencies of htSNP167. 

Phrase: "LD block 2 with only one htSNP"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0023746:Linkage Disequilibrium [Quantitative Concept]
   744   C0023745:linkage [Molecular Function]
   744   C0028778:Block [Pathologic Function]
   744   C0205171:Only [Quantitative Concept]
   744   C0205447:One [Quantitative Concept]
   744   C0281825:Disequilibrium [Finding]
   744   C0332206:Block [Functional Concept]
   744   C0394006:Disequilibrium [Disease or Syndrome]
   744   C1533157:Block [Substance]
   744   C1706084:Block [Geographic Area]
   744   C1720467:Only [Intellectual Product]
   744   C2828370:Block [Quantitative Concept]

Phrase: "is"

Phrase: "represented by allelic frequencies of htSNP167."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   773   C0017270:allelic frequency [Quantitative Concept]
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]
   719   C1882932:Represent [Activity]
Processing 00000000.tx.63: In the overall sample, htSNP subhaplotype distributions were significantly different in blocks 1 and 4 (Table 3). 

Phrase: "In the overall sample,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "htSNP subhaplotype distributions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0037775:Distributions [Spatial Concept]
   793 E C0520511:distribution [Idea or Concept]
   793 E C1704711:Distribution [Functional Concept]

Phrase: "were"

Phrase: "significantly different in blocks 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "4"

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.64: In LD block 1, the association was primarily accounted for by a 9% increase of H1-B1B (CGTGT) (PH1-B1B=0.002), and in LD block 4 by an 8% increase of H1-B4C (GCTG) (PH1-B4C=0.002). 

Phrase: "In LD block 1,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   861   C0023746:Linkage Disequilibrium [Quantitative Concept]
   812   C0023745:linkage [Molecular Function]
   812   C0028778:Block [Pathologic Function]
   812   C0281825:Disequilibrium [Finding]
   812   C0332206:Block [Functional Concept]
   812   C0394006:Disequilibrium [Disease or Syndrome]
   812   C1533157:Block [Substance]
   812   C1706084:Block [Geographic Area]
   812   C2828370:Block [Quantitative Concept]
   741 E C2983591:BLOCKED [Research Activity]

Phrase: "the association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "primarily"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by a 9% increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "of H1-B1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1180679:B1b [Body Part, Organ, or Organ Component]

Phrase: "(CGTGT"

Phrase: ")"

Phrase: "(PH1-B1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1180679:B1b [Body Part, Organ, or Organ Component]

Phrase: "=0.002"

Phrase: ")"

Phrase: ","

Phrase: "and in LD block 4"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0023746:Linkage Disequilibrium [Quantitative Concept]
   753   C0023745:linkage [Molecular Function]
   753   C0028778:Block [Pathologic Function]
   753   C0281825:Disequilibrium [Finding]
   753   C0332206:Block [Functional Concept]
   753   C0394006:Disequilibrium [Disease or Syndrome]
   753   C1515981:And [Idea or Concept]
   753   C1533157:Block [Substance]
   753   C1706084:Block [Geographic Area]
   753   C2828370:Block [Quantitative Concept]

Phrase: "by an 8% increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "of H1-B4C"

Phrase: "(GCTG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415027:GCTG [Gene or Genome]

Phrase: ")"

Phrase: "(PH1-B4C"

Phrase: "=0.002"

Phrase: ")."
Processing 00000000.tx.65: Although not significant, we also observed a 5% increased frequency of H1-B3B (GCGG) in LD block 3. 

Phrase: "Although"

Phrase: "not significant,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "we also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a 5% increased frequency of H1-B3B"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]

Phrase: "(GCGG"

Phrase: ")"

Phrase: "in LD block 3."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   861   C0023746:Linkage Disequilibrium [Quantitative Concept]
   812   C0023745:linkage [Molecular Function]
   812   C0028778:Block [Pathologic Function]
   812   C0281825:Disequilibrium [Finding]
   812   C0332206:Block [Functional Concept]
   812   C0394006:Disequilibrium [Disease or Syndrome]
   812   C1533157:Block [Substance]
   812   C1706084:Block [Geographic Area]
   812   C2828370:Block [Quantitative Concept]
   741 E C2983591:BLOCKED [Research Activity]
Processing 00000000.tx.66: Moreover, highly significant association was observed for the ancestral H1 subhaplotype, H1B (CGTGT-A-GCGG-GCTG), increasing from 14% in control individuals to 22% in PSP patients (P=0.002). 

Phrase: "Moreover,"

Phrase: "highly significant association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
   734   C1299395:Highly significant [Qualitative Concept]

Phrase: "was"

Phrase: "observed for the ancestral H1 subhaplotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1441672:Observed [Functional Concept]

Phrase: "H1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415389:H1B [Gene or Genome]

Phrase: "(CGTGT-A-GCGG-GCTG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1415027:GCTG [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "increasing from 14%"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0442808:Increasing [Functional Concept]
   756 E C0442805:Increase [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "in control individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "to 22%"

Phrase: "in PSP patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030705:Patients [Patient or Disabled Group]
   756   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "(P=0.002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.67: Haplotype association analysis in the age strata indicated that htSNP subhaplotype distributions for LD blocks 1, 3 and 4 were not associated within the subgroup of young PSP patients (Table 4). 

Phrase: "Haplotype association analysis in the age strata"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that htSNP subhaplotype distributions for LD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0037775:Distributions [Spatial Concept]
   714 E C0520511:distribution [Idea or Concept]
   714 E C1704711:Distribution [Functional Concept]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated within the subgroup of young PSP patients"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   782   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   760   C0270920:Supranuclear palsy [Disease or Syndrome]
   739   C0030705:Patients [Patient or Disabled Group]
   739   C0205329:Progressive [Functional Concept]
   739   C0332239:Young [Temporal Concept]
   739   C0332281:Associated [Qualitative Concept]
   739   C0522224:Palsy [Finding]
   739   C1079230:subgroup [Virus]
   739   C1515021:Subgroup [Classification]
   730   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   706 E C0750490:Associate [Idea or Concept]
   706 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.68: In the old PSP patients, htSNP subhaplotype distributions in blocks 1, 3 and 4 were significantly different only in LD block 4 (P=0.046). 

Phrase: "In the old PSP patients,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030705:Patients [Patient or Disabled Group]
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "htSNP subhaplotype distributions in blocks 1,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0037775:Distributions [Spatial Concept]
   719 E C0520511:distribution [Idea or Concept]
   719 E C1704711:Distribution [Functional Concept]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4"

Phrase: "were"

Phrase: "significantly different only in LD block 4"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0023746:Linkage Disequilibrium [Quantitative Concept]
   744   C0023745:linkage [Molecular Function]
   744   C0028778:Block [Pathologic Function]
   744   C0205171:Only [Quantitative Concept]
   744   C0281825:Disequilibrium [Finding]
   744   C0332206:Block [Functional Concept]
   744   C0394006:Disequilibrium [Disease or Syndrome]
   744   C1533157:Block [Substance]
   744   C1705242:Different [Qualitative Concept]
   744   C1706084:Block [Geographic Area]
   744   C1720467:Only [Intellectual Product]
   744   C2828370:Block [Quantitative Concept]

Phrase: "(P=0.046"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.69: This association was primarily accounted for by an 8% increase of H1-B4C (GCTG) (PH1-B4C=0.01). 

Phrase: "This association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "primarily"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by an 8% increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "of H1-B4C"

Phrase: "(GCTG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415027:GCTG [Gene or Genome]

Phrase: ")"

Phrase: "(PH1-B4C"

Phrase: "=0.01"

Phrase: ")."
Processing 00000000.tx.70: In addition, the ancestral H1 subhaplotype H1B (CGTGT-A-GCGG-GCTG) showed a strong association (P=0.002) in old PSP patients. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the ancestral H1 subhaplotype H1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1415389:H1B [Gene or Genome]

Phrase: "(CGTGT-A-GCGG-GCTG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1415027:GCTG [Gene or Genome]

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a strong association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "(P=0.002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in old PSP patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030705:Patients [Patient or Disabled Group]
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
Processing 00000000.tx.71: View this table: [in this window] [in a new window]  Table3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table3."
Processing 00000000.tx.72: H1 htSNP subhaplotype associations overall and in age-strata  View this table: [in this window] [in a new window]  Table4. 

Phrase: "H1 htSNP subhaplotype associations overall"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0004083:Associations [Mental Process]
   771 E C0439849:Association [Qualitative Concept]
   771 E C0596306:Association [Phenomenon or Process]
   771 E C0699792:association [Social Behavior]

Phrase: "and in age-strata"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001779:Age [Organism Attribute]
   770   C1515981:And [Idea or Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table4."
Processing 00000000.tx.73: H1 SNP finemapping of young PSP risk  High-density SNP mapping To finemap the H1 genetic risk for PSP detected with htSNP167, we selected a genomic region of 63kb between htSNPs SNP120 and SNP364 extending into LD blocks 1 and 3 by at least 20kb (Fig.1B). 

Phrase: "H1 SNP finemapping of young PSP"

Phrase: "risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "High-density SNP mapping To finemap"

Phrase: "the H1 genetic risk for PSP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1517512:Genetic Risk [Quantitative Concept]
   744   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   744   C0035647:Risk [Qualitative Concept]
   744   C0314603:Genetic [Functional Concept]

Phrase: "detected with htSNP167,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "we"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "a genomic region of 63kb"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017428:Genomic [Gene or Genome]
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "between htSNPs SNP120"

Phrase: "and"

Phrase: "SNP364 extending into LD"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439792:Extending [Spatial Concept]
   726 E C0231448:Extend [Functional Concept]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "3 by"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0439086:<3 [Quantitative Concept]
   833   C2827736:3+ [Quantitative Concept]
   833   C2981702:3+ [Classification]

Phrase: "at least 20kb"

Phrase: "(Fig.1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.74: In this region that spanned 40kb of MAPT intron 0 and exons 1 to 4A, we genotyped 11 extra H1 SNPs identified during the genomic MAPT sequencing in the young PSP patients and control individuals. 

Phrase: "In this region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "that spanned 40kb of MAPT intron 0"

Phrase: "and"

Phrase: "exons 1 to 4A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0450373:4a [Intellectual Product]
   770   C1553636:4a [Medical Device]

Phrase: "we"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "11 extra H1 SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0752046:SNPs [Nucleotide Sequence]
   779 E C1527094:SNP [Conceptual Entity]

Phrase: "identified during the genomic MAPT sequencing"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0017428:Genomic [Gene or Genome]
   753   C0205396:Identified [Qualitative Concept]
   753   C0887950:genomic [Biomedical Occupation or Discipline]
   753   C1446659:MAPT [Gene or Genome]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1553778:Sequencing [Intellectual Product]
   753   C1561491:Sequencing [Functional Concept]

Phrase: "in the young PSP patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030705:Patients [Patient or Disabled Group]
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "and"

Phrase: "control individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]
Processing 00000000.tx.75: Allelic associations were highly significant for htSNP167 (OR=1.8; 95% CI 1.32.5; Pallelic<0.001) and SNP421 (OR=2.0; 95% CI 1.42.7; Pallelic<0.001) (Table 4). 

Phrase: "Allelic associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0004083:Associations [Mental Process]
   827 E C0439849:Association [Qualitative Concept]
   827 E C0596306:Association [Phenomenon or Process]
   827 E C0699792:association [Social Behavior]

Phrase: "were"

Phrase: "highly significant for htSNP167"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1299395:Highly significant [Qualitative Concept]
   770   C0237881:significant [Quantitative Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]

Phrase: "(OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "=1.8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; 95% CI 1.32.5"

Phrase: "; Pallelic"

Phrase: "<0.001"

Phrase: ")"

Phrase: "and"

Phrase: "SNP421"

Phrase: "(OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "=2.0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "; 95% CI 1.42.7"

Phrase: "; Pallelic"

Phrase: "<0.001"

Phrase: ")"

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.76: Genotypic associations for htSNP167 and SNP421 in the H1/H1 individuals were P=0.002 with ORs (A/A versus A/G+G/G) of 2.2 (95% CI 1.33.7) for htSNP167 and 2.3 (95% CI 1.43.9) for SNP421 (data not shown). 

Phrase: "Genotypic associations for htSNP167"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0004083:Associations [Mental Process]
   737 E C0439849:Association [Qualitative Concept]
   737 E C0596306:Association [Phenomenon or Process]
   737 E C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "SNP421 in the H1/H1 individuals"

Phrase: "were"

Phrase: "P=0.002 with ORs ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0069590:ORS [Inorganic Chemical,Pharmacologic Substance]
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]

Phrase: "A/"

Phrase: "A"

Phrase: "versus"

Phrase: "A/G+G/G) of 2.2"

Phrase: "(95% CI 1.33.7"

Phrase: ")"

Phrase: "for htSNP167"

Phrase: "and"

Phrase: "2.3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1519042:2-3 [Research Activity]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "(95% CI 1.43.9"

Phrase: ")"

Phrase: "for SNP421"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.77: Haplotype association analysis using sliding windows of three SNPs was significant within a region of seven SNPs (SNP191htSNP319) with the highest significance observed for htSNP167SNP195SNP421 (P<0.001) (Fig.2). 

Phrase: "Haplotype association analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "sliding windows of three SNPs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0557702:windows [Manufactured Object]
   726 E C1272706:Window [Temporal Concept]
   726 E C1704674:Window [Manufactured Object]

Phrase: "was"

Phrase: "significant within a region of seven SNPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0237881:significant [Quantitative Concept]
   748   C0750502:Significant [Idea or Concept]
   748   C1546944:Significant [Qualitative Concept]

Phrase: "(SNP191htSNP319"

Phrase: ")"

Phrase: "with the highest significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0237881:Significance [Quantitative Concept]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "observed for htSNP167SNP195SNP421"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "(P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.78: Sliding window analysis using two-SNP haplotypes showed significant association within a 22kb interval (SNP162SNP243) when the haplotype included either htSNP167 or SNP421. 

Phrase: "Sliding window analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two-SNP haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "significant association within a 22kb interval"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "(SNP162SNP243"

Phrase: ")"

Phrase: "when"

Phrase: "the haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "either htSNP167"

Phrase: "or"

Phrase: "SNP421."
Processing 00000000.tx.79: The most significant association was observed when both htSNP167 and SNP421, which showed a high degree of LD with D'=0.97, were combined (P<0.001) (data not shown). 

Phrase: "The most significant association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
   734   C1299394:Most significant [Qualitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "both htSNP167"

Phrase: "and"

Phrase: "SNP421,"

Phrase: "which"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a high degree of LD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441889:Degree [Qualitative Concept]
   753   C0449286:Degree [Quantitative Concept]
   753   C0542560:Degree [Intellectual Product]
   753   C1561545:degree [Quantitative Concept]
   753   C2348088:Degree [Quantitative Concept]

Phrase: "with"

Phrase: "D'="

Phrase: "0.97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]

Phrase: "were"

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "(P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.80: View larger version (13K): [in this window] [in a new window]  Figure2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure2."
Processing 00000000.tx.81: Sliding window SNP haplotype analyses. 

Phrase: "Sliding window SNP haplotype analyses."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0002778:Analysis [Laboratory Procedure]
   771   C0936012:Analysis [Research Activity]
   771   C1524024:analysis [Functional Concept]
Processing 00000000.tx.82: The H1 SNPs used are located in a 63kb region spanning 40kb of MAPT intron 0 and exons 14A. 

Phrase: "The H1 SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0752046:SNPs [Nucleotide Sequence]
   827 E C1527094:SNP [Conceptual Entity]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: "located in a 63kb region spanning 40kb of MAPT intron 0"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   738   C0017446:Region [Geographic Area]
   738   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0205147:Region [Spatial Concept]
   738   C1446659:MAPT [Gene or Genome]
   704   C1711300:Span [Conceptual Entity]
   704   C2700613:Span [Quantitative Concept]

Phrase: "and"

Phrase: "exons 14A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553646:14a [Medical Device]
Processing 00000000.tx.83: log10 (P) values are indicated with full lines (three SNP haplotypes) and dashed lines (two SNP haplotypes).  

Phrase: "log10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1690986:log10 [Quantitative Concept]

Phrase: "(P) values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709380:P-Value [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "indicated with full lines"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205132:lines [Spatial Concept]
   770   C0443225:Full [Qualitative Concept]
   770   C1444656:Indicated [Finding]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "(three SNP haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "dashed lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "(two SNP haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: ")."
Processing 00000000.tx.84: Transcriptional effect of htSNP167A>G Of the SNPs in the 22kb candidate interval, including 10 rare SNPs (minor allele frequency<5%) that we previously identified in our resequencing effort (Fig.1C), 11 SNPs altered one or more putative transcription factor binding sites (Table 5). 

Phrase: "Transcriptional effect of htSNP167A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: ">G Of the SNPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439267:g% [Quantitative Concept]

Phrase: "in the 22kb candidate interval,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "10 rare SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0752046:SNPs [Nucleotide Sequence]
   793 E C1527094:SNP [Conceptual Entity]

Phrase: "(minor allele frequency"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0017270:Allele Frequency [Quantitative Concept]
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "<5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "that"

Phrase: "we previously"

Phrase: "identified in our resequencing effort"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0015264:Effort [Organism Function]
   760   C0205396:Identified [Qualitative Concept]
   760   C1511693:Resequencing [Molecular Biology Research Technique]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]

Phrase: "(Fig.1C"

Phrase: ")"

Phrase: ","

Phrase: "11 SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0752046:SNPs [Nucleotide Sequence]
   827 E C1527094:SNP [Conceptual Entity]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "more putative transcription factor binding sites"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   861   C1149367:transcription factor binding [Genetic Function]
   827   C0005456:Binding Sites [Receptor]
   827   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0040649:Transcription [Genetic Function]
   799   C0205145:Sites [Spatial Concept]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1521761:Factor [Functional Concept]
   799   C2827422:Factor [Conceptual Entity]
   793 E C0682969:Binding Site [Amino Acid Sequence]
   766 E C1515974:Site [Body Location or Region]
   766 E C2825164:Site [Spatial Concept]

Phrase: "(Table 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.85: However, only htSNP167 was located in a region that was highly conserved compared with chimpanzee, dog, mouse and rat (Fig.1D). 

Phrase: "However,"

Phrase: "only htSNP167"

Phrase: "was"

Phrase: "located in a region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]

Phrase: "that"

Phrase: "was"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "conserved"

Phrase: "compared with chimpanzee,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0008111:Chimpanzee [Mammal]
   790   C0085999:Chimpanzee [Mammal]
   790   C1707455:Compared [Activity]

Phrase: "dog,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012984:Dog [Mammal]
  1000   C1280551:Dog [Mammal]

Phrase: "mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.86: The degree of conservation in this 182bp region (91.5%) was higher than that of MAPT exon 1 and suggested the presence of functionally important cis-elements. 

Phrase: "The degree of conservation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "in this 182bp region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "(91.5%"

Phrase: ")"

Phrase: "was"

Phrase: "higher than that of MAPT exon 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of functionally important cis-elements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.87: In silico analysis showed that the allele A of htSNP167 abolished putative binding sites for the CP2-erythrocyte Factor related to drosophila Elf1 (LBP-1c/LSF/CP2, short CP2) (core/matrix similarity 0.83/0.843) and for the Se-Cys tRNA gene transcription-activating factor (STAF.01) (core/matrix similarity 1/0.805) (Table 5). 

Phrase: "In silico analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C3489666:In Silico [Machine Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the allele A of htSNP167"

Phrase: "abolished"

Phrase: "putative binding sites for the CP2-erythrocyte Factor"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0005456:Binding Sites [Receptor]
   744   C0205145:Sites [Spatial Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   737 E C0682969:Binding Site [Amino Acid Sequence]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "related to drosophila Elf1"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0013138:Drosophila [Eukaryote]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C1028876:Drosophila [Fungus]
   770   C1414375:ELF1 [Gene or Genome]
   770   C1504613:Drosophila [Eukaryote]
   770   C1539355:ELF1 [Gene or Genome]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "(LBP-1c/LSF/CP2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1456377:CP2 [Gene or Genome]

Phrase: "short CP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1456377:CP2 [Gene or Genome]

Phrase: ")"

Phrase: "(core/matrix similarity 0.83/0.843"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   795   C0444669:Core [Spatial Concept]
   795   C1167518:core [Cell Component]
   795   C1704640:Matrix [Spatial Concept]
   795   C1706352:Core [Medical Device]
   795   C1706515:Matrix [Body Substance]
   795   C1882467:Core [Manufactured Object]
   795   C2348205:Similarity [Qualitative Concept]
   795   C3274653:Core [Body Substance]

Phrase: ")"

Phrase: "and for the Se-Cys tRNA gene transcription-activating factor"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   775   C0812327:Transcription Factor Gene [Gene or Genome]
   775   C1148798:activating transcription factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0040649:Gene Transcription [Genetic Function]
           Transcription
   757   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1158829:tRNA transcription [Genetic Function]
   739   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0017337:Gene [Gene or Genome]
   739   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C1515981:And [Idea or Concept]
   739   C1521761:Factor [Functional Concept]
   739   C1537998:trnA [Gene or Genome]
   739   C1879547:activating [Activity]
   739   C2827422:Factor [Conceptual Entity]
   706 E C1515877:Activate [Functional Concept]

Phrase: "(STAF.01"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421635:STAF [Gene or Genome]

Phrase: ")"

Phrase: "(core/matrix similarity 1/0.805"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   799   C0444669:Core [Spatial Concept]
   799   C1167518:core [Cell Component]
   799   C1704640:Matrix [Spatial Concept]
   799   C1706352:Core [Medical Device]
   799   C1706515:Matrix [Body Substance]
   799   C1882467:Core [Manufactured Object]
   799   C2348205:Similarity [Qualitative Concept]
   799   C3274653:Core [Body Substance]

Phrase: ")"

Phrase: "(Table 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.88: View this table: [in this window] [in a new window]  Table5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table5."
Processing 00000000.tx.89: MatInspector analysis of SNPs in the 22kb candidate region  To test whether the 182bp fragment surrounding htSNP167 contained functional elements, we used a luciferase reporter gene analysis. 

Phrase: "MatInspector analysis of SNPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "in the 22kb candidate region  To"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "the 182bp fragment surrounding htSNP167"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "functional elements,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a luciferase reporter gene analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
   708   C1334435:Luciferase Gene [Gene or Genome]
Processing 00000000.tx.90: We cloned the 182bp fragment of the MAPT regulatory region in intron 0 upstream of the minimal SV40 early promoter and obtained significantly enhanced transcription in transiently transfected non-neuronal (HEK293, P<0.001) and neuronal (N2a, P<0.001) cells (Fig.3A). 

Phrase: "We"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "the 182bp fragment of the MAPT regulatory region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "in intron 0"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "upstream of the minimal SV40 early promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "significantly enhanced transcription in transiently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040649:Transcription [Genetic Function]

Phrase: "transfected"

Phrase: "non-neuronal"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518422:Non [Functional Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "(HEK293,"

Phrase: "P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "neuronal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521390:Neuronal [Immunologic Factor]
   928 E C0027882:Neuron [Cell]

Phrase: "(N2a,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445079:N2a [Finding]

Phrase: "P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig.3A"

Phrase: ")."
Processing 00000000.tx.91: Both htSNP167 alleles, increased expression with allele G showing a small (16%) but significant (P<0.001) higher increase in activity than allele A in N2a cells. 

Phrase: "Both htSNP167 alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "increased expression with allele G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "(16%"

Phrase: ")"

Phrase: "but"

Phrase: "significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "(P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "higher increase in activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "than allele A"

Phrase: "in N2a cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.92: When we used a fragment of the MAPT H1 proximal promoter, the luciferase expression in mouse and human neuroblastoma cells was significantly higher than in the SV40 promoter (P<0.001) (Fig.3B). 

Phrase: "When"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a fragment of the MAPT H1 proximal promoter,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "the luciferase expression in mouse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "human neuroblastoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0427861:Human cells [Laboratory or Test Result]
   884   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "significantly higher than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "in the SV40 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig.3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.93: When we cloned the 182bp regulatory fragment upstream of the H1 promoter, luciferase activity of both htSNP167 alleles differed again by 31% in N2a cells and 27% in SHSY-5Y cells (P<0.001, Fig.3B). 

Phrase: "When"

Phrase: "we"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "the 182bp regulatory fragment upstream of the H1 promoter,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332255:fragment [Functional Concept]
   742   C1708096:Fragment [Qualitative Concept]

Phrase: "luciferase activity of both htSNP167 alleles"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1151115:luciferase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "differed"

Phrase: "again by 31%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0450355:31 [Intellectual Product]

Phrase: "in N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "27% in SHSY-5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(P<0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Fig.3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.94: View larger version (22K): [in this window] [in a new window]  Figure3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure3."
Processing 00000000.tx.95: Luciferase reporter gene analyses. 

Phrase: "Luciferase reporter gene analyses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]
   708   C1334435:Luciferase Gene [Gene or Genome]
Processing 00000000.tx.96: Bars represent relative luciferase activity of at least 12 independent transient transfection experiments and its standard error of the mean (SEM). 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "relative luciferase activity of"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1151115:luciferase activity [Molecular Function]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "at least 12 independent transient transfection experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0681814:Experiments [Research Activity]
   766 E C1706386:Experiment [Conceptual Entity]
   716 E C1517586:Experimental [Qualitative Concept]

Phrase: "and"

Phrase: "its standard error of the mean (SEM)."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   938   C1710181:Standard Error of the Mean [Quantitative Concept]
           Standard Error
   753   C0743559:error [Qualitative Concept]
   753   C1442989:Standard [Qualitative Concept]
   753   C1608199:Error [Functional Concept]
   753   C2828392:Standard [Intellectual Product]
Processing 00000000.tx.97: (A) Effect of the 182bp conserved sequence in the MAPT regulatory region of intron 0 containing htSNP167 allele A or G on SV40 driven luciferase activity. 

Phrase: "(A) Effect of the 182bp"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "conserved"

Phrase: "sequence in the MAPT regulatory region of intron 0 containing htSNP167 allele A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   749   C0314642:Regulatory sequence [Nucleotide Sequence]
   735   C0004793:Sequence [Nucleotide Sequence]
   735   C0162326:Sequence [Nucleotide Sequence]
   735   C0162327:Sequence [Nucleotide Sequence]
   735   C1519249:Sequence [Functional Concept]

Phrase: "or"

Phrase: "G on SV40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439267:g% [Quantitative Concept]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "luciferase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.98: White bars correspond to data obtained in HEK293 cells and black bars in N2A cells. 

Phrase: "White bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "correspond to data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1511726:Data [Idea or Concept]
   790   C3245479:data [Medical Device]

Phrase: "obtained in HEK293 cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C2936239:HEK293 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C1301820:Obtained [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1706701:Obtain [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "black bars in N2A cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1707156:BARS [Gene or Genome]
   760   C3274014:BARS [Intellectual Product]
   760   C3541345:BARS [Intellectual Product]
Processing 00000000.tx.99: * represents the difference compared with SV40 expression P<0.0001. 

Phrase: "*"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "compared with SV40 expression P<0.0001."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0038975:SV 40 [Virus]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C1707455:Compared [Activity]
Processing 00000000.tx.100: [*] represents the difference between alleles A and G at htSNP167P<0.001. 

Phrase: "["

Phrase: "*"

Phrase: "]"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the difference between alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "A"

Phrase: "and"

Phrase: "G at htSNP167P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439267:g% [Quantitative Concept]

Phrase: "<0.001."
Processing 00000000.tx.101: (B) The effect of the 182bp regulatory fragment on MAPT H1 promoter driven luciferase activity. 

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The effect of the 182bp regulatory fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on MAPT H1 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "luciferase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.102: White bars correspond to data obtained in N2a cells and black bars in SHSY-5Y cells. 

Phrase: "White bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "correspond to data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1511726:Data [Idea or Concept]
   790   C3245479:data [Medical Device]

Phrase: "obtained in N2a cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0445079:N2a [Finding]
   770   C1301820:Obtained [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1706701:Obtain [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "black bars in SHSY-5Y cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1707156:BARS [Gene or Genome]
   753   C3274014:BARS [Intellectual Product]
   753   C3541345:BARS [Intellectual Product]
Processing 00000000.tx.103: * represents the difference between alleles A and G P<0.001.  

Phrase: "*"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the difference between alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "A"

Phrase: "and"

Phrase: "G P<0.001."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.104: Replication of htSNP167 association We replicated the htSNP167 association in an independent US PSP patientcontrol sample that showed significant association when examining the extended MAPT haplotypes H1 and H2, with an OR for H1/H1 versus H1/H2+H2/H2 of 5.0 (95% CI 3.08.4). 

Phrase: "Replication of htSNP167 association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0598312:Replication [Genetic Function]
   770   C1883725:replication [Qualitative Concept]

Phrase: "We"

Phrase: "replicated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205173:replicated [Functional Concept]
   966 E C0205341:Replicate [Functional Concept]
   966 E C1883725:Replicate [Qualitative Concept]

Phrase: "the htSNP167 association in an independent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "US PSP patientcontrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "that"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "significant association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "when"

Phrase: "examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332128:examining [Finding]
  1000   C2004054:Examining [Activity]

Phrase: "the extended MAPT haplotypes H1"

Phrase: "and"

Phrase: "H2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0919509:H2 [Gene or Genome]
  1000   C1419394:H2 [Gene or Genome]

Phrase: "with an OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "for H1/H1"

Phrase: "versus"

Phrase: "H1/H2+H2/H2 of 5.0"

Phrase: "(95% CI 3.08.4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C0387382:CI 4 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.105: Significant allelic association was calculated with htSNP167 resulting from a 9% increase of allele A (OR=1.4; 95% CI 1.11.9; P=0.01) (Table 6). 

Phrase: "Significant allelic association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "calculated with htSNP167"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]

Phrase: "resulting from a 9% increase of allele A (OR"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0028873:Odds Ratios [Quantitative Concept]
   739   C0002085:Allele [Gene or Genome]
   739   C0442805:Increase [Functional Concept]
   739   C0456603:Ratios [Quantitative Concept]
   739   C0678226:resulting [Functional Concept]
   739   C1610540:*Ratios [Quantitative Concept]
   706 E C1274040:Result [Functional Concept]
   706 E C1546471:Result [Idea or Concept]
   706 E C1547037:Ratio [Intellectual Product]
   706 E C2825142:Result [Finding]

Phrase: "=1.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; 95% CI 1.11.9"

Phrase: "; P=0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Table 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.106: When only young, pathologically confirmed PSP patients were considered (n=30), the allele A frequency of htSNP167 further increased to 58.6% compared with 46.3% in control individuals; 

Phrase: "When"

Phrase: "only young, pathologically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205171:Only [Quantitative Concept]
   827   C0332239:Young [Temporal Concept]
   827   C1720467:Only [Intellectual Product]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "PSP patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030705:Patients [Patient or Disabled Group]
   756   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "(n=30"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0632490:N 30 [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: "A frequency of htSNP167 further"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]

Phrase: "increased to 58.6%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: "compared with 46.3%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]

Phrase: "in control individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: ";"
Processing 00000000.tx.107: however, this finding did not reach significance because of the small number of patients in this subgroup (P=0.07). 

Phrase: "however,"

Phrase: "this finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "significance because of the small number of patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0237881:Significance [Quantitative Concept]
   744   C0750502:Significance [Idea or Concept]

Phrase: "in this subgroup"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1079230:subgroup [Virus]
  1000   C1515021:Subgroup [Classification]

Phrase: "(P=0.07"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.108: When patient and control groups of both US association samples were compared, similar htSNP167 allele distributions were obtained (Phomogeneity=0.52), and a highly significant association of PSP with htSNP167 was obtained in the overall combined US patientcontrol samples (P<0.001). 

Phrase: "When"

Phrase: "patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "and"

Phrase: "control groups of both"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0009932:Control Groups [Group]
   770   C0243148:control [Qualitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1550141:Control [Substance]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "US association samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: ","

Phrase: "similar htSNP167 allele distributions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0037775:Distributions [Spatial Concept]
   779 E C0520511:distribution [Idea or Concept]
   779 E C1704711:Distribution [Functional Concept]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(Phomogeneity"

Phrase: "=0.52"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a highly significant association of PSP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "with htSNP167"

Phrase: "was"

Phrase: "obtained in the overall"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282416:Overall [Intellectual Product]
   770   C1301820:Obtained [Functional Concept]
   770   C1561607:Overall [Qualitative Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "US patientcontrol samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "(P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.109: View this table: [in this window] [in a new window]  Table6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table6."
Processing 00000000.tx.110: Allelic association of htSNP167 in the US replication sample   DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  In this study, we were able to refine the genetic association of PSP within MAPT by detailed association analysis in one of the largest known collections of pathologically confirmed PSP patients worldwide, using a highly informative htSNP panel capturing >95% of MAPT haplotype diversity. 

Phrase: "Allelic association of htSNP167"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "in the"

Phrase: "US replication sample   DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES  In this study,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C2985663:Study Reference [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   770   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "refine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C1947930:Cleanse [Activity]
   916   C1998793:Purified [Functional Concept]

Phrase: "the genetic association of PSP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1328885:genetic association [Occupation or Discipline]
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "within MAPT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1446659:MAPT [Gene or Genome]

Phrase: "by detailed association analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "in one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "of the largest known collections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0600644:Collections [Intellectual Product]
   827   C1516698:Collection [Functional Concept]
   827   C1704814:Collection [Idea or Concept]
   743 E C1516695:Collected [Idea or Concept]

Phrase: "of pathologically"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "PSP patients worldwide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030705:Patients [Patient or Disabled Group]
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a highly informative htSNP panel capturing"

Phrase: ">95% of MAPT haplotype diversity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0018591:Haplotype [Organism Attribute]
   760   C1446659:MAPT [Gene or Genome]
   760   C1880371:Diversity [Qualitative Concept]
Processing 00000000.tx.111: Previous attempts to finemap PSP risk in MAPT had been less successful because of lack of power in the experimental patientcontrol samples, and absence of a detailed high-density SNP map and full knowledge of the LD substructure of MAPT. 

Phrase: "Previous attempts to finemap PSP risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1516084:Attempt [Event]

Phrase: "in MAPT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1446659:MAPT [Gene or Genome]

Phrase: "had"

Phrase: "been"

Phrase: "less successful because of lack of power"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1272703:Successful [Qualitative Concept]

Phrase: "in the experimental patientcontrol samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "absence of a detailed high-density SNP map"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332197:absence [Quantitative Concept]
   744   C1689985:Absence [Anatomical Abnormality]

Phrase: "and"

Phrase: "full knowledge of the LD substructure of MAPT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0376554:Knowledge [Intellectual Product]
Processing 00000000.tx.112: We showed that PSP risk in the extended US PSP patientcontrol sample originated on one of the two major ancestral MAPT H1 subhaplotypes, H1B (P<0.001), which had a frequency of 14% in US control individuals comparable to what we previously observed in other Caucasian control samples (25,26) (unpublished data). 

Phrase: "We"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that PSP risk in the extended"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0035647:Risk [Qualitative Concept]

Phrase: "US PSP patientcontrol sample"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0370003:Sample [Substance]
   804   C2347026:Sample [Conceptual Entity]
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "originated on one of the two major ancestral MAPT H1 subhaplotypes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0205164:Major [Qualitative Concept]
   738   C0205447:One [Quantitative Concept]
   738   C0205448:Two [Quantitative Concept]
   738   C1446659:MAPT [Gene or Genome]

Phrase: "H1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415389:H1B [Gene or Genome]

Phrase: "(P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "had"

Phrase: "a frequency of 14%"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0376249:frequency [Quantitative Concept]
   770   C0439603:Frequency [Temporal Concept]
   770   C0871396:Frequency [Quantitative Concept]
   770   C1561548:Frequency [Qualitative Concept]
   770   C1705502:Frequency [Quantitative Concept]

Phrase: "in US"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "comparable to what"

Phrase: "we previously"

Phrase: "observed in other Caucasian control samples"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007457:Caucasian [Population Group]
   753   C0043157:Caucasian [Population Group]
   753   C0243148:control [Qualitative Concept]
   753   C1441672:Observed [Functional Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719   C0370003:Sample [Substance]
   719   C2347026:Sample [Conceptual Entity]

Phrase: "(25,"

Phrase: "26"

Phrase: ")"

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.113: In the overall sample, the highest significance was obtained in LD block 2 spanning 10kb of regulatory sequences in intron 0 of MAPT and tagged by htSNP167 (P<0.001). 

Phrase: "In the overall sample,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "the highest significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0237881:Significance [Quantitative Concept]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "obtained in LD block 2 spanning 10kb of regulatory sequences"
Meta Candidates (Total=20; Excluded=4; Pruned=0; Remaining=16)
   756   C0023746:Linkage Disequilibrium [Quantitative Concept]
   738   C0023745:linkage [Molecular Function]
   738   C0028778:Block [Pathologic Function]
   738   C0162326:Sequences [Nucleotide Sequence]
   738   C0220905:regulatory [Regulation or Law]
   738   C0281825:Disequilibrium [Finding]
   738   C0332206:Block [Functional Concept]
   738   C0394006:Disequilibrium [Disease or Syndrome]
   738   C1301820:Obtained [Functional Concept]
   738   C1533157:Block [Substance]
   738   C1704735:Regulatory [Conceptual Entity]
   738   C1706084:Block [Geographic Area]
   738   C2828370:Block [Quantitative Concept]
   722   C0314642:Regulatory sequence [Nucleotide Sequence]
   704 E C0004793:Sequence [Nucleotide Sequence]
   704 E C0162327:Sequence [Nucleotide Sequence]
   704 E C1519249:Sequence [Functional Concept]
   704 E C1706701:Obtain [Activity]
   704   C1711300:Span [Conceptual Entity]
   704   C2700613:Span [Quantitative Concept]

Phrase: "in intron 0"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of MAPT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1446659:MAPT [Gene or Genome]

Phrase: "and"

Phrase: "tagged by htSNP167"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   790   C1708632:Tagged [Qualitative Concept]
   756 E C0037293:Tag [Neoplastic Process]
   756 E C0181496:Tag [Manufactured Object]
   756 E C1710492:TAG [Gene or Genome]

Phrase: "(P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.114: In the age and pathology stratified analyses, we also observed highly significant genotypic association with htSNP167 in young and PSP-pure patients (P=0.002), which remained significant when we performed a Bonferroni correction to adjust for multiple testing. 

Phrase: "In the age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "pathology stratified analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "we also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "highly significant genotypic association with htSNP167"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "in young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "and"

Phrase: "PSP-pure patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030705:Patients [Patient or Disabled Group]
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "(P=0.002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "remained"

Phrase: "significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "when"

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a Bonferroni correction to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705565:CORRECTION [Intellectual Product]
   770   C1947976:Correction [Functional Concept]

Phrase: "adjust for multiple testing."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039593:Testing [Functional Concept]
   770   C0392366:testing [Intellectual Product]
   770   C0439064:Multiple [Quantitative Concept]
Processing 00000000.tx.115: As the stratified data were highly similar in the young and PSP-pure patients, overlapping by 63%, further stratified analyses were performed only in the age strata. 

Phrase: "As the stratified data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "highly similar in the young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "PSP-pure patients,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030705:Patients [Patient or Disabled Group]
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "overlapping by 63%,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0185027:Overlapping [Therapeutic or Preventive Procedure]
   790   C1948020:Overlapping [Conceptual Entity]

Phrase: "further stratified analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "only in the age strata."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0001779:Age [Organism Attribute]
   760   C0205171:Only [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]
Processing 00000000.tx.116: In young PSP patients, only 5% of the allele A-tagged htSNP167 subhaplotypes corresponded with the ancestral H1B, whereas all others represented different recombined derivatives of H1B explaining the finemapping to LD block 2. 

Phrase: "In young PSP patients,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030705:Patients [Patient or Disabled Group]
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "only 5% of the allele A-tagged htSNP167 subhaplotypes"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   742   C0002085:Allele [Gene or Genome]
   742   C0205171:Only [Quantitative Concept]
   742   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   742   C1708632:Tagged [Qualitative Concept]
   742   C1720467:Only [Intellectual Product]
   708 E C0037293:Tag [Neoplastic Process]
   708 E C0181496:Tag [Manufactured Object]
   708 E C1710492:TAG [Gene or Genome]

Phrase: "corresponded with the ancestral H1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1415389:H1B [Gene or Genome]

Phrase: "whereas"

Phrase: "all others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "different recombined derivatives of H1B"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0243072:derivatives [Chemical Viewed Structurally]
   726 E C1527240:Derivative [Functional Concept]

Phrase: "explaining"

Phrase: "the finemapping to LD block 2."
Processing 00000000.tx.117: In contrast, in the old PSP patients, the htSNP167 allele A association was explained nearly entirely by association to H1B (P0.002). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "in the old PSP patients,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030705:Patients [Patient or Disabled Group]
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "the htSNP167 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "A association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "explained"

Phrase: "nearly entirely by association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "to H1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415389:H1B [Gene or Genome]

Phrase: "(P0.002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1417248:P0 [Gene or Genome]
   861   C1419691:P0 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.118: Our data in the US sample suggested that the genetic H1 risk variants for PSP in intron 0 are old mutations that appeared on H1B and have been separated over time by recombination in flanking regions that define the current LD block structure in MAPT. 

Phrase: "Our data in the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "US"

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the genetic H1 risk variants for PSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205419:variants [Qualitative Concept]

Phrase: "in intron 0"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "old mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "appeared on H1B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1415389:H1B [Gene or Genome]
   756   C0700364:APPEAR [Qualitative Concept]

Phrase: "and"

Phrase: "have"

Phrase: "been"

Phrase: "separated over time"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0040223:Time [Temporal Concept]
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "by recombination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034865:Recombination [Genetic Function]

Phrase: "in flanking regions"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0230171:flanking [Body Location or Region]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "that"

Phrase: "define"

Phrase: "the current LD block structure in MAPT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.119: In young patients, the larger genetic component of the disease or greater genetic homogeneity allowed finemapping of these functional variants to MAPT intron 0. 

Phrase: "In young patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "the larger genetic component of the disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "or"

Phrase: "greater genetic homogeneity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881065:Homogeneity [Qualitative Concept]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "finemapping of these functional variants"

Phrase: "to MAPT intron 0."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1446659:MAPT [Gene or Genome]
Processing 00000000.tx.120: In contrast, in the old patients, the genetic risk variants could not be finemapped possibly because these PSP subgroups are indeed more genetically heterogeneous with other weaker modifiers existing on H1B beyond htSNP167. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "in the old patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "the genetic risk variants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205419:variants [Qualitative Concept]
   734   C1517512:Genetic Risk [Quantitative Concept]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "finemapped possibly"

Phrase: "because"

Phrase: "these PSP subgroups"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1079230:subgroups [Virus]
   779 E C1515021:Subgroup [Classification]
   756   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "are"

Phrase: "indeed more genetically heterogeneous with other weaker modifiers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0019409:Heterogeneous [Qualitative Concept]

Phrase: "existing on H1B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1415389:H1B [Gene or Genome]
   756   C2987476:Exist [Conceptual Entity]

Phrase: "beyond htSNP167."
Processing 00000000.tx.121: Next we finemapped the young PSP risk to a region of 22kb in LD block 2 surrounding htSNP167 and located upstream of exon 1, 48kb downstream of the major transcriptional start site (27). 

Phrase: "Next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "we finemapped"

Phrase: "the young PSP risk to a region of 22kb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0035647:Risk [Qualitative Concept]

Phrase: "in LD block 2 surrounding htSNP167"

Phrase: "and"

Phrase: "located upstream of exon 1,"

Phrase: "48kb downstream of the major transcriptional start site"

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.122: Significant association with young PSP was observed only with subhaplotypes that included htSNP167 or SNP421. 

Phrase: "Significant association with young PSP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "only with subhaplotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205171:Only [Quantitative Concept]
   790   C1720467:Only [Intellectual Product]

Phrase: "that included htSNP167"

Phrase: "or"

Phrase: "SNP421."
Processing 00000000.tx.123: When haplotype frequencies composed of htSNP167 and SNP421 were estimated in young PSP patients, a 15% increase of haplotype AA was observed in the US sample. 

Phrase: "When"

Phrase: "haplotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "composed of htSNP167"

Phrase: "and"

Phrase: "SNP421"

Phrase: "were"

Phrase: "estimated in young PSP patients,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   778   C0270920:Supranuclear palsy [Disease or Syndrome]
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0205329:Progressive [Functional Concept]
   748   C0332239:Young [Temporal Concept]
   748   C0522224:Palsy [Finding]
   748   C0750572:Estimated [Quantitative Concept]
   746   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]

Phrase: "a 15% increase of haplotype AA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "observed in the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "US"

Phrase: "sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.124: In an attempt to replicate the significant association in the 5' regulatory region of MAPT, we analyzed htSNP167 in a second, independently ascertained US PSP patientcontrol sample that predominantly comprised clinical diagnosed PSP patients and identified significant allelic association in the replication sample (P=0.01) and in the combined samples (P<0.001). 

Phrase: "In an attempt to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516084:Attempt [Event]

Phrase: "replicate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]

Phrase: "the significant association in the 5' regulatory region of MAPT,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0004083:Association [Mental Process]
   739   C0439849:Association [Qualitative Concept]
   739   C0596306:Association [Phenomenon or Process]
   739   C0699792:association [Social Behavior]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "htSNP167 in a second,"

Phrase: "independently"

Phrase: "ascertained"

Phrase: "US PSP patientcontrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "that predominantly"

Phrase: "comprised"

Phrase: "clinical diagnosed PSP patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "identified significant allelic association in the replication sample"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "(P=0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and in the combined samples"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0205195:Combined [Qualitative Concept]
   760   C1515981:And [Idea or Concept]
   726 E C0336789:Combine [Manufactured Object]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "(P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.125: Recently, Pittman etal. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "Pittman etal."
Processing 00000000.tx.126: (28) published association data from a PSP patientcontrol sample that overlapped with the extended US sample we used in our study. 

Phrase: "(28"

Phrase: ")"

Phrase: "published association data from a PSP patientcontrol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1511726:Data [Idea or Concept]
   742   C3245479:data [Medical Device]

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "that overlapped with the extended"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0185027:overlapped [Therapeutic or Preventive Procedure]
   726 E C1948020:Overlap [Conceptual Entity]

Phrase: "US"

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "we"

Phrase: "used in our study."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.127: They identified two common ancestral H1 subhaplotypes, B and C, which could correspond to, respectively, H1A and H1B that we identified on the basis of MAPT resequencing and LD mapping (25) (unpublished data). 

Phrase: "They"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "two common ancestral H1 subhaplotypes,"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C,"

Phrase: "which"

Phrase: "could"

Phrase: "correspond"

Phrase: "to,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "respectively,"

Phrase: "H1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415385:H1A [Gene or Genome]

Phrase: "and"

Phrase: "H1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415389:H1B [Gene or Genome]

Phrase: "that"

Phrase: "we"

Phrase: "identified on the basis of MAPT resequencing"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0205396:Identified [Qualitative Concept]
   748   C1446659:MAPT [Gene or Genome]
   748   C1511693:Resequencing [Molecular Biology Research Technique]
   748   C1527178:Basis [Functional Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C1874451:Basis [Pharmacologic Substance]

Phrase: "and"

Phrase: "LD mapping"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1517888:Linkage Disequilibrium Mapping [Molecular Biology Research Technique]
   913   C0008630:Linkage Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   827   C1283195:Mapping [Activity]
   734   C0023746:Linkage Disequilibrium [Quantitative Concept]

Phrase: "(25"

Phrase: ")"

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.128: They identified a 56.3kb interval on subhaplotype C spanning a region starting in exon 0 to intron 9. 

Phrase: "They"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a 56.3kb interval on subhaplotype C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1272706:Interval [Temporal Concept]
   748   C1552654:Interval [Idea or Concept]
   748   C1552713:Interval [Intellectual Product]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "a region starting in exon 0"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0439659:Start [Temporal Concept]

Phrase: "to intron 9."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.129: We were able to significantly reduce the candidate region, because we analyzed the data in the most genetic and homogenous group of young PSP patients and made optimal use of our high-density SNP map. 

Phrase: "We"

Phrase: "were"

Phrase: "able to significantly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "reduce"

Phrase: "the candidate region,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "because"

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the data in the most genetic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C3641102:Data Origin [Idea or Concept]
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "homogenous group of young PSP patients"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0441833:Group [Idea or Concept]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1552516:Group [Health Care Related Organization]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "made optimal use of our high-density SNP map."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1524063:Use of [Functional Concept]
   742   C0042153:use [Functional Concept]
   742   C0457083:Use [Functional Concept]
   742   C1947944:Use [Intellectual Product]
Processing 00000000.tx.130: Nevertheless, their data is likely to be consistent with ours, as htSNP167 (rs242557) on subhaplotype C also gave the highest significant association in their study (P<0.001). 

Phrase: "Nevertheless,"

Phrase: "their data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "consistent with ours,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "as"

Phrase: "htSNP167"

Phrase: "(rs242557"

Phrase: ")"

Phrase: "on subhaplotype C also"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "the highest significant association in their study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "(P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.131: Also of interest is that in a Norwegian PD sample an H1 subhaplotype containing SNP421 (rs242562) defined the PD-associated risk (23). 

Phrase: "Also of interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0543488:Interest [Mental Process]

Phrase: "is"

Phrase: "that in a Norwegian PD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0030567:Parkinson Disease [Disease or Syndrome]
   790   C1521736:Parkinson's Disease [Functional Concept]
   790   C2681933:PARKINSON DISEASE [Gene or Genome]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0337812:Norwegian [Population Group]

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "an H1 subhaplotype containing SNP421"

Phrase: "(rs242562"

Phrase: ")"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "the PD-associated risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C1281905:disease risk [Finding]
   812   C0035647:Risk [Qualitative Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.132: In addition, we recently identified a protective two-SNP haplotypes including htSNP167 spanning 1kb in MAPT intron 0 in a Belgian late-onset PD sample (age at onset 76) (26). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a protective two-SNP haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018591:Haplotypes [Organism Attribute]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "htSNP167 spanning 1kb in MAPT intron 0"

Phrase: "in a Belgian late-onset PD sample"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0370003:Sample [Substance]
   799   C2347026:Sample [Conceptual Entity]
   734   C3160718:PARKINSON DISEASE, LATE-ONSET [Disease or Syndrome]

Phrase: "(age at onset 76"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0206132:age onset [Quantitative Concept]
   812   C0001779:Age [Organism Attribute]
   812   C0332162:Onset [Qualitative Concept]

Phrase: ")"

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.133: Together these data support a role for altered regulation of transcription due to specific genetic variants in intron 0 of MAPT underlying the risk in different neurodegenerative brain diseases characterized by tauopathy. 

Phrase: "Together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a role for altered regulation of transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "due to specific genetic variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variants [Qualitative Concept]

Phrase: "in intron 0"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of MAPT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1446659:MAPT [Gene or Genome]

Phrase: "underlying"

Phrase: "the risk in different neurodegenerative brain diseases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1281905:diseases risk [Finding]
   748   C0035647:Risk [Qualitative Concept]

Phrase: "characterized by tauopathy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0949664:Tauopathy [Disease or Syndrome]
   790   C1880022:Characterized [Activity]
Processing 00000000.tx.134: The most parsimonious explanation for the PSP association, we observed in our analyses, is that a functional variant influences the regulation of transcription of MAPT resulting in increased risk for disease. 

Phrase: "The most parsimonious explanation for the PSP association,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0681841:Explanation [Intellectual Product]

Phrase: "we"

Phrase: "observed in our analyses,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1441672:Observed [Functional Concept]
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]

Phrase: "is"

Phrase: "that"

Phrase: "a functional variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "influences"

Phrase: "the regulation of transcription of MAPT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1158770:Transcription Regulation [Genetic Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "resulting in increased risk"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0332294:Resulting in [Functional Concept]
   770   C0035647:Risk [Qualitative Concept]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C0678226:resulting [Functional Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "for disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.135: In silico analysis further indicated that htSNP167 was located in a highly conserved 182bp sequence (Fig.2D). 

Phrase: "In silico analysis further"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that htSNP167"

Phrase: "was"

Phrase: "located in a highly conserved 182bp sequence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0009802:Conserved Sequence [Nucleotide Sequence]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0205250:Highly [Qualitative Concept]
   748   C1519249:Sequence [Functional Concept]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705052:2D [Spatial Concept]
  1000   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.136: htSNP167A>G created an LBP-1c/LSF/CP2 binding site that belongs to a family of transcription factors regulating genes involved in development and cell fate determination and has previously been shown to regulate the expression of genes associated with neurodegenerative disorders (2931). 

Phrase: "htSNP167A"

Phrase: ">G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "created"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706214:Created [Activity]
   966 E C3244320:create [Functional Concept]

Phrase: "an LBP-1c/LSF/CP2 binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0005456:Binding Site [Receptor]
   827   C0682969:Binding Site [Amino Acid Sequence]
   799   C0205145:Site [Spatial Concept]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1515974:Site [Body Location or Region]
   799   C2825164:Site [Spatial Concept]

Phrase: "that"

Phrase: "belongs to a family of transcription factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0960756:factor A [Organic Chemical]
   748   C0015576:Family [Family Group]
   748   C0040649:Transcription [Genetic Function]
   748   C1704727:Family [Conceptual Entity]
   714   C1521761:Factor [Functional Concept]
   714   C2827422:Factor [Conceptual Entity]

Phrase: "regulating"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "involved in development"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0243107:development [Physiologic Function]
   790   C0678723:Development [Organism Function]
   790   C1314939:Involved [Functional Concept]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "cell fate determination"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1160037:cell fate determination [Cell Function]
   827   C1148554:determination [Laboratory Procedure]
   734   C1540661:cell fate [Cell Function]

Phrase: "and"

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "the expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "associated with neurodegenerative disorders"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
   833   C1522560:Neurodegenerative Disorders [Functional Concept]
   819   C1292726:associated disorders [Functional Concept]
   770   C0012634:Disorders [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(2931"

Phrase: ")."
Processing 00000000.tx.137: The absence of the LBP-1c/LSF/CP2 site in carriers of the htSNP167 allele A may affect MAPT expression overall or under specific circumstances (e.g. stress), which could in turn modify the risk for developing PSP. 

Phrase: "The absence of the LBP-1c/LSF/CP2 site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332197:absence [Quantitative Concept]
   742   C1689985:Absence [Anatomical Abnormality]

Phrase: "in carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0007294:carriers [Finding]
   966 E C0560175:Carrier [Finding]
   966 E C1706209:Carrier [Medical Device]
   966 E C3273162:Carrier [Intellectual Product]

Phrase: "of the htSNP167 allele A"

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "MAPT expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "overall"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "or under specific circumstances"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "("

Phrase: "e.g. stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0038435:Stress [Finding]
   928 E C0231297:Stressful [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "could"

Phrase: "in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the risk for developing PSP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.138: Initial reporter gene analyses showed that the 182bp fragment was able to enhance SV40 promoter driven luciferase activity confirming that it contained functional cis-elements. 

Phrase: "Initial reporter gene analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the 182bp fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "SV40 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "it"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "functional cis-elements."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013879:Elements [Element, Ion, or Isotope]
   793 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.139: Also an artificial construct, in which the 182bp fragment was cloned upstream of an active MAPT H1 promoter fragment, showed that the htSNP167 alleles A and G had differential effects on H1 promoter driven luciferase activity in neuronal cells. 

Phrase: "Also"

Phrase: "an artificial construct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "in which"

Phrase: "the 182bp fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "cloned upstream of an active MAPT H1 promoter fragment,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   742   C0009013:cloned [Cell]
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205177:Active [Functional Concept]
   742   C0332255:fragment [Functional Concept]
   742   C0522505:Upstream [Spatial Concept]
   742   C1446659:MAPT [Gene or Genome]
   742   C1708096:Fragment [Qualitative Concept]
   708 E C1522642:Clone [Tissue]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the htSNP167 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "A"

Phrase: "and"

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "had"

Phrase: "differential effects on H1 promoter"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "luciferase activity in neuronal cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1151115:luciferase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.140: The observation that allele G rather than the risk allele A increased promoter activity may seem counterintuitive but should not be considered as biologically relevant. 

Phrase: "The observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that allele G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "rather than"

Phrase: "the risk allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "A increased promoter activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0474395:increased activity [Finding]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "may"

Phrase: "seem"

Phrase: "counterintuitive"

Phrase: "but"

Phrase: "should"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "considered as biologically relevant."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205460:Biologically [Qualitative Concept]
   770   C0750591:considered [Idea or Concept]
   770   C2347946:Relevant [Qualitative Concept]
Processing 00000000.tx.141: In our construct, the 182bp regulatory sequence was cloned upstream of the H1 promoter to test its effect on H1 expression dependent on the htSNP167 allele. 

Phrase: "In our construct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "the 182bp regulatory sequence"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0314642:Regulatory sequence [Nucleotide Sequence]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C0220905:regulatory [Regulation or Law]
   827   C1519249:Sequence [Functional Concept]
   827   C1704735:Regulatory [Conceptual Entity]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "cloned upstream of the H1 promoter to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0009013:cloned [Cell]
   748   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0522505:Upstream [Spatial Concept]
   714 E C1522642:Clone [Tissue]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "its effect on H1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "dependent on the htSNP167 allele."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]
Processing 00000000.tx.142: An experimental approach using a larger genomic construct of the MAPT regulatory region would be needed to better mimic the in vivo situation. 

Phrase: "An experimental approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a larger genomic construct of the MAPT regulatory region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2827421:Construct [Classification]

Phrase: "would"

Phrase: "be"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to better"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0332272:Better [Qualitative Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205170:Well [Qualitative Concept]
   827 E C3146287:Well [Manufactured Object]

Phrase: "mimic"

Phrase: "the in vivo situation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1515655:In Vivo [Spatial Concept]
Processing 00000000.tx.143: In summary, we have shown that the allele A of the functional htSNP167, located on the ancestral MAPT H1B haplotype, is associated with PSP in two independent US PSP patientcontrol populations. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the allele A of the functional htSNP167,"

Phrase: "located on the ancestral MAPT H1B haplotype,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0018591:Haplotype [Organism Attribute]
   748   C1415389:H1B [Gene or Genome]
   748   C1446659:MAPT [Gene or Genome]

Phrase: "is"

Phrase: "associated with PSP"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   862   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   806   C0270920:Supranuclear palsy [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   760   C0205329:Progressive [Functional Concept]
   760   C0522224:Palsy [Finding]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in two independent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085862:Independent [Idea or Concept]
   861   C1299583:Independent [Finding]

Phrase: "US PSP patientcontrol populations."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0032659:Population [Quantitative Concept]
   804   C1257890:Population [Population Group]
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
Processing 00000000.tx.144: In our combined US sample, the risk for PSP associated with htSNP167 is predominantly accounted for by an increase in the frequency of the homozygous genotype A/A, suggesting a recessive or a gene dose-dependent mode of inheritance. 

Phrase: "In our combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "US"

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: ","

Phrase: "the risk for PSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035647:Risk [Qualitative Concept]

Phrase: "associated with htSNP167"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "is"

Phrase: "predominantly"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by an increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "in the frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: "of the homozygous genotype A/A,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a recessive"

Phrase: "or"

Phrase: "a gene dose-dependent mode of inheritance."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C1708511:Mode of Inheritance [Functional Concept]
           Inheritance Mode
   748   C1513371:Mode [Functional Concept]
   748   C1705738:Mode [Quantitative Concept]
   748   C2347637:Mode [Quantitative Concept]
   748   C2348146:Mode [Quantitative Concept]
Processing 00000000.tx.145: However, htSNP167 alone does not completely account for the PSP association with the extended MAPT haplotype H1 in the US population. 

Phrase: "However,"

Phrase: "htSNP167"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "does"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "account for the PSP association"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   778   C0270920:Supranuclear palsy [Disease or Syndrome]
   748   C0004083:Association [Mental Process]
   748   C0205329:Progressive [Functional Concept]
   748   C0439849:Association [Qualitative Concept]
   748   C0522224:Palsy [Finding]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]
   748   C1551359:account [Idea or Concept]
   748   C2741673:Account # [Clinical Attribute]
   748   C2981730:Account [Classification]
   746   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]

Phrase: "with the extended MAPT haplotype H1"

Phrase: "in the"

Phrase: "US population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]
Processing 00000000.tx.146: This is clear, as removal of individuals carrying the htSNP167 genotype A/A from the analysis did not completely eliminate the association based on H1 and H2 frequencies in the remaining US patients and control individuals (OR reduced from 4.6 to 4.2). 

Phrase: "This"

Phrase: "is"

Phrase: "clear,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "as"

Phrase: "removal of individuals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C0557957:Removal of individual [Therapeutic or Preventive Procedure]
   790   C0015252:Removal [Therapeutic or Preventive Procedure]
   790   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the htSNP167 genotype A/A from the analysis"

Phrase: "did"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "eliminate"

Phrase: "the association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "based on H1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1527178:Based [Functional Concept]
   790   C1705938:Based [Idea or Concept]
   756 E C0002055:base [Inorganic Chemical]
   756 E C0178499:Base [Chemical Viewed Functionally]
   756 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "H2 frequencies in the remaining"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   760   C0439603:Frequencies [Temporal Concept]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]
   726 E C1705502:Frequency [Quantitative Concept]

Phrase: "US patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "control individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "(OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "reduced from 4.6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392756:Reduced [Qualitative Concept]

Phrase: "to 4.2"

Phrase: ")."
Processing 00000000.tx.147: This implies that in addition to high-risk H1 subhaplotypes (e.g. tagged by htSNP167 allele A), H2 itself behaves as a protective haplotype that accounts for a major component of the H1H2 association with PSP in the US population. 

Phrase: "This"

Phrase: "implies"

Phrase: "that in addition to high-risk H1 subhaplotypes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0332167:High Risk [Qualitative Concept]
   770   C3272283:High Risk [Finding]
   744   C0035647:Risk [Qualitative Concept]
   744   C0205250:High [Qualitative Concept]
   744   C1299351:High [Qualitative Concept]
   744   C1883712:Addition [Functional Concept]
   744   C2700149:HIGH [Intellectual Product]

Phrase: "("

Phrase: "e.g."

Phrase: "tagged by htSNP167 allele A"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0002085:Allele [Gene or Genome]
   760   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   760   C1708632:Tagged [Qualitative Concept]
   726 E C0037293:Tag [Neoplastic Process]
   726 E C0181496:Tag [Manufactured Object]
   726 E C1710492:TAG [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "H2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0919509:H2 [Gene or Genome]
  1000   C1419394:H2 [Gene or Genome]

Phrase: "itself"

Phrase: "behaves as a protective haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0018591:Haplotype [Organism Attribute]

Phrase: "that accounts for a major component of the H1H2 association"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C1551359:account [Idea or Concept]
   706   C2741673:Account # [Clinical Attribute]
   706   C2981730:Account [Classification]

Phrase: "with PSP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "in the"

Phrase: "US population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]
Processing 00000000.tx.148: The protective effect of H2 may reflect the functional impact of one or more H2-specific genetic variants and indeed the H2 tau promoter has recently been reported to show reduced activity in reporter gene assays (32). 

Phrase: "The protective effect of H2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the functional impact of one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1825598:IMPACT [Gene or Genome]

Phrase: "or"

Phrase: "more H2-specific genetic variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0205419:variants [Qualitative Concept]

Phrase: "and"

Phrase: "indeed"

Phrase: "the H2 tau promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "reduced activity in reporter gene assays"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0086439:Reduced Activity [Sign or Symptom]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.149: Reduced tau expression may well explain the protective effect of H2 in PSP, as lowered total tau levels might slow the process of aggregation, NFT formation and thus prevent or delay PSP onset. 

Phrase: "Reduced tau expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "explain"

Phrase: "the protective effect of H2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "in PSP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "as"

Phrase: "lowered total tau levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "might"

Phrase: "slow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slow [Qualitative Concept]

Phrase: "the process of aggregation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1184743:Process [Body Part, Organ, or Organ Component]
   770   C1522240:Process [Phenomenon or Process]

Phrase: "NFT formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "or"

Phrase: "delay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205421:Delay [Temporal Concept]

Phrase: "PSP onset."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332162:Onset [Qualitative Concept]
   756   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
Processing 00000000.tx.150: In addition, as MAPT H1 and H2 are inverted (24,25), it is tempting to speculate that the inversion is involved in conferring a protective effect to H2, for example by altering the higher order structure in this region leading to differential expression of H1 and H2. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "as"

Phrase: "MAPT H1"

Phrase: "and"

Phrase: "H2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0919509:H2 [Gene or Genome]
  1000   C1419394:H2 [Gene or Genome]

Phrase: "are"

Phrase: "inverted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443241:Inverted [Qualitative Concept]

Phrase: "(24,"

Phrase: "25"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "tempting"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "speculate"

Phrase: "that"

Phrase: "the inversion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021943:Inversion [Cell or Molecular Dysfunction]
  1000   C0021945:Inversion [Anatomical Abnormality]
  1000   C1705687:Inversion [Cell or Molecular Dysfunction]
  1000   C2349984:Inversion [Spatial Concept]

Phrase: "is"

Phrase: "involved in conferring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1314939:Involved [Functional Concept]

Phrase: "a protective effect to H2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "for example"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "by altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "the higher order structure in this region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   814   C1512460:Higher Order Structure [Cell Component]
   748   C0678594:Structure [Spatial Concept]

Phrase: "leading to differential expression of H1"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0332152:Leading [Temporal Concept]
   753   C0443199:Differential [Qualitative Concept]
   753   C1522538:Leading [Functional Concept]
   753   C1705242:Differential [Qualitative Concept]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "H2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0919509:H2 [Gene or Genome]
  1000   C1419394:H2 [Gene or Genome]
Processing 00000000.tx.151: However, importantly, the observed MAPT inversion does not contradict our identification of htSNP167 allele A as a high risk H1 variant because in this study, we finemapped PSP risk on H1. 

Phrase: "However,"

Phrase: "importantly,"

Phrase: "the observed MAPT inversion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0021943:Inversion [Cell or Molecular Dysfunction]
   827   C0021945:Inversion [Anatomical Abnormality]
   827   C1705687:Inversion [Cell or Molecular Dysfunction]
   827   C2349984:Inversion [Spatial Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contradict"

Phrase: "our identification of htSNP167 allele A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "as a high risk H1 variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:Variant [Qualitative Concept]

Phrase: "because in this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "we finemapped PSP risk on H1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.152: Future studies based on our findings in the US PSP populations should help determining the underlying functional basis for the association between PSP and MAPT haplotypes. 

Phrase: "Future studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "based on our findings"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C0243095:Finding [Finding]
   737 E C1880279:Base [Biomedical or Dental Material]
   737 E C2825141:Finding [Finding]

Phrase: "in the"

Phrase: "US PSP populations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0032659:Population [Quantitative Concept]
   812   C1257890:Population [Population Group]
   756   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "should"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "determining"

Phrase: "the underlying functional basis for the association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1527178:Basis [Functional Concept]
   748   C1874451:Basis [Pharmacologic Substance]

Phrase: "between PSP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "and"

Phrase: "MAPT haplotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]
Processing 00000000.tx.153: This will in turn have important implications for understanding the etiology of PSP and other neurodegenerative tauopathies and for identifying potential therapeutic targets.  

Phrase: "This"

Phrase: "will"

Phrase: "in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "have"

Phrase: "important implications for understanding"

Phrase: "the etiology of PSP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0015127:aetiology [Functional Concept]
   753   C1314792:Aetiology [Functional Concept]
   753   C1524003:Etiology [Conceptual Entity]

Phrase: "and"

Phrase: "other neurodegenerative tauopathies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0949664:Tauopathies [Disease or Syndrome]

Phrase: "and for identifying potential therapeutic targets."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   753   C0302350:Therapeutic [Functional Concept]
   753   C1515981:And [Idea or Concept]
   753   C3245505:Potential [Qualitative Concept]
   719   C1521840:Target [Functional Concept]
   719   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.154: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  PSP patientcontrol samples PSP society US sample We selected 244 patients, collected between 1993 and 2004, with a primary pathological diagnosis of PSP and with frozen material available, from the Mayo Clinic (Jacksonville) brain bank. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "PSP patientcontrol samples PSP society"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0037455:society [Organization]

Phrase: "US"

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "We"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "244 patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "collected between 1993"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "2004,"

Phrase: "with a primary pathological diagnosis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0332137:primary diagnosis [Qualitative Concept]
   913   C0801658:Primary diagnosis [Clinical Attribute]
   865   C0332142:Pathology diagnosis [Functional Concept]
   827   C0011900:Diagnosis [Finding]
   827   C1704338:diagnosis [Qualitative Concept]
   827   C1704656:DIAGNOSIS [Research Activity]

Phrase: "of PSP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "and with frozen material"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0520510:Material [Substance]
   770   C0677542:Frozen [Functional Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "available,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Available [Functional Concept]

Phrase: "from the Mayo Clinic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   861   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   789 E C0205210:Clinical [Qualitative Concept]

Phrase: "(Jacksonville"

Phrase: ")"

Phrase: "brain bank."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442598:Bank [Manufactured Object]
   861   C0872261:Bank [Manufactured Object]
Processing 00000000.tx.155: The majority of the patients (n=208) were obtained through the Society of PSP brain bank. 

Phrase: "The majority of the patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "(n=208"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "obtained through the Society of PSP brain bank."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   782   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   760   C0270920:Supranuclear palsy [Disease or Syndrome]
   739   C0006104:Brain [Body Part, Organ, or Organ Component]
   739   C0037455:society [Organization]
   739   C0205329:Progressive [Functional Concept]
   739   C0442598:Bank [Manufactured Object]
   739   C0522224:Palsy [Finding]
   739   C0872261:Bank [Manufactured Object]
   739   C1269537:Brain [Body Part, Organ, or Organ Component]
   739   C1301820:Obtained [Functional Concept]
   730   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   706 E C1706701:Obtain [Activity]
Processing 00000000.tx.156: Patients from the following studies were also included in the analysis: Mayo Clinic Alzheimer Disease Center (n=4), Mayo Clinic PD Center (n=12), Alzheimer Disease and Related Disorders Association (n=5) and the Florida AD Initiative (n=15). 

Phrase: "Patients from the following studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "also"

Phrase: "included in the analysis"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0332257:included [Functional Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: ":"

Phrase: "Mayo Clinic Alzheimer Disease Center"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   875   C1552416:Clinic/Center [Intellectual Product]
   839 E C2347782:Clinical Center [Organization]
   804   C0205099:Center [Spatial Concept]

Phrase: "(n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Mayo Clinic PD Center"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   875   C1552416:Clinic/Center [Intellectual Product]
   839 E C2347782:Clinical Center [Organization]
   804   C0205099:Center [Spatial Concept]

Phrase: "(n=12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Alzheimer Disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Related Disorders Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "(n=5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the Florida AD Initiative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0424093:Initiative [Mental Process]

Phrase: "(n=15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.157: Two additional pathologically confirmed PSP patients were obtained from the Northwestern University ADC. 

Phrase: "Two additional pathologically"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205448:Two [Quantitative Concept]
   827   C1524062:Additional [Functional Concept]
   755 E C1883712:Addition [Functional Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "PSP patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030705:Patients [Patient or Disabled Group]
   756   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "were"

Phrase: "obtained from the Northwestern University ADC."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0041740:University [Manufactured Object,Organization]
   753   C0879593:ADC [Cell,Pharmacologic Substance]
   753   C1301820:Obtained [Functional Concept]
   753   C1709274:Northwestern [Spatial Concept]
   753   C1826409:ADC [Gene or Genome]
   753   C3539026:ADC [Intellectual Product]
   719 E C1706701:Obtain [Activity]
Processing 00000000.tx.158: Pathological assessment of the patients was as previously described (33). 

Phrase: "Pathological assessment of the patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0679830:assessment patients [Health Care Activity]
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "was"

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.159: The mean age at death in the complete sample was 75.67.7 (range 5398). 

Phrase: "The mean age at death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C1543138:Age at death [Clinical Attribute]
   862   C1546180:Age at death [Clinical Attribute]
   797   C0742983:age death [Finding]
   760   C0001779:Age [Organism Attribute]

Phrase: "in the complete sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "75.67.7"

Phrase: "(range 5398"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.160: In addition, a total of 30 clinically defined patients of PSP were also included in the analysis. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "a total of 30 clinically defined patients of PSP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0439175:% total [Quantitative Concept]
   738   C0439810:Total [Qualitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "included in the analysis."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0332257:included [Functional Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]
Processing 00000000.tx.161: Twenty one patients were collected from 1998 to 2002 at the Henry L. 

Phrase: "Twenty one patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "collected from 1998"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "to 2002"

Phrase: "at the Henry L."
Processing 00000000.tx.162: Jackson Foundation/National Institutes of Health. 

Phrase: "Jackson Foundation/National Institutes of Health."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   799   C0018684:Health [Idea or Concept]
   799   C0021622:Institutes [Organization]
   799   C3245503:national [Intellectual Product]
   766 E C1272753:Institute [Idea or Concept]
Processing 00000000.tx.163: Additional clinical patients were recruited from the Mayo Clinic (Jacksonville) Movement Disorders Clinic (n=4), Mayo Clinic (Scottsdale) (n=2), the University of Minnesota (n=1) and the University of British Columbia (n=2). 

Phrase: "Additional clinical patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "recruited from the Mayo Clinic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   760   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   760   C0454788:Mayo [Geographic Area]
   760   C1077578:mayo [Plant]

Phrase: "(Jacksonville"

Phrase: ")"

Phrase: "Movement Disorders Clinic"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   827   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   755 E C0205210:Clinical [Qualitative Concept]
   734   C0026650:Movement Disorders [Disease or Syndrome]

Phrase: "(n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Mayo Clinic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   861   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   789 E C0205210:Clinical [Qualitative Concept]

Phrase: "(Scottsdale"

Phrase: ")"

Phrase: "(n=2),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "the University of Minnesota"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026183:Minnesota [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "(n=1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the University of British Columbia"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0006193:British Columbia [Geographic Area]
   812   C0041740:University [Manufactured Object,Organization]
   812   C0596227:British [Population Group]
   812   C1551442:Columbia [Population Group]
   812   C3245499:Columbia [Health Care Related Organization]
   741 E C1551955:Columbian [Language]

Phrase: "(n=2)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.164: The mean age at collection for the clinical patients was 68.17.4 (range 4783). 

Phrase: "The mean age at collection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0001779:Age [Organism Attribute]

Phrase: "for the clinical patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "was"

Phrase: "68.17.4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450387:68 [Intellectual Product]

Phrase: "(range 4783"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.165: A total of 424 age and gender matched cognitively normal control individuals were obtained through the Normal and Pathological Aging protocol at the Mayo Clinic (34,35). 

Phrase: "A total of 424 age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "gender"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "matched"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:matched [Research Activity]
  1000   C1708943:Matched [Qualitative Concept]

Phrase: "cognitively normal control individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]

Phrase: "were"

Phrase: "obtained through the Normal"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1301820:Obtained [Functional Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "Pathological Aging protocol at the Mayo Clinic"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0442711:Protocol [Intellectual Product]
   748   C1507394:Protocol [Intellectual Product]
   748   C1522729:Protocol [Intellectual Product]
   748   C2348563:Protocol [Intellectual Product]
   738   C0008971:Protocol, Clinical [Therapeutic or Preventive Procedure]

Phrase: "(34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.166: All patients and control individuals were Caucasian, from the USA and Canada. 

Phrase: "All patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "control individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "were"

Phrase: "Caucasian,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007457:Caucasian [Population Group]
  1000   C0043157:Caucasian [Population Group]

Phrase: "from the USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "and"

Phrase: "Canada."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]
Processing 00000000.tx.167: In the stratified analyses, we used pathologically confirmed PSP patients (n=244) that comprised two groups, i.e. patients with pathological findings consistent with PSP-alone (PSP-pure, n=87) and those whose primary pathological diagnosis was PSP but who also had a major secondary pathology such as AD-like amyloid plaques (PSP-plus, n=157). 

Phrase: "In the stratified analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "pathologically"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "PSP patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030705:Patients [Patient or Disabled Group]
   756   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "(n=244"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "that comprised two groups,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "i.e. patients with pathological findings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "consistent with PSP-alone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(PSP-pure, n=87"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   827   C0270920:Supranuclear palsy [Disease or Syndrome]
   811   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   799   C0205329:Progressive [Functional Concept]
   799   C0522224:Palsy [Finding]
   799   C2247561:PurE [Molecular Function]
   727 E C1882508:Purity [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "those whose primary pathological diagnosis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0332137:primary diagnosis [Qualitative Concept]
   913   C0801658:Primary diagnosis [Clinical Attribute]
   865   C0332142:Pathology diagnosis [Functional Concept]
   827   C0011900:Diagnosis [Finding]
   827   C1704338:diagnosis [Qualitative Concept]
   827   C1704656:DIAGNOSIS [Research Activity]

Phrase: "was"

Phrase: "PSP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "but"

Phrase: "who also"

Phrase: "had"

Phrase: "a major secondary pathology such as AD-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0030664:Pathology [Biomedical Occupation or Discipline]
   748   C0205469:pathology [Functional Concept]
   748   C0677042:pathology [Pathologic Function]

Phrase: "like amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
  1000   C2936349:Plaques, Amyloid [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "(PSP-plus, n=157"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   827   C0270920:Supranuclear palsy [Disease or Syndrome]
   811   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   799   C0205329:Progressive [Functional Concept]
   799   C0332287:Plus [Qualitative Concept]
   799   C0522224:Palsy [Finding]

Phrase: ")."
Processing 00000000.tx.168: In addition, we stratified the PSP patient group by age; 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "stratified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205363:Stratified [Qualitative Concept]

Phrase: "the PSP patient group by age"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0027362:Age Group [Age Group]
   767   C2348001:Age Group [Population Group]
   744   C0441833:Group [Idea or Concept]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1552516:Group [Health Care Related Organization]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]

Phrase: ";"
Processing 00000000.tx.169: we chose an age at death of 75 as cut-off age to roughly match numbers in the young PSP (75, n=106) and PSP-pure patient groups. 

Phrase: "we"

Phrase: "chose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Choose [Activity]

Phrase: "an age at death of 75"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1543138:Age at death [Clinical Attribute]
   833   C1546180:Age at death [Clinical Attribute]
   783   C0742983:age death [Finding]
   753   C0001779:Age [Organism Attribute]

Phrase: "as cut-off age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001779:Age [Organism Attribute]
   734   C1442160:Cutoff [Functional Concept]

Phrase: "to roughly"

Phrase: "match"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:match [Research Activity]
  1000   C1708943:Match [Qualitative Concept]

Phrase: "numbers in the young PSP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "(75,"

Phrase: "n=106"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "PSP-pure patient groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0441833:Group [Idea or Concept]
   799   C0687744:group [Population Group]
   799   C1257890:Group [Population Group]
   799   C1552516:Group [Health Care Related Organization]
   799   C1552839:groups [Idea or Concept]
   799   C1705428:Group [Conceptual Entity]
   799   C1705429:Group [Population Group]
Processing 00000000.tx.170: Tertiary referral center US replication sample A total of 48 patients, collected between 2004 and 2005, with a primary pathologic diagnosis of PSP and with frozen material available were selected from the Mayo Clinic (Jacksonville) brain bank. 

Phrase: "Tertiary referral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034927:Referral [Health Care Activity]

Phrase: "center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:Center [Spatial Concept]

Phrase: "US replication"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0598312:Replication [Genetic Function]
  1000   C1883725:replication [Qualitative Concept]
   928 E C0205173:Replicate [Functional Concept]
   928 E C0205341:Replicate [Functional Concept]

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "A total of 48 patients,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "collected between 2004"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "2005,"

Phrase: "with a primary pathologic diagnosis"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   913   C0332137:primary diagnosis [Qualitative Concept]
   913   C0801658:Primary diagnosis [Clinical Attribute]
   865   C0332142:Pathology diagnosis [Functional Concept]
   827   C0011900:Diagnosis [Finding]
   827   C1521733:Pathologic [Functional Concept]
   827   C1704338:diagnosis [Qualitative Concept]
   827   C1704656:DIAGNOSIS [Research Activity]
   755 E C0030664:Pathologies [Biomedical Occupation or Discipline]
   755 E C0205469:pathology [Functional Concept]
   755 E C0677042:pathology [Pathologic Function]

Phrase: "of PSP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "and with frozen material"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0520510:Material [Substance]
   770   C0677542:Frozen [Functional Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "available"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Available [Functional Concept]

Phrase: "were"

Phrase: "selected from the Mayo Clinic"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   760   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   760   C0454788:Mayo [Geographic Area]
   760   C1077578:mayo [Plant]
   726   C1707391:Select [Activity]

Phrase: "(Jacksonville"

Phrase: ")"

Phrase: "brain bank."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442598:Bank [Manufactured Object]
   861   C0872261:Bank [Manufactured Object]
Processing 00000000.tx.171: The majority of the patients were obtained through the Society of PSP brain bank. 

Phrase: "The majority of the patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "were"

Phrase: "obtained through the Society of PSP brain bank."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   782   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   760   C0270920:Supranuclear palsy [Disease or Syndrome]
   739   C0006104:Brain [Body Part, Organ, or Organ Component]
   739   C0037455:society [Organization]
   739   C0205329:Progressive [Functional Concept]
   739   C0442598:Bank [Manufactured Object]
   739   C0522224:Palsy [Finding]
   739   C0872261:Bank [Manufactured Object]
   739   C1269537:Brain [Body Part, Organ, or Organ Component]
   739   C1301820:Obtained [Functional Concept]
   730   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   706 E C1706701:Obtain [Activity]
Processing 00000000.tx.172: Additional patients with a pathologic diagnosis of PSP were obtained from the Harvard Brain Tissue Resource Center (n=20) and the University of Texas Southwestern Medical Center in Dallas (n=8). 

Phrase: "Additional patients with a pathologic diagnosis of PSP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "obtained from the Harvard Brain Tissue Resource Center"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0440746:Brain tissue [Tissue]
   770   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   770   C0920665:tissue resource [Intellectual Product]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0035201:Resource [Idea or Concept]
   744   C0040300:Tissue [Tissue]
   744   C0205099:Center [Spatial Concept]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   744   C1301820:Obtained [Functional Concept]
   744   C1547928:Tissue [Intellectual Product]
   711 E C1706701:Obtain [Activity]

Phrase: "(n=20"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the University of Texas Southwestern Medical Center in Dallas"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   784   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   764   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   764   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   742   C0039711:Texas [Geographic Area]
   742   C0041740:University [Manufactured Object,Organization]
   742   C0205099:Center [Spatial Concept]
   742   C0205476:Medical [Functional Concept]
   742   C1710136:Southwestern [Spatial Concept]

Phrase: "(n=8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.173: The mean age at death for the pathologically confirmed patients was 74.97.7 (range 4693) including 30 young PSP patients (age at death 75) and 29 old PSP patients (age at death 76). 

Phrase: "The mean age at death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C1543138:Age at death [Clinical Attribute]
   862   C1546180:Age at death [Clinical Attribute]
   797   C0742983:age death [Finding]
   760   C0001779:Age [Organism Attribute]

Phrase: "for the pathologically confirmed patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "was"

Phrase: "74.97.7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439073:97 [Intellectual Product]
   827   C0439082:>97 [Quantitative Concept]

Phrase: "(range 4693"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: ")"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "30 young PSP patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030705:Patients [Patient or Disabled Group]

Phrase: "(age at death 75"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   909   C1543138:Age at death [Clinical Attribute]
   909   C1546180:Age at death [Clinical Attribute]
   819   C0742983:age death [Finding]
   770   C0001779:Age [Organism Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "29 old PSP patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030705:Patients [Patient or Disabled Group]

Phrase: "(age at death 76"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   909   C1543138:Age at death [Clinical Attribute]
   909   C1546180:Age at death [Clinical Attribute]
   819   C0742983:age death [Finding]
   770   C0001779:Age [Organism Attribute]

Phrase: ")."
Processing 00000000.tx.174: In addition, a total of 102 patients with a clinical diagnosis of PSP were included in the analysis. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "a total of 102 patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "with a clinical diagnosis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332140:Diagnosis, clinical [Qualitative Concept]
   861   C0011900:Diagnosis [Finding]
   861   C0205210:Clinical [Qualitative Concept]
   861   C1704338:diagnosis [Qualitative Concept]
   861   C1704656:DIAGNOSIS [Research Activity]

Phrase: "of PSP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "were"

Phrase: "included in the analysis."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0332257:included [Functional Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]
Processing 00000000.tx.175: Sixty-four clinical patients were collected from movement disorder clinics at the University of Kansas, the Toronto Hospital and Buffalo Veterans Affairs Medical Center. 

Phrase: "Sixty-four clinical patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "collected from movement disorder clinics"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0026650:Movement disorder [Disease or Syndrome]
   760   C0012634:Disorder [Disease or Syndrome]
   760   C0026649:Movement [Organism Function]
   760   C0442592:clinics [Health Care Related Organization,Manufactured Object]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   726 E C0002424:Clinic [Health Care Related Organization,Manufactured Object]

Phrase: "at the University of Kansas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022497:Kansas [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "the Toronto Hospital"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "and"

Phrase: "Buffalo Veterans Affairs Medical Center."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1549054:Veterans Affairs [Organization]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0042610:Veterans [Population Group]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]
   771 E C3245459:veteran [Intellectual Product]
Processing 00000000.tx.176: Additional clinical patients were recruited from the Mayo Clinic (Jacksonville) Department of Neurology (n=34), the University of Louisville School of Medicine (n=1), Mayo Clinic (Scottsdale) (n=2) and the University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School (n=1). 

Phrase: "Additional clinical patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "recruited from the Mayo Clinic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   760   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   760   C0454788:Mayo [Geographic Area]
   760   C1077578:mayo [Plant]

Phrase: "(Jacksonville"

Phrase: ")"

Phrase: "Department of Neurology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587475:Neurology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "(n=34"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the University of Louisville School of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0036375:School [Manufactured Object,Organization]

Phrase: "(n=1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Mayo Clinic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   861   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   789 E C0205210:Clinical [Qualitative Concept]

Phrase: "(Scottsdale"

Phrase: ")"

Phrase: "(n=2)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "the University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   856   C0036367:dentistry school [Biomedical Occupation or Discipline]
   797   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   786   C0036375:School [Manufactured Object,Organization]

Phrase: "(n=1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.177: The mean age at collection for the clinical sample was 71.26.3 (range 5686). 

Phrase: "The mean age at collection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0001779:Age [Organism Attribute]

Phrase: "for the clinical sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "71.26.3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450389:71 [Intellectual Product]

Phrase: "(range 5686"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.178: A total of 396 age and gender matched cognitively normal control individuals were obtained from the Memory Disorders Clinic at Mayo Clinic (Jacksonville) (n=216) and from the Normal and Pathological Aging protocol at the Mayo Clinic (n=180) (34,35). 

Phrase: "A total of 396 age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "gender"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "matched"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:matched [Research Activity]
  1000   C1708943:Matched [Qualitative Concept]

Phrase: "cognitively normal control individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]

Phrase: "were"

Phrase: "obtained from the Memory Disorders Clinic"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0025261:Memory Disorders [Mental or Behavioral Dysfunction]
   753   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   753   C0012634:Disorders [Disease or Syndrome]
   753   C0025260:Memory [Mental Process]
   753   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   753   C0700327:memory [Finding]
   753   C1301820:Obtained [Functional Concept]
   753   C1706377:Memory [Manufactured Object]
   720   C1834645:Acquired disorder [Finding]
   719 E C1706701:Obtain [Activity]

Phrase: "at Mayo Clinic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   861   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   789 E C0205210:Clinical [Qualitative Concept]

Phrase: "(Jacksonville"

Phrase: ")"

Phrase: "(n=216"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and from the Normal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "Pathological Aging protocol at the Mayo Clinic"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0442711:Protocol [Intellectual Product]
   748   C1507394:Protocol [Intellectual Product]
   748   C1522729:Protocol [Intellectual Product]
   748   C2348563:Protocol [Intellectual Product]
   738   C0008971:Protocol, Clinical [Therapeutic or Preventive Procedure]

Phrase: "(n=180"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "(34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.179: All patients and control individuals were Caucasian from the USA and Canada. 

Phrase: "All patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "control individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "were"

Phrase: "Caucasian from the USA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007457:Caucasian [Population Group]
   770   C0043157:Caucasian [Population Group]

Phrase: "and"

Phrase: "Canada."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]
Processing 00000000.tx.180: MAPT genomic sequencing We performed an extensive MAPT genomic sequencing in 23 Caucasian Dutch-speaking individuals (25) (unpublished data). 

Phrase: "MAPT genomic sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1553778:Sequencing [Intellectual Product]
   827   C1561491:Sequencing [Functional Concept]

Phrase: "We"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "an extensive MAPT genomic sequencing in 23 Caucasian Dutch-speaking individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1553778:Sequencing [Intellectual Product]
   738   C1561491:Sequencing [Functional Concept]

Phrase: "(25"

Phrase: ")"

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.181: This large-scale MAPT sequencing effort served multiple goals: (i) genomic mutation analysis in related individuals, i.e. four FTDU-17 patients linked to 17q21 and three unaffected non-segregating siblings (25), (ii) high-density SNP detection in unrelated individuals, i.e. eight PSP and two CBD patients and (iii) six community control individuals. 

Phrase: "This large-scale MAPT sequencing effort"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0015264:Effort [Organism Function]
   722   C1517723:Large-Scale Sequencing [Molecular Biology Research Technique]

Phrase: "served"

Phrase: "multiple goals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0018017:Goals [Intellectual Product]
   827 E C1571704:Goal [Idea or Concept]

Phrase: ":"

Phrase: "(i) genomic mutation analysis in related individuals,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0796357:mutation analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "i.e. four FTDU-17 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030705:Patients [Patient or Disabled Group]

Phrase: "linked to 17q21"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1520768:17q21 [Cell Component]
   756   C1517892:Link [Intellectual Product]
   756   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "three unaffected non-segregating siblings"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0037047:Siblings [Family Group]
   771 E C1611273:Sibling [Intellectual Product]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "(ii"

Phrase: ")"

Phrase: "high-density SNP detection in unrelated individuals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "i.e. eight PSP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   827   C0270920:Supranuclear palsy [Disease or Syndrome]
   811   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   799   C0205329:Progressive [Functional Concept]
   799   C0522224:Palsy [Finding]

Phrase: "and"

Phrase: "two CBD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "and ("

Phrase: "iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "six community control individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]
Processing 00000000.tx.182: The ten sporadic tauopathy patients were recruited in a prospective Belgian study of neurodegenerative and vascular dementia (36), were diagnosed based on NINCDS-PSP criteria and had a mean onset age 67.67.8. 

Phrase: "The ten sporadic tauopathy patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "recruited in a prospective Belgian study of neurodegenerative"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0033522:prospective study [Research Activity]
   767   C1709709:Prospective Study [Research Activity]
   744   C0023981:prospective [Research Activity]
   744   C0337797:belgian [Population Group]
   744   C0557651:Study [Manufactured Object]
   744   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "vascular dementia"
Meta Candidates (Total=14; Excluded=8; Pruned=0; Remaining=6)
  1000   C0011269:Dementia, Vascular [Disease or Syndrome]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   861   C1558950:VASCULAR [Finding]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
   745 E C0333275:Bloody [Qualitative Concept]

Phrase: "(36"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "based on NINCDS-PSP criteria"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   814   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   778   C0270920:Supranuclear palsy [Disease or Syndrome]
   748   C0205329:Progressive [Functional Concept]
   748   C0243161:criteria [Intellectual Product]
   748   C0522224:Palsy [Finding]
   748   C1527178:Based [Functional Concept]
   748   C1705938:Based [Idea or Concept]
   746   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "had"

Phrase: "a mean onset age 67.67.8."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0206132:Onset Age [Quantitative Concept]
   799   C0001779:Age [Organism Attribute]
   799   C0332162:Onset [Qualitative Concept]
   799   C0444504:Mean [Quantitative Concept]
   799   C2347634:Mean [Quantitative Concept]
   799   C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.183: The 23 individuals together represented 43 unrelated chromosomes of which 36 carried H1 and seven H2. 

Phrase: "The 23 individuals together"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0027361:Individual [Population Group]
   793   C0237401:Individual [Human]

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "43 unrelated chromosomes of which 36 carried H1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0008633:Chromosomes [Cell Component]

Phrase: "and"

Phrase: "seven H2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0919509:H2 [Gene or Genome]
   861   C1419394:H2 [Gene or Genome]
Processing 00000000.tx.184: We sequenced a genomic region of 138.5kb of MAPT (GenBank accession number NC_000017.9 from position 4132374641462318), including 3.9kb upstream of exon 0 and 3.7kb downstream exons 13/14, which were conserved in rodent. 

Phrase: "We"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "a genomic region of 138.5kb of MAPT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0017428:Genomic [Gene or Genome]
   744   C0017446:Region [Geographic Area]
   744   C0205147:Region [Spatial Concept]
   744   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "(GenBank accession number NC_000017.9 from position 4132374641462318"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C1708200:GenBank_Accession_Number [Intellectual Product]
   764   C1510755:Accession Number [Intellectual Product]
           Accession
   762   C0213800:9-NC [Organic Chemical,Pharmacologic Substance]
   762   C2985830:Position Number [Quantitative Concept]
   742   C0027964:NC [Geographic Area]
   742   C0028407:NC [Geographic Area]
   742   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0237753:*Number [Quantitative Concept]
   742   C0449788:Number [Quantitative Concept]
   742   C0598211:GenBank [Intellectual Product]
   742   C0733755:Position [Spatial Concept]
   742   C1706078:Accession [Activity]

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "3.9kb upstream of exon 0"

Phrase: "and"

Phrase: "3.7kb downstream exons 13/14,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0439086:<3 [Quantitative Concept]
   799   C0522506:Downstream [Spatial Concept]
   799   C2827736:3+ [Quantitative Concept]
   799   C2981702:3+ [Classification]

Phrase: "which"

Phrase: "were"

Phrase: "conserved in rodent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035804:Rodent [Mammal]
Processing 00000000.tx.185: PCR primers were developed to cover the complete genomic sequence with the exclusion of long stretches of interspersed repeat elements using SNPbox (37). 

Phrase: "PCR primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "developed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0180153:cover [Medical Device]
  1000   C1707529:Cover [Medical Device]
  1000   C1999244:Cover [Functional Concept]

Phrase: "the complete genomic sequence with the exclusion of long stretches of interspersed repeat elements"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   734   C0004793:Sequence [Nucleotide Sequence]
   734   C0162326:Sequence [Nucleotide Sequence]
   734   C0162327:Sequence [Nucleotide Sequence]
   734   C1519249:Sequence [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SNPbox"

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.186: Standard PCR reactions were performed and amplification products were purified, sequenced in both directions using the BigDye Terminator Cycle Sequencing v3.1 (Applied Biosystems) and analyzed on an ABI3730 DNA analyzer (Applied Biosystems). 

Phrase: "Standard PCR reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0443286:Reaction [Functional Concept]
   793   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "amplification products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: ","

Phrase: "sequenced in both directions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0439755:Directions [Spatial Concept]
   737   C0004793:Sequence [Nucleotide Sequence]
   737   C0162326:Sequence [Nucleotide Sequence]
   737   C0162327:Sequence [Nucleotide Sequence]
   737 E C0449738:Direction [Spatial Concept]
   737   C1519249:Sequence [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BigDye Terminator Cycle Sequencing v3.1"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   822   C0039554:Terminator Sequence [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0507236:V3 [Body Part, Organ, or Organ Component]
   799   C0851166:TERMINATOR [Pharmacologic Substance]
   799   C1511572:Cycle [Temporal Concept]
   799   C1553778:Sequencing [Intellectual Product]
   799   C1561491:Sequencing [Functional Concept]
   799   C1705818:Terminator [Manufactured Object]
   799   C3205287:Terminator [Pharmacologic Substance]
   766 E C0004793:Sequence [Nucleotide Sequence]
   766 E C0162326:Sequence [Nucleotide Sequence]
   766 E C0162327:Sequence [Nucleotide Sequence]
   766 E C1519249:Sequence [Functional Concept]

Phrase: "(Applied Biosystems"

Phrase: ")"

Phrase: "and"

Phrase: "analyzed on an ABI3730 DNA analyzer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0179038:Analyzer [Medical Device]
   753   C0936012:Analyzed [Research Activity]
   753   C1706246:Analyzer [Manufactured Object]

Phrase: "(Applied Biosystems"

Phrase: ")."
Processing 00000000.tx.187: Sequences were analyzed using NovoSNP (38) and by visual inspection of the sequence reads. 

Phrase: "Sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "NovoSNP"

Phrase: "(38"

Phrase: ")"

Phrase: "and by visual inspection of the sequence reads."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C2984756:VISUAL INSPECTION [Functional Concept]
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0034754:reads [Daily or Recreational Activity]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0199219:Inspection [Functional Concept]
   744   C0234621:Visual [Functional Concept]
   744   C1515981:And [Idea or Concept]
   744   C1519249:Sequence [Functional Concept]
   711 E C1705179:read [Finding]
Processing 00000000.tx.188: No causal mutations were detected in the FTDU-17 patients (25). 

Phrase: "No causal mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "detected in the FTDU-17 patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1843792:FTDU [Disease or Syndrome]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.189: In the ten sporadic tauopathy patients, we identified 30 patient-only genetic variants of which 14 were absent in 102 unrelated community control individuals (Supplementary Material, Table S1). 

Phrase: "In the ten sporadic tauopathy patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "30 patient-only genetic variants of which 14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:variants [Qualitative Concept]

Phrase: "were"

Phrase: "absent in 102 unrelated community control individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332197:Absent [Quantitative Concept]
   748   C2699517:ABSENT [Finding]

Phrase: "(Supplementary Material,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936424:Supplementary Material [Intellectual Product]
   861   C0520510:Material [Substance]

Phrase: "Table S1"

Phrase: ")."
Processing 00000000.tx.190: Subsequent analysis of the 14 SNPs in 80 unrelated US PSP patients identified SNP163 (g.54661A/T) and SNP461 (g.127153_127154delCT) in one patient each. 

Phrase: "Subsequent analysis of the 14 SNPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in 80 unrelated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0445356:Unrelated [Finding]
   861   C1704623:Unrelated [Qualitative Concept]
   789 E C0680208:unrelatedness [Social Behavior]

Phrase: "US PSP patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030705:Patients [Patient or Disabled Group]
   756   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "SNP163"

Phrase: "(g.54661A/T)"

Phrase: "and"

Phrase: "SNP461"

Phrase: "(g.127153_127154delCT"

Phrase: ")"

Phrase: "in one patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "each."
Processing 00000000.tx.191: In total 577 genetic variants were observed in the MAPT genomic sequence of which 424 variants (388 SNPs and 36 indels) were assigned to H2 based on their absence in H1/H1 individuals (n=16) and their heterozygosity in H1/H2 individuals (n=7). 

Phrase: "In total 577 genetic variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:variants [Qualitative Concept]

Phrase: "were"

Phrase: "observed in the MAPT genomic sequence of which 424 variants"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0017428:Genomic [Gene or Genome]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C0205419:variants [Qualitative Concept]
   739   C0887950:genomic [Biomedical Occupation or Discipline]
   739   C1441672:Observed [Functional Concept]
   739   C1446659:MAPT [Gene or Genome]
   739   C1519249:Sequence [Functional Concept]

Phrase: "(388 SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0752046:SNPs [Nucleotide Sequence]
   827 E C1527094:SNP [Conceptual Entity]

Phrase: "and"

Phrase: "36 indels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1956002:Indel [Genetic Function]

Phrase: ")"

Phrase: "were"

Phrase: "assigned to H2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0919509:H2 [Gene or Genome]
   790   C1419394:H2 [Gene or Genome]
   790   C1516050:Assigned [Functional Concept]
   790   C1552601:assigned [Intellectual Product]

Phrase: "based on their absence"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0332197:absence [Quantitative Concept]
   770   C1527178:Based [Functional Concept]
   770   C1689985:Absence [Anatomical Abnormality]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "in H1/H1 individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0027361:Individual [Population Group]
   793   C0237401:Individual [Human]

Phrase: "(n=16"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "their heterozygosity in H1/H2 individuals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0019425:Heterozygosity [Organism Attribute]

Phrase: "(n=7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.192: The remaining 153 were designated H1 variants (140 SNPs and 13 indels). 

Phrase: "The remaining 153"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1527428:Remaining [Qualitative Concept]

Phrase: "were"

Phrase: "designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: "H1 variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "(140 SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0752046:SNPs [Nucleotide Sequence]
   827 E C1527094:SNP [Conceptual Entity]

Phrase: "and"

Phrase: "13 indels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1956002:Indel [Genetic Function]

Phrase: ")."
Processing 00000000.tx.193: For H2 genotyping, we selected SNP16 (g.8117G>A; numbering for this SNP and all genetic variants relative to AC091628.2) located in intron 0 as ht SNP. 

Phrase: "For H2 genotyping,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1285573:Genotyping [Laboratory Procedure]

Phrase: "we"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "SNP16"

Phrase: "(g.8117G"

Phrase: ">A"

Phrase: "; numbering for this SNP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0449788:numbering [Quantitative Concept]
   737 E C0237753:*Number [Quantitative Concept]

Phrase: "and"

Phrase: "all genetic variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "relative to AC091628.2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: ")"

Phrase: "located in intron 0"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as ht SNP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0752046:SNP [Nucleotide Sequence]
   861   C1527094:SNP [Conceptual Entity]
Processing 00000000.tx.194: Validation of SNP16 in 91 Belgian PD patients showed complete LD of SNP16 with two previously published H2 SNPs, SNP9i (g.109929A>G) and SNP9ii (g.110013T>C) (12). 

Phrase: "Validation of SNP16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1519941:Validation [Research Activity]

Phrase: "in 91 Belgian PD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "complete LD of SNP16"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   806   C1880153:Complete Linkage [Research Activity]
   760   C0023745:linkage [Molecular Function]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "with two previously published H2 SNPs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0752046:SNPs [Nucleotide Sequence]
   771 E C1527094:SNP [Conceptual Entity]

Phrase: "SNP9i"

Phrase: "(g.109929A"

Phrase: ">G)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "SNP9ii"

Phrase: "(g.110013T"

Phrase: ">C) (12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.195: LD substructure of MAPT Pairwise measures of linkage disequilibrium (LD) were calculated using Ldmax (http://www.sph.umich.edu/csg/abecasis/GOLD/docs/ldmax.html). 

Phrase: "LD substructure of MAPT"

Phrase: "Pairwise"

Phrase: "measures of linkage disequilibrium (LD)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0079809:Measure [Quantitative Concept]
   770   C0242485:Measure [Functional Concept]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]
   770   C1879489:Measures [Functional Concept]

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Ldmax"

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.sph.umich.edu/csg/abecasis/GOLD/docs/ldmax.html"

Phrase: ")."
Processing 00000000.tx.196: In the LD mapping of MAPT, we used only the 85 common H1 variants with rare allele frequencies of 5%. 

Phrase: "In the LD mapping"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1517888:Linkage Disequilibrium Mapping [Molecular Biology Research Technique]
   913   C0008630:Linkage Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   827   C1283195:Mapping [Activity]
   734   C0023746:Linkage Disequilibrium [Quantitative Concept]

Phrase: "of MAPT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1446659:MAPT [Gene or Genome]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the 85 common H1 variants with rare allele frequencies of 5%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0205419:variants [Qualitative Concept]
Processing 00000000.tx.197: Further, we excluded 42 H1 variants from further analyses as they showed complete LD with at least one other H1 variant in the pairwise analyses. 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "we"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "42 H1 variants from further analyses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:variants [Qualitative Concept]

Phrase: "as"

Phrase: "they"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "complete LD with"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   833   C1880153:Complete Linkage [Research Activity]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "at least one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "other H1 variant in the pairwise analyses."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:Variant [Qualitative Concept]
Processing 00000000.tx.198: As we used pyrosequencing as SNP genotyping method, we preferred SNPs to indels. 

Phrase: "As"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "pyrosequencing as SNP genotyping method,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2737269:Pyrosequencing [Laboratory Procedure]

Phrase: "we"

Phrase: "preferred"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0558295:Preferred [Idea or Concept]
  1000   C1548789:Preferred [Qualitative Concept]
  1000   C3543840:Preferred [Qualitative Concept]

Phrase: "SNPs to indels."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0752046:SNPs [Nucleotide Sequence]
   756 E C1527094:SNP [Conceptual Entity]
Processing 00000000.tx.199: The remaining 43 H1 variants were genotyped in 51 control triads ascertained in Flanders. 

Phrase: "The remaining 43 H1 variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:variants [Qualitative Concept]

Phrase: "were"

Phrase: "genotyped in 51 control triads"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0076994:triads [Biomedical or Dental Material,Organic Chemical]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726   C0017431:Genotype [Organism Attribute]
   726 E C1179122:triad [Cell Component]

Phrase: "ascertained in Flanders."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1875156:Flanders [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.200: One SNP, SNP162, was excluded from the LD analysis as in 7.9% of control individuals, the rare H1 allele was observed on H2. 

Phrase: "One SNP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0752046:SNP [Nucleotide Sequence]
   861   C1527094:SNP [Conceptual Entity]

Phrase: "SNP162,"

Phrase: "was"

Phrase: "excluded from the LD analysis"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0023746:Linkage Disequilibrium [Quantitative Concept]
   783   C0796345:analysis linkage [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0023745:linkage [Molecular Function]
   753   C0281825:Disequilibrium [Finding]
   753   C0394006:Disequilibrium [Disease or Syndrome]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1554077:Excluded [Idea or Concept]
   753   C2828389:Excluded [Activity]
   719 E C0332196:Exclude [Functional Concept]

Phrase: "as in 7.9% of control individuals,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714   C0027361:Individual [Population Group]
   714   C0237401:Individual [Human]

Phrase: "the rare H1 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "observed on H2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0919509:H2 [Gene or Genome]
   790   C1419394:H2 [Gene or Genome]
   790   C1441672:Observed [Functional Concept]
Processing 00000000.tx.201: We defined four LD blocks that spanned 45kb including exon 0 and the 5' part of intron 0 (block 1), 10kb in intron 0 (block 2), 63kb of the 3' end of intron 0 and exons 19 (block 3) and 20kb comprising exons 1013/14 (block 4) (Fig.1A). 

Phrase: "We"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "four LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "that spanned 45kb"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "exon 0"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the 5' part of intron 0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "(block 1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0028778:Block [Pathologic Function]
   861   C0332206:Block [Functional Concept]
   861   C1533157:Block [Substance]
   861   C1706084:Block [Geographic Area]
   861   C2828370:Block [Quantitative Concept]
   789 E C2983591:BLOCKED [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "10kb in intron 0"

Phrase: "(block 2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0028778:Block [Pathologic Function]
   861   C0332206:Block [Functional Concept]
   861   C1533157:Block [Substance]
   861   C1706084:Block [Geographic Area]
   861   C2828370:Block [Quantitative Concept]
   789 E C2983591:BLOCKED [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "63kb of the 3' end of intron 0"

Phrase: "and"

Phrase: "exons 19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(block 3"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0028778:Block [Pathologic Function]
   861   C0332206:Block [Functional Concept]
   861   C1533157:Block [Substance]
   861   C1706084:Block [Geographic Area]
   861   C2828370:Block [Quantitative Concept]
   789 E C2983591:BLOCKED [Research Activity]

Phrase: ")"

Phrase: "and"

Phrase: "20kb comprising exons 1013/14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771   C2700400:Comprise [Activity]

Phrase: "(block 4"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0028778:Block [Pathologic Function]
   861   C0332206:Block [Functional Concept]
   861   C1533157:Block [Substance]
   861   C1706084:Block [Geographic Area]
   861   C2828370:Block [Quantitative Concept]
   789 E C2983591:BLOCKED [Research Activity]

Phrase: ")"

Phrase: "(Fig.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.202: In each LD block, we estimated common H1 subhaplotypes (frequency 2%) in the parental chromosomes in which subhaplotypes could be set unambiguously and obtained nine subhaplotypes in block 1 (n=17), seven in block 3 (n=18) and six in block 4 (n=6) representing 87, 85 and 96%, respectively, of the H1 subhaplotype diversity. 

Phrase: "In each LD block,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0028778:Block [Pathologic Function]
   827   C0332206:Block [Functional Concept]
   827   C1533157:Block [Substance]
   827   C1706084:Block [Geographic Area]
   827   C2828370:Block [Quantitative Concept]
   755 E C2983591:BLOCKED [Research Activity]
   734   C0023746:Linkage Disequilibrium [Quantitative Concept]

Phrase: "we"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "common H1 subhaplotypes"

Phrase: "(frequency 2%"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: ")"

Phrase: "in the parental chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosomes [Cell Component]

Phrase: "in which subhaplotypes"

Phrase: "could"

Phrase: "be"

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "unambiguously"

Phrase: "and"

Phrase: "obtained nine subhaplotypes in block 1"

Phrase: "(n=17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "seven in block 3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0028778:Block [Pathologic Function]
   770   C0205453:Seven [Quantitative Concept]
   770   C0332206:Block [Functional Concept]
   770   C1533157:Block [Substance]
   770   C1706084:Block [Geographic Area]
   770   C2828370:Block [Quantitative Concept]

Phrase: "(n=18"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "six in block 4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0028778:Block [Pathologic Function]
   770   C0205452:Six [Quantitative Concept]
   770   C0332206:Block [Functional Concept]
   770   C1533157:Block [Substance]
   770   C1706084:Block [Geographic Area]
   770   C2828370:Block [Quantitative Concept]

Phrase: "(n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "87,"

Phrase: "85"

Phrase: "and"

Phrase: "96%,"

Phrase: "respectively,"

Phrase: "of the H1 subhaplotype diversity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1880371:Diversity [Qualitative Concept]
Processing 00000000.tx.203: Block 2 contained only one common H1 SNP, SNP167. 

Phrase: "Block 2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0028778:Block [Pathologic Function]
   861   C0332206:Block [Functional Concept]
   861   C1533157:Block [Substance]
   861   C1706084:Block [Geographic Area]
   861   C2828370:Block [Quantitative Concept]
   789 E C2983591:BLOCKED [Research Activity]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "only one common H1 SNP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0752046:SNP [Nucleotide Sequence]
   804   C1527094:SNP [Conceptual Entity]

Phrase: "SNP167."
Processing 00000000.tx.204: Using the computer program TagnTell (http://snp.cgb.ki.se/tagntell/), we selected 14 htSNPsfive in block 1, one in block 2 and four in blocks 3 and 4 each (Fig.1A)tagging together 94% of MAPT H1 haplotype diversity. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the computer program TagnTell"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0037585:Computer Program [Intellectual Product,Manufactured Object]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//snp.cgb.ki.se/tagntell/"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "14 htSNPsfive in block 1,"

Phrase: "one in block 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "and"

Phrase: "four in blocks 3"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0028778:blocks [Pathologic Function]
   770   C0205450:Four [Quantitative Concept]
   770   C0332206:Blocks [Functional Concept]
   770   C1533157:Blocks [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "4"

Phrase: "each"

Phrase: "(Fig.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: "tagging"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0037293:Tag [Neoplastic Process]
   966   C0181496:Tag [Manufactured Object]
   966   C1710492:TAG [Gene or Genome]

Phrase: "together 94% of MAPT H1 haplotype diversity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0018591:Haplotype [Organism Attribute]
   748   C1446659:MAPT [Gene or Genome]
   748   C1880371:Diversity [Qualitative Concept]
   748   C1883357:Together [Qualitative Concept]
Processing 00000000.tx.205: Together with H2 SNP16, the htSNP panel captured 95% of MAPT haplotype diversity. 

Phrase: "Together with H2 SNP16,"

Phrase: "the htSNP panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "captured"

Phrase: "95% of MAPT haplotype diversity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0018591:Haplotype [Organism Attribute]
   760   C1446659:MAPT [Gene or Genome]
   760   C1880371:Diversity [Qualitative Concept]
Processing 00000000.tx.206: In the US control chromosomes (n=632), the two ancestral MAPT H1 haplotypes, H1A (CTTGA-G-ACAG-ATTA) and H1B (CGTGT-A-GCGG-GCTG), had frequencies of 20 and 14%, respectively, similar to those we previously observed in Belgian (n=291, H1A=19%; H1B=14%), French (n=412, H1A=22%; H1B=15%) and Spanish (n=84, H1A=19%; H1B=13%) control samples (25,26) (unpublished data). 

Phrase: "In the"

Phrase: "US"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008633:Chromosomes [Cell Component]

Phrase: "(n=632"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the two ancestral MAPT H1 haplotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0018591:Haplotypes [Organism Attribute]

Phrase: "H1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415385:H1A [Gene or Genome]

Phrase: "(CTTGA-G-ACAG-ATTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1000491:Atta [Eukaryote]

Phrase: ")"

Phrase: "and"

Phrase: "H1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415389:H1B [Gene or Genome]

Phrase: "(CGTGT-A-GCGG-GCTG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1415027:GCTG [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "had"

Phrase: "frequencies of 20"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   790   C0439603:Frequencies [Temporal Concept]
   756 E C0376249:frequency [Quantitative Concept]
   756 E C0871396:Frequency [Quantitative Concept]
   756 E C1561548:Frequency [Qualitative Concept]
   756 E C1705502:Frequency [Quantitative Concept]
   706 E C0332183:Frequent [Temporal Concept]

Phrase: "and"

Phrase: "14%,"

Phrase: "respectively,"

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "we previously"

Phrase: "observed in Belgian"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0337797:belgian [Population Group]
   790   C1441672:Observed [Functional Concept]

Phrase: "(n=291,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "H1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415385:H1A [Gene or Genome]

Phrase: "=19%"

Phrase: "; H1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415389:H1B [Gene or Genome]

Phrase: "=14%"

Phrase: ")"

Phrase: ","

Phrase: "French"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556084:French [Population Group]

Phrase: "(n=412,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "H1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415385:H1A [Gene or Genome]

Phrase: "=22%"

Phrase: "; H1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415389:H1B [Gene or Genome]

Phrase: "=15%"

Phrase: ")"

Phrase: "and"

Phrase: "Spanish"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086409:SPANISH [Population Group]
  1000   C3161473:Spanish [Population Group]

Phrase: "(n=84,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "H1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415385:H1A [Gene or Genome]

Phrase: "=19%"

Phrase: "; H1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415389:H1B [Gene or Genome]

Phrase: "=13%"

Phrase: ")"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "(25,"

Phrase: "26"

Phrase: ")"

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.207: SNP genotyping MAPT H1 and H2 haplotyping was performed by htSNP16 (g.8117G>A) with the allele G tagging H1 and the allele A tagging H2. 

Phrase: "SNP genotyping MAPT H1"

Phrase: "and"

Phrase: "H2 haplotyping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotype [Organism Attribute]

Phrase: "was"

Phrase: "performed by htSNP16"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(g.8117G"

Phrase: ">A) with the allele G tagging H1"

Phrase: "and"

Phrase: "the allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: "A tagging H2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0919509:H2 [Gene or Genome]
   861   C1419394:H2 [Gene or Genome]
Processing 00000000.tx.208: htSNP16 genotyping was performed by pyrosequencing on a PSQTM pyrosequencer using 5'-bio-CCT CTG TCG ACT ATC AGG TAA GC-3' and 5'-CTT GCT CAG GTC CCT TTC C-3' as PCR primers and 5'-CGG CGC ACG AAG C-3' as reverse sequencing primer. 

Phrase: "htSNP16 genotyping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1285573:Genotyping [Laboratory Procedure]

Phrase: "was"

Phrase: "performed by pyrosequencing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0884358:Performed [Functional Concept]
   790   C2737269:Pyrosequencing [Laboratory Procedure]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "on a PSQTM pyrosequencer"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "5'-bio-CCT CTG TCG"

Phrase: "ACT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "ATC AGG TAA GC-3'"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0039872:TAA [Hazardous or Poisonous Substance,Organic Chemical]
   804   C0162872:TAA [Disease or Syndrome]
   804   C3537453:GC [Gene or Genome]

Phrase: "and"

Phrase: "5'-CTT GCT CAG GTC CCT TTC C-3'"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   791   C0040405:ctt [Diagnostic Procedure]
   791   C0266539:CCT [Congenital Abnormality,Disease or Syndrome]
   791   C0439084:>5 [Quantitative Concept]
   791   C0728893:+5 [Quantitative Concept]
   791   C3538813:GCT [Gene or Genome]

Phrase: "as"

Phrase: "PCR primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "5'-CGG CGC ACG AAG C-3'"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   795   C0050397:AcG [Amino Acid, Peptide, or Protein]
   795   C0439084:>5 [Quantitative Concept]
   795   C0728893:+5 [Quantitative Concept]
   795   C0796552:AAG [Antibiotic,Organic Chemical]
   795   C1417239:AAG [Gene or Genome]
   795   C1428097:ACG [Gene or Genome]
   795   C1832232:CGC [Disease or Syndrome]
   795   C1864172:CGG [Disease or Syndrome]
   795   C2986643:AAG [Gene or Genome]

Phrase: "as"

Phrase: "reverse sequencing primer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.209: Pyrosequencing assays were also developed for all H1 htSNPs except for htSNP352 (g.97065C>T) and for 10 additional H1 SNPs selected for high-density SNP LD mapping (Supplementary Material, Table S2). 

Phrase: "Pyrosequencing assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "also"

Phrase: "developed for all H1 htSNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   762   C2985510:Tagging SNP [Nucleotide Sequence]
   748   C0018591:Haplotype [Organism Attribute]
   748   C0752046:SNPs [Nucleotide Sequence]
   714   C0037293:Tag [Neoplastic Process]
   714   C0181496:Tag [Manufactured Object]
   714 E C1527094:SNP [Conceptual Entity]
   714   C1710492:TAG [Gene or Genome]

Phrase: "except for htSNP352"

Phrase: "(g.97065C"

Phrase: ">T)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and for 10 additional H1 SNPs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0752046:SNPs [Nucleotide Sequence]
   753   C1515981:And [Idea or Concept]
   753   C1524062:Additional [Functional Concept]
   719 E C1527094:SNP [Conceptual Entity]

Phrase: "selected for high-density SNP LD mapping"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   800   C1517888:Linkage Disequilibrium Mapping [Molecular Biology Research Technique]
   770   C0023746:Linkage Disequilibrium [Quantitative Concept]
   767   C0008630:Linkage Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0023745:linkage [Molecular Function]
   744   C0178587:density [Quantitative Concept]
   744   C0205250:High [Qualitative Concept]
   744   C0281825:Disequilibrium [Finding]
   744   C0394006:Disequilibrium [Disease or Syndrome]
   744   C0752046:SNP [Nucleotide Sequence]
   744   C1283195:Mapping [Activity]
   744   C1299351:High [Qualitative Concept]
   744   C1527094:SNP [Conceptual Entity]
   744   C2700149:HIGH [Intellectual Product]
   711   C1707391:Select [Activity]

Phrase: "(Supplementary Material,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936424:Supplementary Material [Intellectual Product]
   861   C0520510:Material [Substance]

Phrase: "Table S2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1179705:S2 [Body Location or Region]
   861   C1419032:S2 [Gene or Genome]
   861   C1419718:S2 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.210: htSNP352 and SNP355 (g.96899A/G) were genotyped by direct sequencing. 

Phrase: "htSNP352"

Phrase: "and"

Phrase: "SNP355"

Phrase: "(g.96899A/G)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C1319635:g/g [Quantitative Concept]

Phrase: "were"

Phrase: "genotyped by direct sequencing."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0439851:Direct [Qualitative Concept]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]
   770   C1947931:Direct [Qualitative Concept]
   737   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.211: For all known H1 SNPs that were analyzed in this study, rs-numbers are included in Supplementary Material, Table S2. 

Phrase: "For all known H1 SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0752046:SNPs [Nucleotide Sequence]
   793 E C1527094:SNP [Conceptual Entity]

Phrase: "that"

Phrase: "were"

Phrase: "analyzed in this study,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C0936012:Analyzed [Research Activity]
   770   C2603343:Study [Research Activity]

Phrase: "rs-numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "are"

Phrase: "included in Supplementary Material,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C2936424:Supplementary Material [Intellectual Product]
   770   C0332257:included [Functional Concept]
   770   C0520510:Material [Substance]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "Table S2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1179705:S2 [Body Location or Region]
   861   C1419032:S2 [Gene or Genome]
   861   C1419718:S2 [Gene or Genome]
Processing 00000000.tx.212: Statistical analyses Hardy Weinberg equilibrium (HWE) was calculated for the all htSNPs using the HWE program and all patient and control populations were in HWE (39). 

Phrase: "Statistical analyses Hardy Weinberg equilibrium (HWE)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0014653:Equilibrium [Organism Function]
   804   C1547026:Equilibrium [Quantitative Concept]

Phrase: "was"

Phrase: "calculated for the"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]

Phrase: "all htSNPs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C2985510:Tagging SNP [Nucleotide Sequence]
   827   C0752046:SNPs [Nucleotide Sequence]
   793 E C1527094:SNP [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the HWE program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1709697:Program [Conceptual Entity]
   812   C2728259:Program [Pharmacologic Substance]
   812   C3484370:Program [Functional Concept]

Phrase: "and"

Phrase: "all patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "and"

Phrase: "control populations"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C0032662:control population [Occupation or Discipline]
   861   C0032659:Population [Quantitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1257890:Population [Population Group]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "were in HWE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014653:Equilibrium [Organism Function]
   760   C1547026:Equilibrium [Quantitative Concept]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.213: For single H1 htSNP association analysis, two different strategies were applied to compensate for the significant differences in relative numbers of H1 chromosomes between PSP patients and control individuals. 

Phrase: "For single H1 htSNP association analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]

Phrase: "two different strategies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679199:strategies [Mental Process]

Phrase: "were"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compensate for the significant differences"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205432:compensate [Qualitative Concept]
   760   C0237881:significant [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "in relative numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of H1 chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosomes [Cell Component]

Phrase: "between PSP patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030705:Patients [Patient or Disabled Group]
   756   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "and"

Phrase: "control individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]
Processing 00000000.tx.214: For allelic single htSNP association, we used all H1 htSNP haplotypes including H1/H1+H1/H2 individuals as all htSNPs were invariable on H2. 

Phrase: "For allelic single htSNP association,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0004083:Association [Mental Process]
   812   C0439849:Association [Qualitative Concept]
   812   C0596306:Association [Phenomenon or Process]
   812   C0699792:association [Social Behavior]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "all H1 htSNP haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "H1/H1+H1/H2 individuals as all htSNPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   706   C0027361:Individual [Population Group]
   706   C0237401:Individual [Human]

Phrase: "were"

Phrase: "invariable on H2."
Processing 00000000.tx.215: Genotypic single htSNP associations were assessed using Genepop (http://wbiomed.curtin.edu.au/genepop/) in subpopulations of H1/H1 patients and control individuals. 

Phrase: "Genotypic single htSNP associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0004083:Associations [Mental Process]
   779 E C0439849:Association [Qualitative Concept]
   779 E C0596306:Association [Phenomenon or Process]
   779 E C0699792:association [Social Behavior]

Phrase: "were"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Genepop"

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//wbiomed.curtin.edu.au/genepop/"

Phrase: ")"

Phrase: "in subpopulations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1257890:Subpopulation [Population Group]

Phrase: "of H1/H1 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "control individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]
Processing 00000000.tx.216: To investigate H1 haplotype associations, we used the score method of Schaid etal. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "H1 haplotype associations,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0004083:Associations [Mental Process]
   793 E C0439849:Association [Qualitative Concept]
   793 E C0596306:Association [Phenomenon or Process]
   793 E C0699792:association [Social Behavior]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the score method of Schaid etal."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.217: (40). 

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.218: Only haplotypes with an estimated overall frequency of 5% were considered for these analyses. 

Phrase: "Only haplotypes with an estimated overall frequency of 5%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "considered for these analyses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0750591:considered [Idea or Concept]
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]
Processing 00000000.tx.219: The P-values reported are those based on asymptotic assumptions. 

Phrase: "The P-values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709380:P-Value [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "are"

Phrase: "those"

Phrase: "based on asymptotic assumptions."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.220: These assumptions were verified also by calculating simulation P-values based on 1000 random permutations of patient and control labels and results were found to be consistent. 

Phrase: "These assumptions"

Phrase: "were"

Phrase: "verified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verified [Functional Concept]

Phrase: "also by calculating simulation P-values"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   756   C1709380:P-Value [Quantitative Concept]
   753   C0042295:Values [Qualitative Concept]
   753   C0679083:Simulation [Research Activity]
   753   C1441506:Calculating [Activity]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "based on 1000 random permutations of patient"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   757   C1709483:Patient Base [Quantitative Concept]
   748   C0030705:*^patient [Patient or Disabled Group]
   748   C0034656:RANDOM [Research Activity]
   748   C0439605:Random [Qualitative Concept]
   748   C1527178:Based [Functional Concept]
   748   C1705938:Based [Idea or Concept]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]
   714   C1882348:Permutation [Qualitative Concept]

Phrase: "and"

Phrase: "control labels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0181496:labels [Manufactured Object]
   827 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "consistent."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332290:Consistent [Idea or Concept]
   928 E C0332529:Consistencies [Qualitative Concept]
   928 E C1547017:Consistency [Quantitative Concept]
Processing 00000000.tx.221: The H1 htSNP haplotypes of H1/H2 individuals were included by separating out the H1 haplotypes and randomly pairing these up to create a set of pseudo-H1/H1 individuals to add to the pool of H1/H1 individuals. 

Phrase: "The H1 htSNP haplotypes of H1/H2 individuals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "included by separating out"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0332257:included [Functional Concept]
   770   C0439787:Out [Spatial Concept]
   770   C0443299:separating [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "the H1 haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "and"

Phrase: "randomly"

Phrase: "pairing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1709450:Pair [Qualitative Concept]

Phrase: "these up to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0039828:these [Intellectual Product]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "a set of pseudo-H1/H1 individuals to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0036849:Set [Mental Process]
   744   C1442518:Set [Functional Concept]
   744   C1705195:Set [Conceptual Entity]

Phrase: "add to the pool of H1/H1 individuals."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0337051:Pool [Geographic Area]
   744   C1509144:pool [Clinical Attribute]
   744   C1883712:Add [Functional Concept]
   744   C2349200:Pool [Functional Concept]
   711   C0027361:Individual [Population Group]
   711   C0237401:Individual [Human]
Processing 00000000.tx.222: Although overall results were not found to be sensitive to this random pairing, this process was repeated 11 times for each analysis, and the results of the analysis giving the median overall P-value for haplotype associations are reported. 

Phrase: "Although"

Phrase: "overall results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "sensitive to this random pairing,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]

Phrase: "this process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "was"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "11 times for each analysis,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "the results of the analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "giving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "the median overall P-value for haplotype associations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1709380:P-Value [Quantitative Concept]
   744   C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.223: In the age-stratified analysis, the control group was used as a whole, because none of the single htSNPs allelic distributions was significantly different when comparing young versus old control individuals grouped on the basis of median age of 75 at inclusion. 

Phrase: "In the age-stratified analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "the control group"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "used as a whole,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0444667:Whole [Quantitative Concept]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "because"

Phrase: "none of the single htSNPs allelic distributions"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   748   C2985510:Tagging SNP [Nucleotide Sequence]
   742   C0018591:Haplotype [Organism Attribute]
   742   C0037179:Single [Population Group]
   742   C0037775:Distributions [Spatial Concept]
   742   C0087136:single [Finding]
   742   C0205171:Single [Quantitative Concept]
   742   C0456148:None [Quantitative Concept]
   742   C0549184:None [Quantitative Concept]
   742   C0752046:SNPs [Nucleotide Sequence]
   708   C0037293:Tag [Neoplastic Process]
   708   C0181496:Tag [Manufactured Object]
   708 E C0520511:distribution [Idea or Concept]
   708 E C1527094:SNP [Conceptual Entity]
   708 E C1704711:Distribution [Functional Concept]
   708   C1710492:TAG [Gene or Genome]

Phrase: "was"

Phrase: "significantly different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]

Phrase: "when"

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "versus"

Phrase: "old control individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0027361:Individual [Population Group]
   793   C0237401:Individual [Human]

Phrase: "grouped on the basis of median age of 75"
Meta Candidates (Total=17; Excluded=6; Pruned=0; Remaining=11)
   745   C0027362:Age Group [Age Group]
   745   C2348001:Age Group [Population Group]
   742   C0001779:Age [Organism Attribute]
   742   C0439745:Grouped [Spatial Concept]
   742   C0549183:Median [Spatial Concept]
   742   C0876920:Median [Quantitative Concept]
   742   C1527178:Basis [Functional Concept]
   742   C1874451:Basis [Pharmacologic Substance]
   742   C2347635:Median [Quantitative Concept]
   742   C2348144:Median [Quantitative Concept]
   742   C2939193:Median [Spatial Concept]
   708 E C0441833:Group [Idea or Concept]
   708 E C0687744:group [Population Group]
   708 E C1257890:Group [Population Group]
   708 E C1552516:Group [Health Care Related Organization]
   708 E C1705428:Group [Conceptual Entity]
   708 E C1705429:Group [Population Group]

Phrase: "at inclusion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.224: The level of significance was defined as P<0.05. 

Phrase: "The level of significance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0814896:Significance Level [Research Activity]
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "defined as P<0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.225: OR are shown with their 95% CI. 

Phrase: "OR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "are"

Phrase: "shown with their 95% CI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.226: Sequence predictions of functional elements Transcription factor binding sites were identified in the 22kb candidate region from 54720 to 76720 in AC091628.2 with MatInspector (41) using a core similarity cut-off value of 0.75 and an optimized matrix similarity threshold. 

Phrase: "Sequence predictions of functional elements Transcription factor binding sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0681842:predictions [Idea or Concept]

Phrase: "were"

Phrase: "identified in the 22kb candidate region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
   753   C0205396:Identified [Qualitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]

Phrase: "from 54720"

Phrase: "to 76720"

Phrase: "in AC091628.2"

Phrase: "with MatInspector"

Phrase: "(41"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a core similarity cut-off value of 0.75"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1442160:Cutoff [Functional Concept]
   742   C0000925:Cut [Injury or Poisoning]
   742   C1522609:Value [Quantitative Concept]
   742   C1883724:CUT [Phenomenon or Process]

Phrase: "and"

Phrase: "an optimized matrix similarity threshold."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449864:Threshold [Qualitative Concept]
Processing 00000000.tx.227: Conserved sequences and TFBS were detected using the VISTA tools (http://www-gsd.lbl.gov/vista/index.shtml). 

Phrase: "Conserved sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0009802:Sequences, Conserved [Nucleotide Sequence]
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "TFBS"

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the VISTA tools"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0336791:Tool [Manufactured Object]
   827   C2827396:Tool [Manufactured Object]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www-gsd.lbl.gov/vista/index.shtml"

Phrase: ")."
Processing 00000000.tx.228: MatInspector was applied to investigate the effect of SNP167A>G on putative transcription factor binding sites using a core similarity cut-off value of 0.75 and an optimized matrix similarity threshold. 

Phrase: "MatInspector"

Phrase: "was"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the effect of SNP167A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: ">G on putative transcription factor binding sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439267:g% [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a core similarity cut-off value of 0.75"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1442160:Cutoff [Functional Concept]
   742   C0000925:Cut [Injury or Poisoning]
   742   C1522609:Value [Quantitative Concept]
   742   C1883724:CUT [Phenomenon or Process]

Phrase: "and"

Phrase: "an optimized matrix similarity threshold."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449864:Threshold [Qualitative Concept]
Processing 00000000.tx.229: Luciferase reporter constructs To test whether the 182bp conserved regulatory region, located 4794648127bp downstream of the major MAPT transcription initiation site (27) in intron 0 of MAPT, contained regulatory elements, we amplified genomic DNA of an H1/H1 individual using primers 5'-ggggtaccccTTGATGATGCATGGACCTCTCT-3' and 5'-tccccccggggggaAAGCAAAAGAAAGACTGTGGAAGG-3'. 

Phrase: "Luciferase reporter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0335038:Reporter [Professional or Occupational Group]
   861   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   861   C1705915:Reporter [Conceptual Entity]
   861   C1709908:Reporter [Group]

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "the 182bp"

Phrase: "conserved"

Phrase: "regulatory region,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "located 4794648127bp downstream of the major MAPT transcription initiation site"

Phrase: "(27"

Phrase: ")"

Phrase: "in intron 0"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of MAPT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1446659:MAPT [Gene or Genome]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "regulatory elements,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0013879:Elements [Element, Ion, or Isotope]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "we"

Phrase: "amplified"

Phrase: "genomic DNA of an H1/H1 individual"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0017428:Genomic [Gene or Genome]
   748   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers 5'-ggggtaccccTTGATGATGCATGGACCTCTCT-3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "5'-tccccccggggggaAAGCAAAAGAAAGACTGTGGAAGG-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.230: The H1/H1 individual was selected for homozygosity except htSNP167A>G using genomic sequencing. 

Phrase: "The H1/H1 individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "was"

Phrase: "selected for homozygosity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0019904:Homozygosity [Organism Attribute]
   756   C1707391:Select [Activity]

Phrase: "except htSNP167A"

Phrase: ">G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "genomic sequencing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1553778:Sequencing [Intellectual Product]
   861   C1561491:Sequencing [Functional Concept]
Processing 00000000.tx.231: The primers contained a KpnI and an XmaI, respectively, site for cloning of the 182bp fragment upstream of the SV40 early promoter of the firefly luciferase gene in the pGL3-Promoter vector (Promega). 

Phrase: "The primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "a KpnI"

Phrase: "and"

Phrase: "an XmaI,"

Phrase: "respectively,"

Phrase: "site for cloning of the 182bp"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1705686:Cloning Site [Nucleotide Sequence]
   783   C2945843:Site of [Qualitative Concept]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "fragment upstream of the SV40 early promoter of the firefly luciferase gene"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0311727:Firefly luciferase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1334435:Luciferase Gene [Gene or Genome]
   751   C0314621:Promoter gene [Gene or Genome]
   736   C0017337:Gene [Gene or Genome]
   736   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   736   C0038975:SV 40 [Virus]
   736   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0162328:Firefly [Eukaryote]
   736   C0332255:fragment [Functional Concept]
   736   C0522505:Upstream [Spatial Concept]
   736   C1279919:Early [Temporal Concept]
   736   C1708096:Fragment [Qualitative Concept]

Phrase: "in the pGL3-Promoter vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")."
Processing 00000000.tx.232: Similar experiments were performed using, instead of the SV40 promoter, the H1 MAPT proximal promoter, which we defined as a 1.1kb genomic fragment of 911/+190 including exon 0 (positions relative to the major MAPT transcription start site at nt 7805 in AC091628.2). 

Phrase: "Similar experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "instead of the SV40 promoter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the H1 MAPT proximal promoter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "which"

Phrase: "we"

Phrase: "defined as a 1.1kb genomic fragment of 911/+190"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0017428:Genomic [Gene or Genome]
   739   C0332255:fragment [Functional Concept]
   739   C0887950:genomic [Biomedical Occupation or Discipline]
   739   C1704788:Defined [Conceptual Entity]
   739   C1708096:Fragment [Qualitative Concept]
   739   C3539106:Defined [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "exon 0"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(positions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:positions [Spatial Concept]
   916 E C0240795:POSITIONAL [Finding]

Phrase: "relative to the major MAPT transcription start site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0080103:Relative [Family Group]
   744   C0205345:Relative [Qualitative Concept]
   744   C1547039:*Relative [Quantitative Concept]

Phrase: "at nt 7805"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332126:NT [Qualitative Concept]
   861   C1449832:NT [Diagnostic Procedure]

Phrase: "in AC091628.2"

Phrase: ")."
Processing 00000000.tx.233: The promoter fragment was obtained by PCR amplification of genomic DNA of an H1/H2 individual using primers 5'-tccccccggggggaCTGCCCTAAACCCCCCTACA-3' and 5'-ggaagatcttccCAGCGGAGGAGGAGAAGGT-3', and sequencing indicated that it did not comprise H1 SNPs. 

Phrase: "The promoter fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "obtained by PCR amplification of genomic DNA of an H1/H2 individual"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   753   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   751   C0683230:DNA amplification [Genetic Function]
   736   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0017428:Genomic [Gene or Genome]
   736   C0027361:Individual [Population Group]
   736   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   736   C0237401:Individual [Human]
   736   C0677874:pCR [Finding]
   736   C0887950:genomic [Biomedical Occupation or Discipline]
   736   C0919509:H2 [Gene or Genome]
   736   C1301820:Obtained [Functional Concept]
   736   C1419394:H2 [Gene or Genome]
   736   C1517480:Amplification [Molecular Biology Research Technique]
   736   C1521871:Amplification [Phenomenon or Process]
   736   C1705759:Amplification [Cell or Molecular Dysfunction]
   703 E C1706701:Obtain [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers 5'-tccccccggggggaCTGCCCTAAACCCCCCTACA-3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "5'-ggaagatcttccCAGCGGAGGAGGAGAAGGT-3',"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553778:Sequencing [Intellectual Product]
  1000   C1561491:Sequencing [Functional Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "it"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "comprise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "H1 SNPs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0752046:SNPs [Nucleotide Sequence]
   827 E C1527094:SNP [Conceptual Entity]
Processing 00000000.tx.234: The primers contained an XmaI and a BglII site, respectively, for cloning upstream of the firefly luciferase gene in the pGL3-Basic vector (Promega). 

Phrase: "The primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "an XmaI"

Phrase: "and"

Phrase: "a BglII site,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "respectively,"

Phrase: "for cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009015:Cloning [Research Activity]

Phrase: "upstream of the firefly luciferase gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1334435:Luciferase Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0311727:Firefly luciferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in the pGL3-Basic vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")."
Processing 00000000.tx.235: Both htSNP167 alleles of the 182bp regulatory fragment were subcloned upstream of the MAPT H1 promoter using the KpnI and XmaI restriction sites. 

Phrase: "Both htSNP167 alleles of the 182bp regulatory fragment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0002085:Alleles [Gene or Genome]

Phrase: "were"

Phrase: "subcloned upstream of the MAPT H1 promoter"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the KpnI"

Phrase: "and"

Phrase: "XmaI restriction sites."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   867   C1882940:Restriction Site [Nucleotide Sequence]
   827   C0205145:Sites [Spatial Concept]
   827   C0443288:Restriction [Functional Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.236: The sequence integrity of all inserts was confirmed using vector-specific primers. 

Phrase: "The sequence integrity of all inserts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205266:integrity [Qualitative Concept]
   753   C0872403:integrity [Individual Behavior]
   753   C1947912:Integrity [Qualitative Concept]

Phrase: "was"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "vector-specific primers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.237: Eukaryotic cell culture and transient transfection Human SHSY-5Y and mouse N2a neuroblastoma cells were propagated in a minimal essential medium with Earle's salt, 10% fetal bovine serum, 2mM L-glutamine, 200IU/ml of penicillin, 200g/ml of streptomycin and 0.1mM non-essential amino acids (Invitrogen). 

Phrase: "Eukaryotic cell culture"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0007585:Cell Culture [Laboratory Procedure]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C2242979:Culture [Laboratory Procedure]
   734   C0015161:Eukaryotic Cell [Cell]

Phrase: "and"

Phrase: "transient transfection Human SHSY-5Y"

Phrase: "and"

Phrase: "mouse N2a neuroblastoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   708   C1524043:Mouse Neuroblastoma [Neoplastic Process]

Phrase: "were"

Phrase: "propagated in a minimal essential medium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0009458:Medium [Intellectual Product]
   753   C0205224:Essential [Qualitative Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C0547040:Minimal [Qualitative Concept]
   753   C1524031:MINIMAL [Qualitative Concept]
   753   C1705217:Medium [Substance]
   753   C2945599:Minimal [Qualitative Concept]
   753   C3244283:medium [Intellectual Product]

Phrase: "with Earle's salt,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0036140:Salt [Chemical Viewed Structurally]
   861   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0206136:Salt [Food,Inorganic Chemical]
   789 E C1537053:salty [Qualitative Concept]
   761 E C0678584:saltiness [Qualitative Concept]

Phrase: "10% fetal bovine serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "2mM L-glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "200IU/ml of penicillin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439526:/mL [Quantitative Concept]

Phrase: "200g/ml of streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "0.1mM non-essential amino acids"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0311461:Non-Essential Amino Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0002525:Amino Acids, Essential [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2348468:Essential_Amino_Acid [Conceptual Entity]
   799   C0001128:Acids [Chemical]
   799   C0205224:Essential [Qualitative Concept]
   799   C1518422:Non [Functional Concept]
   793 E C2917660:Amino Acid [Pharmacologic Substance]
   766 E C0202406:Acid [Laboratory Procedure]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.238: Human embryonic kidney cells (HEK293) were propagated in OptiMem (Invitrogen) with 10% fetal bovine serum, 200IU/ml of penicillin and 200g/ml of streptomycin. 

Phrase: "Human embryonic kidney cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   858   C1947950:Embryonic Cell [Embryonic Structure]
   844   C0553257:kidney cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(HEK293"

Phrase: ")"

Phrase: "were"

Phrase: "propagated in OptiMem"

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "with 10% fetal bovine serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "200IU/ml of penicillin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "200g/ml of streptomycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.239: For transient transfection SHSY-5Y, N2a and HEK293 cells were seeded in 24-well tissue culture dishes at 0.65x106, 1.2x105 and 7.5x105 cells/well, respectively, and allowed to recover for 24h. 

Phrase: "For transient transfection SHSY-5Y,"

Phrase: "N2a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445079:N2a [Finding]

Phrase: "and"

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded in 24-well tissue culture dishes"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   797   C0492792:DISH, TISSUE CULTURE [Medical Device]
   778   C0040284:Tissue culture [Laboratory Procedure]
   748   C0010453:Culture [Idea or Concept]
   748   C0040300:Tissue [Tissue]
   748   C0205170:Well [Qualitative Concept]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C1547928:Tissue [Intellectual Product]
   748   C2242979:Culture [Laboratory Procedure]
   748   C3146287:Well [Manufactured Object]
   714   C0020498:DISH [Disease or Syndrome]
   714   C0036563:Seed [Plant]
   714   C1705192:Seed [Laboratory Procedure]
   714   C1882540:{Seed} [Quantitative Concept]
   714   C2346495:Seed [Conceptual Entity]

Phrase: "at 0.65x106,"

Phrase: "1.2x105"

Phrase: "and"

Phrase: "7.5x105 cells/well,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C2347578:Cells/well [Quantitative Concept]
   812   C0007634:Cells [Cell]
   812   C0205170:Well [Qualitative Concept]
   812   C3146287:Well [Manufactured Object]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "respectively,"

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "recover for 24h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0456696:/24h [Temporal Concept]
   790   C0521108:recover [Qualitative Concept]
   790   C1442770:24H [Temporal Concept]
   790   C2004454:recover [Organism Function]
Processing 00000000.tx.240: Cells were co-transfected with 32ng (HEK293, N2a) or 80ng (SHSY-5Y) of pRL-TK plasmid containing the herpes simplex virus thymidine kinase promoter upstream of the renilla luciferase gene (Promega) and 800ng of either one of the MAPT constructs or one of the control plasmids, using Lipofectamine 2000 (2.4l, Invitrogen). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with 32ng"

Phrase: "(HEK293,"

Phrase: "N2a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445079:N2a [Finding]

Phrase: ")"

Phrase: "or"

Phrase: "80ng"

Phrase: "(SHSY-5Y"

Phrase: ")"

Phrase: "of pRL-TK plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the herpes simplex virus thymidine kinase promoter upstream of the renilla luciferase gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   749   C0314621:Promoter gene [Gene or Genome]
   735   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "and"

Phrase: "800ng of either one of the MAPT constructs"

Phrase: "or"

Phrase: "one of the control plasmids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Lipofectamine 2000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1312445:lipofectamine 2000 [Organic Chemical]
   861   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]

Phrase: "(2.4l,"

Phrase: "Invitrogen"

Phrase: ")."
Processing 00000000.tx.241: Empty pGL3-basic vector was used as a negative control, pGL3-Promoter plasmid as a positive control. 

Phrase: "Empty pGL3-basic vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]

Phrase: "was"

Phrase: "used as a negative control,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   806   C1639518:% negative control [Quantitative Concept]
   806   C1947986:Negative Control [Conceptual Entity]
   760   C0205160:Negative [Qualitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1273517:used [Finding]
   760   C1513916:Negative [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "pGL3-Promoter plasmid as a positive control."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.242: Luciferase activity measurements Transfected cells were cultured for 2430h, washed with 1ml phosphate-buffered saline (Invitrogen) and lysed with Passive lysis buffer (Promega). 

Phrase: "Luciferase activity measurements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0242485:measurements [Functional Concept]
   734   C1151115:luciferase activity [Molecular Function]

Phrase: "Transfected"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured for 2430h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "washed with 1ml phosphate-buffered saline"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   783   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0036082:Saline [Substance]
   753   C1548982:Washed [Idea or Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   719 E C0441648:Wash [Activity]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "and"

Phrase: "lysed with Passive lysis buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0024348:Lysis [Pathologic Function]
           lysed
   760   C1536403:lysis [Cell Function]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")."
Processing 00000000.tx.243: Firefly luciferase activities (LAF) and renilla luciferase activities (LAR) were measured sequentially using a Dual-Luciferase reporter assay system and a VeritasTM (Promega) and/or VICTOR Light (Perkin Elmer, Boston, MA, USA) Microplate Luminometer w/Dual Reagent Injectors. 

Phrase: "Firefly luciferase activities"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   983   C1324397:firefly luciferase activity [Molecular Function]
   884   C1151115:luciferase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
   734   C0311727:Firefly luciferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(LAF)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021755:LAF [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "renilla luciferase activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   884   C1151115:luciferase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "(LAR)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419115:LAR [Gene or Genome]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "sequentially"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Dual-Luciferase reporter assay system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "a VeritasTM"

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "and/or"

Phrase: "VICTOR Light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "(Perkin Elmer,"

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "Microplate Luminometer w/Dual Reagent Injectors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0181342:injectors [Medical Device]
Processing 00000000.tx.244: To correct for transfection efficiency and DNA uptake, the relative luciferase activity (RLA) was calculated as RLA=LAF/LAR. 

Phrase: "To correct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349182:Correct [Qualitative Concept]

Phrase: "for transfection efficiency"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0013682:Efficiency [Quantitative Concept]
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: "and"

Phrase: "DNA uptake,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "the relative luciferase activity (RLA)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1151115:luciferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "calculated as RLA"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C1151115:luciferase activity [Molecular Function]
   760   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   760   C0080103:Relative [Family Group]
   760   C0205177:Activity [Functional Concept]
   760   C0205345:Relative [Qualitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0444686:Calculated [Functional Concept]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   760   C1547039:*Relative [Quantitative Concept]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "=LAF/LAR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419115:LAR [Gene or Genome]
Processing 00000000.tx.245: The MannWhitney U test, a non-parametric analog to the unpaired t-test, was used to compare the RLA produced by the different transfectants.  

Phrase: "The MannWhitney U test,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "a non-parametric analog to the unpaired t-test,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0243071:Analog [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the RLA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1151115:luciferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "produced by the different transfectants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.246: ACKNOWLEDGEMENTS  The authors are grateful to the patients and their families for their cooperation in this project, to Eileen Bigio, Neill Graff-Radford, Lawrence Golbe, Donald Calne, Paul Tuite, Francesch Valldeoriola, Mara Jos Marti, Adriana Cardozo, Victor Obach and Matilde Calopa for providing samples and to Sally Serneels for help with MAPT genotyping. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "are"

Phrase: "grateful to the patients"

Phrase: "and"

Phrase: "their families for their cooperation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015576:Families [Family Group]
   760   C1704727:Family [Conceptual Entity]

Phrase: "in this project,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709701:Project [Conceptual Entity]

Phrase: "to Eileen Bigio,"

Phrase: "Neill Graff-Radford,"

Phrase: "Lawrence Golbe,"

Phrase: "Donald Calne,"

Phrase: "Paul Tuite,"

Phrase: "Francesch Valldeoriola,"

Phrase: "Mara Jos Marti,"

Phrase: "Adriana Cardozo,"

Phrase: "Victor Obach"

Phrase: "and"

Phrase: "Matilde Calopa for providing samples"

Phrase: "and to Sally Serneels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "for"

Phrase: "help with MAPT genotyping."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0018896:Help [Social Behavior]
   770   C1285573:Genotyping [Laboratory Procedure]
   770   C1446659:MAPT [Gene or Genome]
   770   C1552861:help [Idea or Concept]
Processing 00000000.tx.247: This research was funded by the Special Research Fund of the University of Antwerp (BOF-UA), the Fund for Scientific Research Flanders (FWO-F), the Interuniversity Attraction Poles program P5/19 of the Belgian Federal Science Policy Office (POD) and the International Alzheimer Research Foundation (IARF); 

Phrase: "This research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "was"

Phrase: "funded by the Special Research Fund of the University of Antwerp"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   754   C0681805:funded research [Research Activity]
   738   C0016820:funded [Quantitative Concept]
   738   C0035168:research [Research Activity]
   738   C0041740:University [Manufactured Object,Organization]
   738   C0205555:Special [Qualitative Concept]
   738   C0242481:Research [Research Activity]

Phrase: "(BOF-UA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041580:UA [Geographic Area]
   861   C0042014:UA [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "the Fund for Scientific Research Flanders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0681805:research fund [Research Activity]
   753   C0016820:Fund [Quantitative Concept]

Phrase: "(FWO-F),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "the Interuniversity Attraction Poles"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   827   C0337815:Poles [Population Group]
   793 E C0935623:Pole [Body Location or Region]
   793 E C1418729:POLE [Gene or Genome]
   743 E C0813983:polar [Quantitative Concept]
   721 E C0596963:Polarity [Quantitative Concept]

Phrase: "program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]

Phrase: "P5/19 of the Belgian Federal Science Policy Office"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C1519200:Science Policy [Governmental or Regulatory Activity]
   742   C0036397:Science [Occupation or Discipline]
   742   C0242456:Policy [Intellectual Product]
   742   C0337797:belgian [Population Group]
   742   C0442603:Office [Manufactured Object]
   742   C1538611:P5 [Gene or Genome]
   742   C1539371:p5 [Gene or Genome]

Phrase: "(POD)"

Phrase: "and"

Phrase: "the International Alzheimer Research Foundation (IARF)"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   819   C2986512:Research Base [Organization]
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.248: the EU contract LSHM-CT-2003-503330 (APOPIS); 

Phrase: "the EU contract LSHM-CT-2003-503330"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0015179:EU [Organization]
   799   C0332522:Contract [Intellectual Product]
   799   C1532290:EU [Quantitative Concept]
   799   C1705564:Contract [Conceptual Entity]
   799   C3540513:CT [Gene or Genome]

Phrase: "(APOPIS"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.249: the Progressive Supranuclear Palsy Association (PSP-Europe) (P.P.); 

Phrase: "the Progressive Supranuclear Palsy Association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0004083:Association [Mental Process]
   812   C0439849:Association [Qualitative Concept]
   812   C0596306:Association [Phenomenon or Process]
   812   C0699792:association [Social Behavior]
   756   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: "(PSP-Europe"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0015176:Europe [Geographic Area]
   756   C0038868:Progressive supranuclear palsy [Disease or Syndrome]

Phrase: ")"

Phrase: "(P.P."

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.250: the Society for Progressive Supranuclear Palsy (PSP-USA) (A.G., E.T. and P.P.), the Harvard Brain Tissue Resource Center (PHS #MH/NS 31862), the NIA (PO1 #AG 17216 to M.H.) and the Mayo Foundation, USA. 

Phrase: "the Society for Progressive Supranuclear Palsy (PSP-USA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0037455:society [Organization]

Phrase: "(A.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "E.T."

Phrase: "and"

Phrase: "P.P."

Phrase: ")"

Phrase: ","

Phrase: "the Harvard Brain Tissue Resource Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0205099:Center [Spatial Concept]

Phrase: "(PHS #MH/NS 31862"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0265220:PHS [Disease or Syndrome]
   812   C1705397:PHS [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "the NIA (PO1 #AG 17216 to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1074110:Nia [Fungus]
   753   C1955974:NIA [Health Care Related Organization]

Phrase: "M."

Phrase: "H.)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "the Mayo Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.251: R.R., M.C. and J.T. are post-doctoral fellows of the FWO-F, Belgium; 

Phrase: "R.R.,"

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "J.T."

Phrase: "are"

Phrase: "post-doctoral fellows of the FWO-F,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ";"
Processing 00000000.tx.252: S.M. was funded by a NRSA post-doctoral fellowship #AG 24030, USA. 

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "was"

Phrase: "funded by a NRSA post-doctoral fellowship #AG 24030,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0015770:Fellowship [Educational Activity]
   742   C0016820:funded [Quantitative Concept]
   742   C0687676:Post [Temporal Concept]
   742   C1513904:NRSA [Governmental or Regulatory Activity]
   742   C1704687:Post [Manufactured Object]

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.253: Conflict of Interest statement. 

Phrase: "Conflict of Interest statement."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1710187:Statement [Idea or Concept]
   756   C0079152:Conflict of Interest [Idea or Concept]
Processing 00000000.tx.254: The authors declare that they have no competing financial interests.  

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "declare"

Phrase: "that"

Phrase: "they"

Phrase: "have"

Phrase: "no competing financial interests."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0543488:interests [Mental Process]
Processing 00000000.tx.255: FOOTNOTES  The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "wish"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1423524:WISH [Gene or Genome]
  1000   C3273411:WISH [Gene or Genome]
  1000   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "it to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that,"

Phrase: "in their opinion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871010:opinion [Mental Process]

Phrase: "the first two authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0221193:Authors [Professional or Occupational Group]

Phrase: "should"

Phrase: "be"

Phrase: "regarded as joint First Authors."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0022417:Joint [Body Space or Junction]
   760   C0205435:First [Quantitative Concept]
   760   C0221193:Authors [Professional or Occupational Group]
   760   C0392905:Joint, NOS [Body System]
   760   C1269611:Joint [Body Space or Junction]
   760   C1279901:First [Qualitative Concept]
   760   C1706309:Joint [Medical Device]
   704 E C0521339:Articular [Functional Concept]
Processing 00000000.tx.256: The authors wish it to be known that, in their opinion, the last two authors should be regarded as joint Last Authors.  

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "wish"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1423524:WISH [Gene or Genome]
  1000   C3273411:WISH [Gene or Genome]
  1000   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "it to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that,"

Phrase: "in their opinion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871010:opinion [Mental Process]

Phrase: "the last two authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0221193:Authors [Professional or Occupational Group]

Phrase: "should"

Phrase: "be"

Phrase: "regarded as joint Last Authors."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0022417:Joint [Body Space or Junction]
   760   C0221193:Authors [Professional or Occupational Group]
   760   C0392905:Joint, NOS [Body System]
   760   C1269611:Joint [Body Space or Junction]
   760   C1706309:Joint [Medical Device]
   704 E C0521339:Articular [Functional Concept]
Processing 00000000.tx.257: REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Bower, J.H., Maraganore, D.M., McDonnell, S.K. and Rocca, W.A. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Bower,"

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Maraganore,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "McDonnell,"

Phrase: "S."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Rocca,"

Phrase: "W."

Phrase: "A."
Processing 00000000.tx.258: (1997) Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Incidence of progressive supranuclear palsy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "and"

Phrase: "multiple system atrophy in Olmsted County,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0037019:Multiple System Atrophy [Disease or Syndrome]
   833   C0393571:Multiple System Atrophy [Disease or Syndrome]
   753   C0333641:Atrophy [Pathologic Function]
   753   C0439064:Multiple [Quantitative Concept]
   753   C0449913:System [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]

Phrase: "Minnesota,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026183:Minnesota [Geographic Area]

Phrase: "1976 to 1990."
Processing 00000000.tx.259: Neurology, 49, 12841288.[Abstract] Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R.C., Goetz, C.G., Golbe, L.I., Grafman, J., Growdon, J.H. etal. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "49,"

Phrase: "12841288."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Litvan,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Agid,"

Phrase: "Y.,"

Phrase: "Calne,"

Phrase: "D."

Phrase: ","

Phrase: "Campbell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331936:Campbell [Health Care Related Organization]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Dubois,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Duvoisin,"

Phrase: "R.C., Goetz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0722969:R & C [Organic Chemical,Pharmacologic Substance]

Phrase: "C.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Golbe,"

Phrase: "L.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Grafman,"

Phrase: "J.,"

Phrase: "Growdon,"

Phrase: "J.H. etal."
Processing 00000000.tx.260: (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (SteeleRichardsonOlszewski syndrome): report of the NINDS-SPSP international workshop. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Clinical research criteria for the diagnosis of progressive supranuclear palsy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0243161:criteria [Intellectual Product]

Phrase: "(SteeleRichardsonOlszewski syndrome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039082:Syndrome [Disease or Syndrome]

Phrase: ")"

Phrase: ":"

Phrase: "report of the NINDS-SPSP international workshop."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0684224:Report [Intellectual Product]
   748   C0700287:Report [Health Care Activity]
   748   C3273238:Report [Intellectual Product]
Processing 00000000.tx.261: Neurology, 47, 19.[Abstract] Ebneth, A., Godemann, R., Stamer, K., Illenberger, S., Trinczek, B. and Mandelkow, E. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "47,"

Phrase: "19."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ebneth,"

Phrase: "A.,"

Phrase: "Godemann,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stamer,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Illenberger,"

Phrase: "S."

Phrase: ","

Phrase: "Trinczek,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Mandelkow,"

Phrase: "E."
Processing 00000000.tx.262: (1998) Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic retziculum: implications for Alzheimer's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Overexpression of tau protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "kinesin-dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0851827:Dependent [Qualitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: "trafficking of vesicles,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   841   C2266273:vesicle trafficking [Cell Function]
   790   C0333262:VESICLES [Acquired Abnormality]
   790   C0599896:trafficking [Cell Function]
   756 E C1622418:vesicle [Cell Component]
   706 E C0205378:Vesicular [Qualitative Concept]

Phrase: "mitochondria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "and"

Phrase: "endoplasmic retziculum"

Phrase: ":"

Phrase: "implications for Alzheimer's disease."
Processing 00000000.tx.263: J. 

Phrase: "J."
Processing 00000000.tx.264: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.265: Biol., 143, 777794.[Abstract/Free FullText] Hirokawa, N. 

Phrase: "Biol.,"

Phrase: "143,"

Phrase: "777794."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hirokawa,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.266: (1994) Microtubule organization and dynamics dependent on microtubule-associated proteins. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Microtubule organization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0029237:Organisation [Physiologic Function]
   861   C0029246:Organization [Organization]
   861   C0220885:organization [Qualitative Concept]
   861   C1300196:Organization [Functional Concept]
   861   C1522486:Organization [Professional or Occupational Group]

Phrase: "and"

Phrase: "dynamics"

Phrase: "dependent on microtubule-associated proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]
Processing 00000000.tx.267: Curr. 

Phrase: "Curr."
Processing 00000000.tx.268: Opin. 

Phrase: "Opin."
Processing 00000000.tx.269: Cell Biol., 6, 7481.[CrossRef][ISI][Medline] Goedert, M., Spillantini, M.G., Jakes, R., Rutherford, D. and Crowther, R.A. 

Phrase: "Cell Biol.,"

Phrase: "6,"

Phrase: "7481."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Spillantini,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rutherford,"

Phrase: "D."

Phrase: "and"

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A."
Processing 00000000.tx.270: (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Multiple isoforms of human microtubule-associated protein tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   703   C1454489:microtubule-associated protein tau, human [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ":"

Phrase: "sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "localization in neurofibrillary tangles of Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]
Processing 00000000.tx.271: Neuron, 3, 519526.[CrossRef][ISI][Medline] Liu, W.K., Le, T.V., Adamson, J., Baker, M., Cookson, N., Hardy, J., Hutton, M., Yen, S.H. and Dickson, D.W. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "519526."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liu,"

Phrase: "W.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Le,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439090:LE [Idea or Concept]
  1000   C1423767:LE [Gene or Genome]

Phrase: "T.V., Adamson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0039461:t.v. [Manufactured Object]

Phrase: "J.,"

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Cookson,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Yen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555429:Yen [Quantitative Concept]

Phrase: "S."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Dickson,"

Phrase: "D.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.272: (2001) Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Relationship of the extended tau haplotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439849:Relationship [Qualitative Concept]
   753   C1705630:Relationship [Idea or Concept]
   753   C1706279:Relationship [Idea or Concept]
   753   C3540605:Relationship [Intellectual Product]

Phrase: "to tau biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "neuropathology in progressive supranuclear palsy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   760   C1540677:neuropathology [Pathologic Function]
   760   C1555824:Neuropathology [Intellectual Product]
Processing 00000000.tx.273: Ann. 

Phrase: "Ann."
Processing 00000000.tx.274: Neurol., 50, 494502.[CrossRef][ISI][Medline] Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A. etal. 

Phrase: "Neurol.,"

Phrase: "50,"

Phrase: "494502."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Lendon,"

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Rizzu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Froelich,"

Phrase: "S."

Phrase: ","

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Pickering-Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "S."

Phrase: ","

Phrase: "Chakraverty,"

Phrase: "S."

Phrase: ","

Phrase: "Isaacs,"

Phrase: "A.,"

Phrase: "Grover,"

Phrase: "A. etal."
Processing 00000000.tx.275: (1998) Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Association of missense"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "5'-splice-site mutations in tau"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0887917:5' Splice Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C1519478:Splice-Site Mutation [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "with the inherited dementia FTDP-17."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0338451:FTDP-17 [Disease or Syndrome]
   861   C1446659:FTDP-17 [Gene or Genome]
   861   C2697954:FTDP-17 [Gene or Genome]
Processing 00000000.tx.276: Nature, 393, 702705.[CrossRef][ISI][Medline] Poorkaj, P., Bird, T.D., Wijsman, E., Nemens, E., Garruto, R.M., Anderson, L., Andreadis, A., Wiederholt, W.C., Raskind, M. and Schellenberg, G.D. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "393,"

Phrase: "702705."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "Wijsman,"

Phrase: "E.,"

Phrase: "Nemens,"

Phrase: "E.,"

Phrase: "Garruto,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "M."

Phrase: ","

Phrase: "Anderson,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Andreadis,"

Phrase: "A.,"

Phrase: "Wiederholt,"

Phrase: "W.C., Raskind,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Schellenberg,"

Phrase: "G.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439417:g d [Quantitative Concept]
Processing 00000000.tx.277: (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "a candidate gene for chromosome 17 frontotemporal dementia."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1332838:Candidate Gene [Gene or Genome]
   767   C0079429:A Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.278: Ann. 

Phrase: "Ann."
Processing 00000000.tx.279: Neurol., 43, 815825.[CrossRef][ISI][Medline] Spillantini, M.G., Murrell, J.R., Goedert, M., Farlow, M.R., Klug, A. and Ghetti, B. 

Phrase: "Neurol.,"

Phrase: "43,"

Phrase: "815825."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Spillantini,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Murrell,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Farlow,"

Phrase: "M."

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Klug,"

Phrase: "A."

Phrase: "and"

Phrase: "Ghetti,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.280: (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mutation in the tau gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0596611:Gene Mutation [Genetic Function]
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in familial multiple system tauopathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0949664:Tauopathy [Disease or Syndrome]

Phrase: "with presenile dementia."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0011265:Pre-senile dementia [Mental or Behavioral Dysfunction]
           dementia
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.281: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.282: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.283: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.284: USA, 95, 77377741.[Abstract/Free FullText] Pastor, P., Pastor, E., Carnero, C., Vela, R., Garcia, T., Amer, G., Tolosa, E. and Oliva, R. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "95,"

Phrase: "77377741."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pastor,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0684012:pastor [Professional or Occupational Group]
   928 E C1555897:Pastoral [Intellectual Product]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Pastor,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0684012:pastor [Professional or Occupational Group]
   928 E C1555897:Pastoral [Intellectual Product]

Phrase: "E.,"

Phrase: "Carnero,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Vela,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Garcia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442999:Garcia [Intellectual Product]
  1000   C1621797:Garcia [Plant]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Amer,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tolosa,"

Phrase: "E."

Phrase: "and"

Phrase: "Oliva,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0228539:oliva [Body Part, Organ, or Organ Component]
  1000   C0228540:Oliva [Body Part, Organ, or Organ Component]
  1000   C0262254:oliva [Body Part, Organ, or Organ Component]
  1000   C1020282:Oliva [Eukaryote]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.285: (2001) Familial atypical progressive supranuclear palsy associated with homozygosity for the delN296 mutation in the tau gene. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Familial atypical progressive supranuclear palsy"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   933   C2931887:Familial progressive supranuclear palsy [Disease or Syndrome]
   884   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   840   C0270920:Supranuclear palsy [Disease or Syndrome]
   825   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   804   C0205329:Progressive [Functional Concept]
   804   C0522224:Palsy [Finding]

Phrase: "associated with homozygosity"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0019904:Homozygosity [Organism Attribute]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for the delN296 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the tau gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.286: Ann. 

Phrase: "Ann."
Processing 00000000.tx.287: Neurol., 49, 263267.[CrossRef][ISI][Medline] Rademakers, R., Cruts, M. and Van Broeckhoven, C. 

Phrase: "Neurol.,"

Phrase: "49,"

Phrase: "263267."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rademakers,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cruts,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.288: (2004) The role of tau (MAPT) in frontotemporal dementia and related tauopathies. 

Phrase: "(2004"

Phrase: ")"

Phrase: "The role of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "(MAPT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1446659:MAPT [Gene or Genome]

Phrase: ")"

Phrase: "in frontotemporal dementia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0236642:frontotemporal dementia [Disease or Syndrome]
  1000   C0338451:Frontotemporal dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "related tauopathies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0949664:Tauopathies [Disease or Syndrome]
Processing 00000000.tx.289: Hum. 

Phrase: "Hum."
Processing 00000000.tx.290: Mutat., 24, 277295.[CrossRef][ISI][Medline] Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E. and Hutton, M. 

Phrase: "Mutat.,"

Phrase: "24,"

Phrase: "277295."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Litvan,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Adamson,"

Phrase: "J.,"

Phrase: "Dickson,"

Phrase: "D."

Phrase: ","

Phrase: "Perez-Tur,"

Phrase: "J.,"

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Lynch,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bigio,"

Phrase: "E."

Phrase: "and"

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.291: (1999) Association of an extended haplotype in the tau gene with progressive supranuclear palsy. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Association of an extended haplotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "in the tau gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "with progressive supranuclear palsy."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]
Processing 00000000.tx.292: Hum. 

Phrase: "Hum."
Processing 00000000.tx.293: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.294: Genet., 8, 711715.[Abstract/Free FullText] Oliveira, S.A., Scott, W.K., Zhang, F., Stajich, J.M., Fujiwara, K., Hauser, M., Scott, B.L., Pericak-Vance, M.A., Vance, J.M. and Martin, E.R. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "711715."

Phrase: "[Abstract/Free FullText"

Phrase: "] Oliveira,"

Phrase: "S.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Scott,"

Phrase: "W.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Zhang,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Stajich,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Fujiwara,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hauser,"

Phrase: "M."

Phrase: ","

Phrase: "Scott,"

Phrase: "B.L., Pericak-Vance,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Vance,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Martin,"

Phrase: "E.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.295: (2004) Linkage disequilibrium and haplotype tagging polymorphisms in the Tau H1 haplotype. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "and"

Phrase: "haplotype tagging polymorphisms in the Tau H1 haplotype."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0032529:polymorphisms [Genetic Function]
   711 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.296: Neurogenetics, 5, 147155.[CrossRef][ISI][Medline] Pastor, P., Ezquerra, M., Perez, J.C., Chakraverty, S., Norton, J., Racette, B.A., McKeel, D., Perlmutter, J.S., Tolosa, E. and Goate, A.M. 

Phrase: "Neurogenetics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597047:Neurogenetics [Biomedical Occupation or Discipline]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "147155."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pastor,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0684012:pastor [Professional or Occupational Group]
   928 E C1555897:Pastoral [Intellectual Product]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ezquerra,"

Phrase: "M."

Phrase: ","

Phrase: "Perez,"

Phrase: "J.C., Chakraverty,"

Phrase: "S."

Phrase: ","

Phrase: "Norton,"

Phrase: "J.,"

Phrase: "Racette,"

Phrase: "B.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "McKeel,"

Phrase: "D."

Phrase: ","

Phrase: "Perlmutter,"

Phrase: "J.S.,"

Phrase: "Tolosa,"

Phrase: "E."

Phrase: "and"

Phrase: "Goate,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.297: (2004) Novel haplotypes in 17q21 are associated with progressive supranuclear palsy. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Novel haplotypes in 17q21"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0018591:Haplotypes [Organism Attribute]

Phrase: "are"

Phrase: "associated with progressive supranuclear palsy."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   862   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   806   C0270920:Supranuclear palsy [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   760   C0205329:Progressive [Functional Concept]
   760   C0522224:Palsy [Finding]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.298: Ann. 

Phrase: "Ann."
Processing 00000000.tx.299: Neurol., 56, 249258.[CrossRef][ISI][Medline] Pittman, A.M., Myers, A.J., Duckworth, J., Bryden, L., Hanson, M., Abou-Sleiman, P., Wood, N.W., Hardy, J., Lees, A. and de Silva, R. 

Phrase: "Neurol.,"

Phrase: "56,"

Phrase: "249258."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pittman,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Myers,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "Duckworth,"

Phrase: "J.,"

Phrase: "Bryden,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hanson,"

Phrase: "M."

Phrase: ","

Phrase: "Abou-Sleiman,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "N.W., Hardy,"

Phrase: "J.,"

Phrase: "Lees,"

Phrase: "A."

Phrase: "and"

Phrase: "de Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   789   C0144237:Silvan [Organic Chemical]
   768 E C0043217:Wood [Substance]
   768 E C0442548:Woods [Geographic Area]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.300: (2004) The structure of the tau haplotype in controls and in progressive supranuclear palsy. 

Phrase: "(2004"

Phrase: ")"

Phrase: "The structure of the tau haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:Structure [Spatial Concept]

Phrase: "in controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "and in progressive supranuclear palsy."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   806   C0270920:Supranuclear palsy [Disease or Syndrome]
   770   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   760   C0205329:Progressive [Functional Concept]
   760   C0522224:Palsy [Finding]
   760   C1515981:And [Idea or Concept]
Processing 00000000.tx.301: Hum. 

Phrase: "Hum."
Processing 00000000.tx.302: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.303: Genet., 13, 12671274.[Abstract/Free FullText] Conrad, C., Andreadis, A., Trojanowski, J.Q., Dickson, D.W., Kang, D., Chen, X., Wiederholt, W., Hansen, L., Masliah, E., Thal, L.J. etal. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "13,"

Phrase: "12671274."

Phrase: "[Abstract/Free FullText"

Phrase: "] Conrad,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Andreadis,"

Phrase: "A.,"

Phrase: "Trojanowski,"

Phrase: "J.Q., Dickson,"

Phrase: "D.W.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kang,"

Phrase: "D."

Phrase: ","

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "X.,"

Phrase: "Wiederholt,"

Phrase: "W.,"

Phrase: "Hansen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Thal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039736:THAL [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "L.J. etal."
Processing 00000000.tx.304: (1997) Genetic evidence for the involvement of tau in progressive supranuclear palsy. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Genetic evidence for the involvement of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in progressive supranuclear palsy."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]
Processing 00000000.tx.305: Ann. 

Phrase: "Ann."
Processing 00000000.tx.306: Neurol., 41, 277281.[CrossRef][ISI][Medline] Higgins, J.J., Golbe, L.I., De Biase, A., Jankovic, J., Factor, S.A. and Adler, R.L. 

Phrase: "Neurol.,"

Phrase: "41,"

Phrase: "277281."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Higgins,"

Phrase: "J.J.,"

Phrase: "Golbe,"

Phrase: "L.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "De Biase,"

Phrase: "A.,"

Phrase: "Jankovic,"

Phrase: "J.,"

Phrase: "Factor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "S.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Adler,"

Phrase: "R.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.307: (2000) An extended 5'-tau susceptibility haplotype in progressive supranuclear palsy. 

Phrase: "(2000"

Phrase: ")"

Phrase: "An extended 5'-tau susceptibility haplotype in progressive supranuclear palsy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0018591:Haplotype [Organism Attribute]
Processing 00000000.tx.308: Neurology, 55, 13641367.[Abstract/Free FullText] Morris, H.R., Janssen, J.C., Bandmann, O., Daniel, S.E., Rossor, M.N., Lees, A.J. and Wood, N.W. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "13641367."

Phrase: "[Abstract/Free FullText"

Phrase: "] Morris,"

Phrase: "H.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Janssen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331842:Janssen [Health Care Related Organization]

Phrase: "J.C., Bandmann,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Daniel,"

Phrase: "S."

Phrase: "E.,"

Phrase: "Rossor,"

Phrase: "M."

Phrase: "N., Lees,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "and"

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "N.W."
Processing 00000000.tx.309: (1999) The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases. 

Phrase: "(1999"

Phrase: ")"

Phrase: "The tau gene A0 polymorphism in progressive supranuclear palsy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0678951:gene polymorphism [Genetic Function]
   742   C0032529:Polymorphism [Genetic Function]
   742   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "related neurodegenerative diseases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   827   C0012634:Diseases [Disease or Syndrome]
   755 E C1836721:MALS [Finding]
   755 E C3538764:MALS [Gene or Genome]
   755 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.310: J. 

Phrase: "J."
Processing 00000000.tx.311: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.312: Neurosurg. 

Phrase: "Neurosurg."
Processing 00000000.tx.313: Psychiatry, 66, 665667.[Abstract/Free FullText] Oliva, R., Tolosa, E., Ezquerra, M., Molinuevo, J.L., Valldeoriola, F., Burguera, J., Calopa, M., Villa, M. and Ballesta, F. 

Phrase: "Psychiatry,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "66,"

Phrase: "665667."

Phrase: "[Abstract/Free FullText"

Phrase: "] Oliva,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0228539:oliva [Body Part, Organ, or Organ Component]
  1000   C0228540:Oliva [Body Part, Organ, or Organ Component]
  1000   C0262254:oliva [Body Part, Organ, or Organ Component]
  1000   C1020282:Oliva [Eukaryote]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tolosa,"

Phrase: "E.,"

Phrase: "Ezquerra,"

Phrase: "M."

Phrase: ","

Phrase: "Molinuevo,"

Phrase: "J.L., Valldeoriola,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Burguera,"

Phrase: "J.,"

Phrase: "Calopa,"

Phrase: "M."

Phrase: ","

Phrase: "Villa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1188484:Villa [Eukaryote]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Ballesta,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.314: (1998) Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Significant changes in the tau A0"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "A3 alleles in progressive supranuclear palsy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Alleles [Gene or Genome]

Phrase: "and"

Phrase: "improved genotyping by silver detection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1285573:Genotyping [Laboratory Procedure]
Processing 00000000.tx.315: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.316: Neurol., 55, 11221124.[Abstract/Free FullText] Di Maria, E., Tabaton, M., Vigo, T., Abbruzzese, G., Bellone, E., Donati, C., Frasson, E., Marchese, R., Montagna, P., Munoz, D.G. etal. 

Phrase: "Neurol.,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "11221124."

Phrase: "[Abstract/Free FullText"

Phrase: "] Di Maria,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0019944:Mare [Mammal]
   827   C1422420:MARE [Gene or Genome]

Phrase: "E.,"

Phrase: "Tabaton,"

Phrase: "M."

Phrase: ","

Phrase: "Vigo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Abbruzzese,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bellone,"

Phrase: "E.,"

Phrase: "Donati,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Frasson,"

Phrase: "E.,"

Phrase: "Marchese,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Montagna,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Munoz,"

Phrase: "D."

Phrase: "G. etal."
Processing 00000000.tx.317: (2000) Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Corticobasal degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0393570:Corticobasal degeneration [Disease or Syndrome]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a common genetic background with progressive supranuclear palsy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   744   C0314603:Genetic [Functional Concept]
   744   C1706907:Background [Conceptual Entity]
Processing 00000000.tx.318: Ann. 

Phrase: "Ann."
Processing 00000000.tx.319: Neurol., 47, 374377.[CrossRef][ISI][Medline] Houlden, H., Baker, M., Morris, H.R., MacDonald, N., Pickering-Brown, S., Adamson, J., Lees, A.J., Rossor, M.N., Quinn, N.P., Kertesz, A. etal. 

Phrase: "Neurol.,"

Phrase: "47,"

Phrase: "374377."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Morris,"

Phrase: "H.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "MacDonald,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Pickering-Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "S."

Phrase: ","

Phrase: "Adamson,"

Phrase: "J.,"

Phrase: "Lees,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "Rossor,"

Phrase: "M."

Phrase: "N., Quinn,"

Phrase: "N.P.,"

Phrase: "Kertesz,"

Phrase: "A. etal."
Processing 00000000.tx.320: (2001) Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Corticobasal degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0393570:Corticobasal degeneration [Disease or Syndrome]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "and"

Phrase: "progressive supranuclear palsy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a common tau haplotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotype [Organism Attribute]
Processing 00000000.tx.321: Neurology, 56, 17021706.[Abstract/Free FullText] Farrer, M., Skipper, L., Berg, M., Bisceglio, G., Hanson, M., Hardy, J., Adam, A., Gwinn-Hardy, K. and Aasly, J. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "56,"

Phrase: "17021706."

Phrase: "[Abstract/Free FullText"

Phrase: "] Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Skipper,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Berg,"

Phrase: "M."

Phrase: ","

Phrase: "Bisceglio,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hanson,"

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Adam,"

Phrase: "A.,"

Phrase: "Gwinn-Hardy,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Aasly,"

Phrase: "J."
Processing 00000000.tx.322: (2002) The tau H1 haplotype is associated with Parkinson's disease in the Norwegian population. 

Phrase: "(2002"

Phrase: ")"

Phrase: "The tau H1 haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotype [Organism Attribute]

Phrase: "is"

Phrase: "associated with Parkinson's disease"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "in the Norwegian population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.323: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.324: Lett., 322, 8386.[CrossRef][ISI][Medline] Skipper, L., Wilkes, K., Toft, M., Baker, M., Lincoln, S., Hulihan, M., Ross, O.A., Hutton, M., Aasly, J. and Farrer, M. 

Phrase: "Lett.,"

Phrase: "322,"

Phrase: "8386."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Skipper,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Wilkes,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Toft,"

Phrase: "M."

Phrase: ","

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Hulihan,"

Phrase: "M."

Phrase: ","

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "O.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0029408:o a [Disease or Syndrome]
   861   C0439114:O NOS [Intellectual Product]

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Aasly,"

Phrase: "J."

Phrase: "and"

Phrase: "Farrer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.325: (2004) Linkage disequilibrium and association of MAPT H1 in Parkinson disease. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "and"

Phrase: "association of MAPT H1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "in Parkinson disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.326: Am. 

Phrase: "Am."
Processing 00000000.tx.327: J. 

Phrase: "J."
Processing 00000000.tx.328: Hum. 

Phrase: "Hum."
Processing 00000000.tx.329: Genet., 75, 669677.[CrossRef][ISI][Medline] Stefansson, H., Helgason, A., Thorleifsson, G., Steinthorsdottir, V., Masson, G., Barnard, J., Baker, A., Jonasdottir, A., Ingason, A., Gudnadottir, V.G. etal. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "75,"

Phrase: "669677."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stefansson,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Helgason,"

Phrase: "A.,"

Phrase: "Thorleifsson,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Steinthorsdottir,"

Phrase: "V.,"

Phrase: "Masson,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Barnard,"

Phrase: "J.,"

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "A.,"

Phrase: "Jonasdottir,"

Phrase: "A.,"

Phrase: "Ingason,"

Phrase: "A.,"

Phrase: "Gudnadottir,"

Phrase: "V.G. etal."
Processing 00000000.tx.330: (2005) A common inversion under selection in Europeans. 

Phrase: "(2005"

Phrase: ")"

Phrase: "A common inversion under selection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021943:Inversion [Cell or Molecular Dysfunction]
   760   C0021945:Inversion [Anatomical Abnormality]
   760   C1705687:Inversion [Cell or Molecular Dysfunction]
   760   C2349984:Inversion [Spatial Concept]

Phrase: "in Europeans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0239307:European [Population Group]
   966   C1535514:European [Population Group]
Processing 00000000.tx.331: Nat. 

Phrase: "Nat."
Processing 00000000.tx.332: Genet., 37, 129137.[CrossRef][ISI][Medline] Cruts, M., Rademakers, R., Gijselinck, I., van der, Z.J., Dermaut, B., De Pooter, T., De Rijk, P., Del Favero, J. and Van Broeckhoven, C. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "37,"

Phrase: "129137."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Rademakers,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gijselinck,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "van der,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "Z.J.,"

Phrase: "Dermaut,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "De Pooter,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "De Rijk,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Del Favero,"

Phrase: "J."

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.333: (2005) Genomic architecture of human 17q21 linked to frontotemporal dementia uncovers a highly homologous family of low copy repeats in the tau region. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Genomic architecture of human 17q21"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003737:Architecture [Occupation or Discipline]

Phrase: "linked to frontotemporal dementia"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0236642:frontotemporal dementia [Disease or Syndrome]
   833   C0338451:Frontotemporal dementia [Disease or Syndrome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "uncovers"

Phrase: "a highly homologous family of low copy repeats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0015576:Family [Family Group]
   744   C1704727:Family [Conceptual Entity]

Phrase: "in the tau region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.334: Hum. 

Phrase: "Hum."
Processing 00000000.tx.335: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.336: Genet, 14, 17531762.[Abstract/Free FullText] Rademakers, R., Pals, P., Lohmann, E., Durr, A., Engelborghs, S., De Pooter, T., Van den Broeck, M., Camuzat, A., Nuytemans, K., Pickut, B.A., Cruts, M., De Deyn, P.P., Cras, P., Brice, A. and Van Broeckhoven, C. 

Phrase: "Genet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "14,"

Phrase: "17531762."

Phrase: "[Abstract/Free FullText"

Phrase: "] Rademakers,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Pals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030360:PALS [Disease or Syndrome]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lohmann,"

Phrase: "E.,"

Phrase: "Durr,"

Phrase: "A.,"

Phrase: "Engelborghs,"

Phrase: "S."

Phrase: ","

Phrase: "De Pooter,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Van den Broeck,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "M."

Phrase: ","

Phrase: "Camuzat,"

Phrase: "A.,"

Phrase: "Nuytemans,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Pickut,"

Phrase: "B.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "De Deyn,"

Phrase: "P.P.,"

Phrase: "Cras,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Brice,"

Phrase: "A."

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.337: High-density SNP haplotyping in two independent Caucasian PD association samples implicates tau splicing in early-onset Parkinson's disease susceptibility. 

Phrase: "High-density SNP haplotyping in two independent Caucasian PD association samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   703   C0018591:Haplotype [Organism Attribute]

Phrase: "implicates"

Phrase: "tau splicing in early-onset Parkinson's disease susceptibility."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035687:Splicing [Genetic Function]
   744   C2610186:splicing [Genetic Function]
Processing 00000000.tx.338: Hum. 

Phrase: "Hum."
Processing 00000000.tx.339: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.340: Genet, in review. 

Phrase: "Genet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "in review."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]
Processing 00000000.tx.341: Andreadis, A., Wagner, B.K., Broderick, J.A. and Kosik, K.S. 

Phrase: "Andreadis,"

Phrase: "A.,"

Phrase: "Wagner,"

Phrase: "B.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Broderick,"

Phrase: "J."

Phrase: "A."

Phrase: "and"

Phrase: "Kosik,"

Phrase: "K.S."
Processing 00000000.tx.342: (1996) A tau promoter region without neuronal specificity. 

Phrase: "(1996"

Phrase: ")"

Phrase: "A tau promoter region without neuronal specificity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0017446:Region [Geographic Area]
   748   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205147:Region [Spatial Concept]
Processing 00000000.tx.343: J. 

Phrase: "J."
Processing 00000000.tx.344: Neurochem., 66, 22572263.[ISI][Medline] Pittman, A.M., Myers, A.J., Abou-Sleiman, P., Fung, H.C., Kaleem, M., Marlowe, L., Duckworth, J., Leung, D., Williams, D., Kilford, L. etal. 

Phrase: "Neurochem.,"

Phrase: "66,"

Phrase: "22572263."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pittman,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Myers,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "Abou-Sleiman,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Fung,"

Phrase: "H.C.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kaleem,"

Phrase: "M."

Phrase: ","

Phrase: "Marlowe,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Duckworth,"

Phrase: "J.,"

Phrase: "Leung,"

Phrase: "D."

Phrase: ","

Phrase: "Williams,"

Phrase: "D."

Phrase: ","

Phrase: "Kilford,"

Phrase: "L. etal."
Processing 00000000.tx.345: (2005) Linkage disequilibrium fine-mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Linkage disequilibrium fine-mapping"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1517888:Linkage Disequilibrium Mapping [Molecular Biology Research Technique]
   902   C0008630:Linkage Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   812   C1283195:Mapping [Activity]

Phrase: "and"

Phrase: "haplotype association analysis of the tau gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "in progressive supranuclear palsy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "and"

Phrase: "corticobasal degeneration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0393570:Corticobasal degeneration [Disease or Syndrome]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]
Processing 00000000.tx.346: J. 

Phrase: "J."
Processing 00000000.tx.347: Med. 

Phrase: "Med."
Processing 00000000.tx.348: Genet, in press. 

Phrase: "Genet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "in press."
Processing 00000000.tx.349: Bing, Z., Reddy, S.A., Ren, Y., Qin, J. and Liao, W.S. 

Phrase: "Bing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596170:bing [Mental or Behavioral Dysfunction]

Phrase: "Z.,"

Phrase: "Reddy,"

Phrase: "S.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Ren,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022646:Ren [Body Part, Organ, or Organ Component]
  1000   C1419338:REN [Gene or Genome]
  1000   C1427479:REN [Gene or Genome]

Phrase: "Y.,"

Phrase: "Qin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812297:QIN [Gene or Genome]
  1000   C1705148:QIN [Gene or Genome]

Phrase: "J."

Phrase: "and"

Phrase: "Liao,"

Phrase: "W.S."
Processing 00000000.tx.350: (1999) Purification and characterization of the serum amyloid A3 enhancer factor. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "characterization of the serum amyloid A3 enhancer factor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880022:Characterization [Activity]
Processing 00000000.tx.351: J. 

Phrase: "J."
Processing 00000000.tx.352: Biol. 

Phrase: "Biol."
Processing 00000000.tx.353: Chem., 274, 2464924656.[Abstract/Free FullText] Kang, H.C., Chae, J.H., Kim, B.S., Han, S.Y., Kim, S.H., Auh, C.K., Yang, S.I. and Kim, C.G. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "274,"

Phrase: "2464924656."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kang,"

Phrase: "H.C.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Chae,"

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kim,"

Phrase: "B.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "S."

Phrase: "Y.,"

Phrase: "Kim,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Auh,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0066377:AUH [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332121:AUH [Gene or Genome]

Phrase: "C.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "S.I."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Kim,"

Phrase: "C.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.354: (2004) Transcription factor CP2 is involved in activating mBMP4 in mouse mesenchymal stem cells. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Transcription factor CP2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1456377:TRANSCRIPTION FACTOR CP2 [Gene or Genome]
           CP2
  1000   C3539874:Transcription Factor CP2 [Amino Acid, Peptide, or Protein]
   734   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "involved in activating mBMP4"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1314939:Involved [Functional Concept]
   770   C1879547:activating [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "in mouse mesenchymal stem cells."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   923   C1257975:Mesenchymal Stem Cells [Cell]
           Mesenchymal cell
   906   C1514965:Mouse Stem Cell [Cell]
   861   C0038250:Stem cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0242767:Stem [Plant]
   812   C1186763:Stem [Body Part, Organ, or Organ Component]
   812   C1513143:Mesenchymal [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0162415:Mesenchyma [Embryonic Structure]
Processing 00000000.tx.355: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.356: Cells, 17, 454461.[ISI][Medline] Lau, K.F., Miller, C.C., Anderton, B.H. and Shaw, P.C. 

Phrase: "Cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "17,"

Phrase: "454461."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lau,"

Phrase: "K.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Anderton,"

Phrase: "B.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Shaw,"

Phrase: "P.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.357: (1999) Molecular cloning and characterization of the human glycogen synthase kinase-3beta promoter. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Molecular cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "characterization of the human glycogen synthase kinase-3beta promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1880022:Characterization [Activity]
Processing 00000000.tx.358: Genomics, 60, 121128.[CrossRef][ISI][Medline] Kwok, J.B., Teber, E.T., Loy, C., Hallupp, M., Nicholson, G., Mellick, G.D., Buchanan, D.D., Silburn, P.A. and Schofield, P.R. 

Phrase: "Genomics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "60,"

Phrase: "121128."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kwok,"

Phrase: "J.B.,"

Phrase: "Teber,"

Phrase: "E.T.,"

Phrase: "Loy,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hallupp,"

Phrase: "M."

Phrase: ","

Phrase: "Nicholson,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mellick,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Buchanan,"

Phrase: "D.D.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0112081:D-D [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Silburn,"

Phrase: "P.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Schofield,"

Phrase: "P.R."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205090:R- [Spatial Concept]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.359: (2004) Tau haplotypes regulate transcription and are associated with Parkinson's disease. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Tau haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "regulate"

Phrase: "transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "and"

Phrase: "are"

Phrase: "associated with Parkinson's disease."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.360: Ann. 

Phrase: "Ann."
Processing 00000000.tx.361: Neurol., 55, 329334.[CrossRef][ISI][Medline] Josephs, K.A. and Dickson, D.W. 

Phrase: "Neurol.,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "329334."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Josephs,"

Phrase: "K.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Dickson,"

Phrase: "D.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.362: (2003) Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Diagnostic accuracy of progressive supranuclear palsy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0598285:Diagnostic Accuracy [Qualitative Concept]
   753   C0443131:Accuracy [Qualitative Concept]

Phrase: "in the Society"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037455:society [Organization]

Phrase: "for Progressive Supranuclear Palsy brain bank."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0442598:Bank [Manufactured Object]
   804   C0872261:Bank [Manufactured Object]
   717   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
Processing 00000000.tx.363: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.364: Disord., 18, 10181026.[CrossRef][ISI][Medline] Caselli, R.J., Osborne, D., Reiman, E.M., Hentz, J.G., Barbieri, C.J., Saunders, A.M., Hardy, J., Graff-Radford, N.R., Hall, G.R. and Alexander, G.E. 

Phrase: "Disord.,"

Phrase: "18,"

Phrase: "10181026."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Caselli,"

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Osborne,"

Phrase: "D."

Phrase: ","

Phrase: "Reiman,"

Phrase: "E.M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hentz,"

Phrase: "J.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Barbieri,"

Phrase: "C.J.,"

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Graff-Radford,"

Phrase: "N.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hall,"

Phrase: "G.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Alexander,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551702:Alexander [Population Group]

Phrase: "G.E."
Processing 00000000.tx.365: (2001) Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication study. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Preclinical cognitive decline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: "in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0019904:Homozygotes [Organism Attribute]

Phrase: ":"

Phrase: "a replication study."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0681825:replication study [Research Activity]
   861   C0557651:Study [Manufactured Object]
   861   C0598312:Replication [Genetic Function]
   861   C1883725:replication [Qualitative Concept]
   861   C2603343:Study [Research Activity]
   789 E C0205173:Replicate [Functional Concept]
   789 E C0205341:Replicate [Functional Concept]
Processing 00000000.tx.366: J. 

Phrase: "J."
Processing 00000000.tx.367: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.368: Sci., 189, 9398.[CrossRef][ISI][Medline] Caselli, R.J., Hentz, J.G., Osborne, D., Graff-Radford, N.R., Barbieri, C.J., Alexander, G.E., Hall, G.R., Reiman, E.M., Hardy, J. and Saunders, A.M. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "189,"

Phrase: "9398."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Caselli,"

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hentz,"

Phrase: "J.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Osborne,"

Phrase: "D."

Phrase: ","

Phrase: "Graff-Radford,"

Phrase: "N.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Barbieri,"

Phrase: "C.J.,"

Phrase: "Alexander,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551702:Alexander [Population Group]

Phrase: "G.E.,"

Phrase: "Hall,"

Phrase: "G.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Reiman,"

Phrase: "E.M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hardy,"

Phrase: "J."

Phrase: "and"

Phrase: "Saunders,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.369: (2002) Apolipoprotein E and intellectual achievement. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "intellectual achievement."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001072:Achievement [Behavior]
Processing 00000000.tx.370: J. 

Phrase: "J."
Processing 00000000.tx.371: Am. 

Phrase: "Am."
Processing 00000000.tx.372: Geriatr. 

Phrase: "Geriatr."
Processing 00000000.tx.373: Soc., 50, 4954.[CrossRef][ISI][Medline] Engelborghs, S., Dermaut, B., Goeman, J., Saerens, J., Marien, P., Pickut, B.A., Van den, B.M., Serneels, S., Cruts, M., Van Broeckhoven, C. etal. 

Phrase: "Soc.,"

Phrase: "50,"

Phrase: "4954."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Engelborghs,"

Phrase: "S."

Phrase: ","

Phrase: "Dermaut,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Goeman,"

Phrase: "J.,"

Phrase: "Saerens,"

Phrase: "J.,"

Phrase: "Marien,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Pickut,"

Phrase: "B.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Van den,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178587:DEN [Quantitative Concept]

Phrase: "B.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2347469:/B [Quantitative Concept]

Phrase: "Serneels,"

Phrase: "S."

Phrase: ","

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Van Broeckhoven,"

Phrase: "C. etal."
Processing 00000000.tx.374: (2003) Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Prospective Belgian study of neurodegenerative"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0033522:prospective study [Research Activity]
   797   C1709709:Prospective Study [Research Activity]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "vascular dementia"
Meta Candidates (Total=14; Excluded=8; Pruned=0; Remaining=6)
  1000   C0011269:Dementia, Vascular [Disease or Syndrome]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   861   C1558950:VASCULAR [Finding]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
   745 E C0333275:Bloody [Qualitative Concept]

Phrase: ":"

Phrase: "APOE genotype effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.375: J. 

Phrase: "J."
Processing 00000000.tx.376: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.377: Neurosurg. 

Phrase: "Neurosurg."
Processing 00000000.tx.378: Psychiatry, 74, 11481151.[Abstract/Free FullText] Weckx, S., De Rijk, P., Van Broeckhoven, C. and Del Favero, J. 

Phrase: "Psychiatry,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "74,"

Phrase: "11481151."

Phrase: "[Abstract/Free FullText"

Phrase: "] Weckx,"

Phrase: "S."

Phrase: ","

Phrase: "De Rijk,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Van Broeckhoven,"

Phrase: "C."

Phrase: "and"

Phrase: "Del Favero,"

Phrase: "J."
Processing 00000000.tx.379: (2004) SNPbox, a modular software package for large scale primer design. 

Phrase: "(2004"

Phrase: ")"

Phrase: "SNPbox,"

Phrase: "a modular software package for large scale primer design."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0013194:Package [Medical Device]
   742   C2700580:Package [Manufactured Object]
Processing 00000000.tx.380: Bioinformatics, 21, 385387.[CrossRef][ISI][Medline] Weckx, S., Del Favero, J., Rademakers, R., Claes, L., Cruts, M., De Jonghe, P., Van Broeckhoven, C. and De Rijk, P. 

Phrase: "Bioinformatics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1140694:Bio-Informatics [Biomedical Occupation or Discipline]

Phrase: "21,"

Phrase: "385387."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Weckx,"

Phrase: "S."

Phrase: ","

Phrase: "Del Favero,"

Phrase: "J.,"

Phrase: "Rademakers,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Claes,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "De Jonghe,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Van Broeckhoven,"

Phrase: "C."

Phrase: "and"

Phrase: "De Rijk,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.381: (2005) novoSNP, a novel computational tool for sequence variation discovery. 

Phrase: "(2005"

Phrase: ")"

Phrase: "novoSNP,"

Phrase: "a novel computational tool for sequence variation discovery."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0336791:Tool [Manufactured Object]
   744   C2827396:Tool [Manufactured Object]
Processing 00000000.tx.382: Genome Res., 15, 436442.[Abstract/Free FullText] Terwilliger, J. and Ott, J. 

Phrase: "Genome Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "15,"

Phrase: "436442."

Phrase: "[Abstract/Free FullText"

Phrase: "] Terwilliger,"

Phrase: "J."

Phrase: "and"

Phrase: "Ott,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1423088:OTT [Gene or Genome]
  1000   C3273338:OTT [Gene or Genome]

Phrase: "J."
Processing 00000000.tx.383: (1994) Handbook of Human Genetic Linkage. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Handbook of Human Genetic Linkage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596654:handbook [Intellectual Product]
Processing 00000000.tx.384: John Hopkins University Press, Baltimore, MD. 

Phrase: "John Hopkins University Press,"

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "MD."
Processing 00000000.tx.385: Schaid, D.J., Rowland, C.M., Tines, D.E., Jacobson, R.M. and Poland, G.A. 

Phrase: "Schaid,"

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Rowland,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Tines,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456171:Tines [Medical Device]

Phrase: "D."

Phrase: "E.,"

Phrase: "Jacobson,"

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Poland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032356:Poland [Geographic Area]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.386: (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Score tests for association"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   816   C0237855:score test [Qualitative Concept]
   816   C0237856:score test [Educational Activity]
   770   C0022885:Tests [Laboratory Procedure]
   770   C0392366:Tests [Intellectual Product]
   737 E C0039593:Test [Functional Concept]

Phrase: "between traits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0599883:traits [Organism Attribute]
  1000   C1427926:TRAITS [Gene or Genome]

Phrase: "and"

Phrase: "haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "when"

Phrase: "linkage phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "is"

Phrase: "ambiguous."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1549102:Ambiguous [Organism Attribute]
  1000   C3539086:Ambiguous [Intellectual Product]
   928 E C2346729:Ambiguity [Qualitative Concept]
Processing 00000000.tx.387: Am. 

Phrase: "Am."
Processing 00000000.tx.388: J. 

Phrase: "J."
Processing 00000000.tx.389: Hum. 

Phrase: "Hum."
Processing 00000000.tx.390: Genet., 70, 425434.[CrossRef][ISI][Medline] Quandt, K., Frech, K., Karas, H., Wingender, E. and Werner, T. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "70,"

Phrase: "425434."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Quandt,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Frech,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Karas,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wingender,"

Phrase: "E."

Phrase: "and"

Phrase: "Werner,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.391: (1995) MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. 

Phrase: "(1995"

Phrase: ")"

Phrase: "MatInd"

Phrase: "and"

Phrase: "MatInspector"

Phrase: ":"

Phrase: "new fast"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015663:Fast [Finding]
   861   C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "versatile tools for detection of consensus matches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0336791:Tool [Manufactured Object]
   714   C2827396:Tool [Manufactured Object]

Phrase: "in nucleotide sequence data."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0004793:Nucleotide Sequence [Nucleotide Sequence]
Processing 00000000.tx.392: Nucleic Acids Res., 23, 48784884.[Abstract]

Phrase: "Nucleic Acids Res.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "48784884."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"

